"### LOVD-version 2000-360 ### Variants/Patients ### Do not remove this line, unless importing in versions before 2.0-04 ###"																																					
{{ Variant/Exon }}	{{ Variant/Nucleotide }}	{{ Variant/Codon }}	{{ Variant/Nucl_change }}	{{ Variant/AA_change }}	{{ Variant/DNA_published }}	{{ Variant/DNA }}	{{ Variant/Protein }}	{{ Variant/Assay }}	{{ Variant/Interaction }}	{{ Variant/Assay_result }}	{{ Variant/Reference }}	{{ Variant/Remarks }}	{{ Variant/DBID }}	{{ Variant/RNA }}	{{ Patient/Patient_ID }}	{{ Patient/Phenotype/Disease }}	{{ Patient/Times_Reported }}	{{ Patient/Remarks }}	{{ Patient/Detection/Template }}	{{ Patient/Detection/Technique }}	{{ Patient/Reference }}	{{ Patient/Remarks_Non_Public }}	{{ ID_variantid_ }}	{{ ID_patientid_ }}	{{ ID_allele_ }}	{{ ID_pathogenic_ }}	{{ ID_status_ }}	{{ ID_sort_ }}	{{ ID_submitterid_ }}	{{ ID_variant_created_by_ }}	{{ variant_created_date_ }}	{{ ID_variant_edited_by_ }}	{{ variant_edited_date_ }}	{{ ID_patient_created_by_ }}	{{ patient_created_date_ }}	{{ ID_patient_edited_by_ }}	{{ patient_edited_date_ }}
1	c.-40+1		G to A	not applicable	c.-40+1G>A	c.-40+1G>A	not applicable	"Embryonic stem cell assay, RNA analysis"	not applicable	strong functional effect	{PMID24395671:Bakker et al. (2014)}	Disruption of the original donor site of exon 1 and the use of an alternative donor site in the middle of exon 1 (BRCA2 c.-139)	BRCA2_00520		not applicable	in vitro	1						981	2531	0	77	9	0001_-999960_0000001	44	4	1/9/14 10:50	4	1/9/14 13:25	4	1/9/14 10:50		
1	188		G to A	-	IVS1+8G/A	c.-40+8G>A	?	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00001		cloned	in vitro	1						1	1456	0	55	9	0001_-999960_0000008	1	0	10/3/09 17:15			0	10/3/09 17:15		
1	203		G to C	-	203G/C	c.-26G>C	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00002		cloned	in vitro	1						2	1457	0	55	9	0001_-999974_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
2	189		ins A	-	IVS1-96insA	c.-39-96dup	?	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00003		cloned	in vitro	1						3	1458	0	55	9	0002_-999961_-999904	1	0	10/3/09 17:15			0	10/3/09 17:15		
2	189		-9 del3	-	IVS1-9del3	c.-39-7_-39-5del	?	mRNA analysis (RT-PCR)	Not Applicable	As wildtype control	{PMID17011978:Bonatti et al. (2006)}		BRCA2_00004		cloned	in vitro	1						4	1459	0	15	9	0002_-999961_-999993_-999961_-999995	1	0	10/3/09 17:15			0	10/3/09 17:15		
2	203		G to A	-	203G/A (5\\\' UTR)	c.-26G>A	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00005		cloned	in vitro	1						5	1460	0	55	9	0002_-999974_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
2	203		G to A	-	203G/A (5\\\' UTR)	c.-26G>A	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00005		cloned	in vitro	1						6	1461	0	15	9	0002_-999974_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
2	217		T to G	-	217T/G	c.-14T>G	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00006		cloned	in vitro	1						7	1462	0	15	9	0002_-999986_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
2	218		C to T	-	218C>T	c.-11C>T	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00007		cloned	in vitro	1						8	1463	0	55	9	0002_-999989_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
2	279	17	del AC	Stop29	279delAC	c.51_52del	p.Arg18LeufsX12	Cell viability (in BRCA-/- cells)	Not Applicable	As mutant control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00008		cloned	in vitro	1						9	1464	0	55	9	0002_0000051_0000000_0000052_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
2	281	18	G to A	Arg to His	R18H	c.53G>A	p.Arg18His	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18375895:Spurdle et al. (2008)}		BRCA2_00009		cloned	in vitro	1						10	1465	0	15	9	0002_0000053_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
2	295		+1 G to A	-	IVS2+1G>A	c.67+1G>A	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID17011978:Bonatti et al. (2006)}		BRCA2_00010		cloned	in vitro	1						11	1466	0	55	9	0002_0000067_0000001	1	0	10/3/09 17:15			0	10/3/09 17:15		
2	295		T to C	-	IVS2+2T/C	c.67+2T>C	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00011		cloned	in vitro	1						12	1467	0	55	9	0002_0000067_0000002	1	0	10/3/09 17:15			0	10/3/09 17:15		
2	295		+62 T to G	-	IVS2+62T/G	c.67+62T>G	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00012		cloned	in vitro	1						13	1468	0	15	9	0002_0000067_0000062	1	0	10/3/09 17:15			0	10/3/09 17:15		
2	295		+62 T to G	-	IVS2+62T/G	c.67+62T>G	?	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00012		cloned	in vitro	1						14	1469	0	55	9	0002_0000067_0000062	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	296	NA	delT	Not applicable	c.68-7delT	c.68-7delT	?	splicing reporter minigene/patient RNA analysis	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00538		cloned	in vitro	1						1009	2585	0	55	9	0003_0000068_-999993	0	4	2/19/14 14:34	4	2/19/14 21:57	4	2/19/14 14:34	4	2/19/14 21:56
3	296		-7 T to A	-	IVS2-7T>A	c.68-7T>A	?	cDNA analysis	Not Applicable	As mutant control	{PMID18693280:Vreeswijk et al. (2008)}		BRCA2_00013		cloned	in vitro	1						15	1470	0	55	9	0003_0000068_-999993	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	296	NA	T to A	Not applicable	c.68-7T>A	c.68-7T>A	?	splicing reporter minigene/patient RNA analysis	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00013		cloned	in vitro	1						1010	2586	0	55	9	0003_0000068_-999993	0	4	2/19/14 14:34	4	2/19/14 21:58	4	2/19/14 14:34		
3		25	G>A	Gly to Arg		c.73G>A	p.Gly25Arg	Embryonic stem cell assay	not applicable	Normal viability/increased sensitivity/reduced HR	{PMID22678057:Biswas et al. (2012)}		BRCA2_00545		Not applicable	in vitro	1						1022	2635	0	75	9	0003_0000073_0000000	10	4	2/19/14 21:42	4	2/19/14 21:59	4	2/19/14 21:42		
3	307	27	A to G	Ile to Val	I27V	c.79A>G	p.Ile27Val	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00014		cloned	in vitro	1						16	1471	0	95	9	0003_0000079_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3		31	T>C	Try to Arg		c.91T>C	p.Try31Arg	Embryonic stem cell assay	not applicable	no rescue ES cell lethality	{PMID22678057:Biswas et al. (2012)}		BRCA2_00546		not applicable	in vitro	1						1023	2636	0	75	9	0003_0000091_0000000	10	4	2/19/14 21:46	4	2/19/14 22:00	4	2/19/14 21:46		
3		31	G>T	Try to Cys		c.93G>T	p.Try31Cys	Embryonic stem cell assay	not applicable	No rescue ES cell lethality	{PMID22678057:Biswas et al. (2012)}		BRCA2_00547		not applicable	in vitro	1						1024	2637	0	75	9	0003_0000093_0000000	10	4	2/19/14 21:49	4	2/19/14 22:00	4	2/19/14 21:49		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00016		cloned	in vitro	1						18	1473	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Nuclear localisation	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00016		cloned	in vitro	1						19	1474	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID15290653:Goldgar et al. (2004)}		BRCA2_00016		cloned	in vitro	1						20	1475	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00016		cloned	in vitro	1						21	1476	0	55	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Co-occurrence with deleterious mutation	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00016		cloned	in vitro	1						22	1477	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Co-segregation in families	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00016		cloned	in vitro	1						23	1478	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00016		cloned	in vitro	1						24	1479	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00016		cloned	in vitro	1						25	1480	0	55	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID15290653:Goldgar et al. (2004)}		BRCA2_00016		cloned	in vitro	1						26	1481	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Survival assay with VC8 (after MMC treatment)	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00016		cloned	in vitro	1						27	1482	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Homology-directed repair assay	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00016		cloned	in vitro	1						28	1483	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Centrosome amplification	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00016		cloned	in vitro	1						29	1484	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00016		cloned	in vitro	1						30	1485	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Transcription activation in yeast (GAL4-fusions)	Not Applicable	As mutant control	{PMID09126734:Milner et al. (1997)}		BRCA2_00016		cloned	in vitro	1						31	1486	0	55	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	?	?	?	{PMID10699917:Spitzer et al. (2000)}		BRCA2_00016		cloned	in vitro	1						32	1487	0	55	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Co-immunoprecipitation	BRCA2:RPA	Predicted deleterious	{PMID12527904:Wong et al. (2003)}		BRCA2_00016		cloned	in vitro	1						33	1488	0	95	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Evolutionary conservation analysis	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00016		cloned	in vitro	1						34	1489	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Cell viability (in BRCA-/- cells)	Not Applicable	As wildtype control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00016		cloned	in vitro	1						35	1490	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00016		cloned	in vitro	1						36	1491	0	55	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	Family history	Not Applicable	Predicted neutral	{PMID19200354:Gomez-Garcia et al. (2009)}		BRCA2_00016		cloned	in vitro	1						37	1492	0	15	9	0003_0000125_0000000	1	0	10/3/09 17:15	4	8/20/10 16:37	0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	?	?	?	{PMID10506595:Turner et al. (1999)}		BRCA2_00016		cloned	in vitro	1						38	1493	0	55	9	0003_0000125_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	353	42	A to G	Tyr to Cys	Y42C	c.125A>G	p.Tyr42Cys	LOH analysis	Not Applicable	Loss of wildtype allele	{PMID20054658:Beristain et al. (2010)}		BRCA2_00016		Not applicable	in vitro	1						942	2462	0	55	9	0003_0000125_0000000	10	4	9/23/11 13:43	4	9/23/11 13:44	4	9/23/11 13:43		
3	373	49	G to T	Glu to Stop	E49X	c.145G>T	p.Glu49X	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00017		cloned	in vitro	1						39	1494	0	55	9	0003_0000145_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	373	49	G to T	Glu to X		c.145G>T	p.Asp23_Leu105del;p.E49X	ESEfinder/ESRsearch.Hybrid minigenes	-	ESE disruption. Exon 3 skipping	{PMID20215541:Sanz et al. (2010)}	"Skipping of exon 3 is almost total, but a small fraction of mRNA species with the c.145G>T change is present"	BRCA2_00017	r.68_316del	Va739	?	1						927	2386	0	95	9	0003_0000145_0000000	6	0	7/2/10 9:57	4	8/20/10 16:52	0	7/2/10 9:57		
3						c.156_157insAlu	ND	ND	ND	ND	{PMID16088935:Teugels et al. (2009)}		BRCA2_00518		S70F59	?	1						978	2527	11	95	9	0003_0000156_0000000_0000157_0000000	39	0	1/24/13 18:11	4	2/19/14 22:02	0	1/24/13 18:11		
3	395	56	A to C	Asn to Thr	N56T	c.167A>C	p.Asn56Thr	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00018		cloned	in vitro	1						40	1495	0	15	9	0003_0000167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	417	63	A to C	Lys to Asn	K63N	c.189A>C	p.Lys63Asn	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00019		cloned	in vitro	1						41	1496	0	95	9	0003_0000189_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	451	75	G to C	Ala to Pro	A75P	c.223G>C	p.Ala75Pro	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00020		cloned	in vitro	1						42	1497	0	15	9	0003_0000223_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	451	75	G to C	Ala to Pro	A75P	c.223G>C	p.Ala75Pro	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00020		cloned	in vitro	1						43	1498	0	55	9	0003_0000223_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	451	75	G to C	Ala to Pro	c.223G>C	c.223G>C	p.Ala75Pro	splicing reporter minigene/patient RNA analysis	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00020		cloned	in vitro	1						987	2563	0	55	9	0003_0000223_0000000	0	4	2/19/14 14:34	4	2/19/14 22:03	4	2/19/14 14:34		
3	459	77	T to G	Thr to Thr	T77T	c.231T>G	p.Thr77Thr	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00021		cloned	in vitro	1						44	1499	0	55	9	0003_0000231_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
3	316		G to C	-	c.316+5G>C	c.316+5G>C	?	mRNA analysis and splicing reporter minigene	Not Applicable	Predicted deleterious	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00015		cloned	in vitro	1						17	1472	0	95	9	0003_0000316_0000005	1	0	10/3/09 17:15			0	10/3/09 17:15		
4	550		-22 C to T	-	IVS3-22C/T	c.317-22C>T	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00023		cloned	in vitro	1						46	1501	0	15	9	0004_0000317_-999978	1	0	10/3/09 17:15			0	10/3/09 17:15		
4	550	108	A to C	Asn to His	N108H	c.322A>C	p.Asn108His	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00024		cloned	in vitro	1						47	1502	0	55	9	0004_0000322_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
4	550	108	A to C	Asn to His	N108H	c.322A>C	p.Asn108His	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00024		cloned	in vitro	1						48	1503	0	15	9	0004_0000322_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
4	653		A to G	-	IVS4+36A/G	c.425+36A>G	?	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00025		cloned	in vitro	1						49	1504	0	55	9	0004_0000425_0000036	1	0	10/3/09 17:15			0	10/3/09 17:15		
4	426		del5	-	IVS4-12del5	c.426-12_426-8del	p.?	mRNA analysis (RT-PCR)	Not Applicable	Predicted deleterious	{PMID19070627:Zhang et al. (2009)}		BRCA2_00022		cloned	in vitro	1						45	1500	0	95	9	0004_0000426_-999988_0000426_-999992	1	0	10/3/09 17:15			0	10/3/09 17:15		
5	654		-84 T to C	-	IVS4-84T/C	unclear	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00027		cloned	in vitro	1						51	1506	0	55	9	0005_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
5	654		-89 T to C	-	IVS4-89T/C	c.426-89T>C	?	?	?	?	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00028		cloned	in vitro	1						52	1507	0	55	9	0005_0000426_-999911	1	0	10/3/09 17:15			0	10/3/09 17:15		
5	654		-47 G to T	-	IVS4-47G/T	c.426-47G>T	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00026		cloned	in vitro	1						50	1505	0	15	9	0005_0000426_-999953	1	0	10/3/09 17:15			0	10/3/09 17:15		
5	667	143	C to T	Q to stop		c.439C>T	p.Pro143GlyfsX22	ESEfinder/ESRsearch. RT-PCR /hybrid minigenes	-	ESE disruption/ESS creation. Exon 5 skipping	{PMID20215541: Sanz et al. (2010)}		BRCA2_00487	r.426_475del	Va482	?	1	Three or more breast cancer cases in the family. Not available additional patients					926	2384	0	95	9	0005_0000439_0000000	6	0	7/1/10 15:17	4	8/20/10 16:53	0	7/1/10 15:17		
5	677	150	A to G	His to Arg	H150R	c.449A>G	p.His150Arg	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00029		cloned	in vitro	1						53	1508	0	55	9	0005_0000449_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
6	704		-2 A to G	-	IVS5-2A>G	c.476-2A>G	?	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00031		cloned	in vitro	1						55	1510	0	95	9	0006_0000476_-999998	1	0	10/3/09 17:15			0	10/3/09 17:15		
6	730	168	C to A	Pro to Thr	P168T	c.502C>A	p.Pro168Thr	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00033		cloned	in vitro	1						57	1512	0	15	9	0006_0000502_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
6	730	168	C to A	Pro to Thr	P168T	c.502C>A	p.Pro168Thr	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00033		cloned	in vitro	1						58	1513	0	95	9	0006_0000502_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
6	730	168	C to G	Pro to Ala	P168A	c.502C>G	p.Pro168Ala	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00032		cloned	in vitro	1						56	1511	0	95	9	0006_0000502_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
6	744	172	G to A	Lys to Lys	K172K	c.516G>A	p.Lys171Lys	cDNA analysis	Not Applicable	Predicted deleterious	{PMID19267246:Hansen et al. (2009)}		BRCA2_00036		cloned	in vitro	1						61	1516	0	95	9	0006_0000516_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
6	744	172	G to A	Lys to Lys	K172K	c.516G>A	p.Lys171Lys	mRNA analysis	Not Applicable	Predicted deleterious	{PMID19267246:Hansen et al. (2010)}	Skipping exon 6 and/or both exon 5 and 6	BRCA2_00036		not applicable	in vitro	1						929	2391	0	95	9	0006_0000516_0000000	10	0	10/26/10 12:54	4	10/29/10 9:51	0	10/26/10 12:54		
6	744		+1 G to A	-	IVS6+1G>A	c.516+1G>A	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID12759930:Claes et al. (2003)}		BRCA2_00035		cloned	in vitro	1						60	1515	0	55	9	0006_0000516_0000001	1	0	10/3/09 17:15			0	10/3/09 17:15		
6	513		C to T	-	c.516+14C>T	c.516+14C>T	?	mRNA analysis and splicing reporter minigene	Not Applicable	Predicted neutral	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00030		cloned	in vitro	1						54	1509	0	15	9	0006_0000516_0000014	1	0	10/3/09 17:15			0	10/3/09 17:15		
6	744		+18 T to C	-	IVS6+18T/C	c.516+18T>C	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00034		cloned	in vitro	1						59	1514	0	15	9	0006_0000516_0000018	1	0	10/3/09 17:15			0	10/3/09 17:15		
7	745		-19 C to T	-	IVS6-19C/T	unclear	?	mRNA analysis (RT-PCR)	Not Applicable	As wildtype control	{PMID16619214:Chen et al. (2006)}		BRCA2_00027		cloned	in vitro	1						62	1517	0	15	9	0007_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
7	745		-19 C to T	-	IVS6-19C/T	unclear	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00027		cloned	in vitro	1						63	1518	0	55	9	0007_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
7	745		-19 C to T	-	IVS6-19C/T	unclear	?	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00027		cloned	in vitro	1						64	1519	0	55	9	0007_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
7	745	NA	A to G	Not applicable	c.517-20A>G	c.517-20A>G	?	splicing reporter minigene/patient RNA analysis	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00539		cloned	in vitro	1						1011	2587	0	55	9	0007_0000517_-999980	0	4	2/19/14 14:34	4	2/19/14 22:03	4	2/19/14 14:34		
7	745		-4 C to G	-	IVS6-4C>G	c.517-4C>G	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00037		cloned	in vitro	1						65	1520	0	15	9	0007_0000517_-999996	1	0	10/3/09 17:15			0	10/3/09 17:15		
7	745	173	G to T	Gly to Cys	c.517G>T	c.517G>T	p.Gly173Cys	splicing reporter minigene	not applicable	major exon skipping	{PMID22962691:Gaildrat et al. (2012)}		BRCA2_00522		cloned	in vitro	1						988	2564	0	75	9	0007_0000517_0000000	0	4	2/19/14 14:34	4	2/19/14 22:04	4	2/19/14 14:34		
7	746	173	G to T	Gly to Val	G173V	c.518G>T	p.Gly173Val	"HR assay, LOH assay"	not applicable	"predicted neutral, no LOH"	{PMID21671020:Balia et al. (2011)}		BRCA2_00502		not applicable	in vitro	1						961	2509	0	35	9	0007_0000518_0000000	27	0	3/23/12 18:16	4	3/27/12 9:53	0	3/23/12 18:16		
7	748	174	C to T	Arg to Cys	c.520C>T	c.520C>T	p.Arg174Cys	splicing reporter minigene/patient RNA analysis	not applicable	major exon skipping	{PMID22962691:Gaildrat et al. (2012)}		BRCA2_00523		cloned	in vitro	1						989	2565	0	75	9	0007_0000520_0000000	0	4	2/19/14 14:34	4	2/19/14 22:05	4	2/19/14 14:34		
7	750	174	T to G	Arg to Arg	c.522T>G	c.522T>G	p.=	splicing reporter minigene	not applicable	No splicing defect	{PMID22962691:Gaildrat et al. (2012)}		BRCA2_00524		cloned	in vitro	1						990	2566	0	55	9	0007_0000522_0000000	0	4	2/19/14 14:34	4	2/19/14 22:05	4	2/19/14 14:34		
7	800	191	A to G	Asp to Gly	c.572A>G	c.572A>G	p.Asp191Gly	splicing reporter minigene	not applicable	major exon skipping	{PMID22962691:Gaildrat et al. (2012)}		BRCA2_00525		cloned	in vitro	1						991	2567	0	75	9	0007_0000572_0000000	0	4	2/19/14 14:34	4	2/19/14 22:06	4	2/19/14 14:34		
7	800	191	A to T	Asp to Val	D191V	c.572A>T	p.Asp191Val	"HR assay, LOH assay"	not applicable	"predicted pathogenic, no LOH"	{PMID21671020:Balia et al. (2011)}		BRCA2_00499		not applicable	in vitro	1						958	2506	0	75	9	0007_0000572_0000000	27	0	3/23/12 18:00	4	3/27/12 10:00	0	3/23/12 18:00		
7	809	194	G to A	Trp to X	809G>A	c.581G>A	p.Thp194X	"Mouse ES cell assay, RNA analysis"	not applicable	Partial rescue lethality;  HR as wt	{PMID21719596:Biswas et al.(2011)}	"effect RNA splicing, partial exon 7 deletion"	BRCA2_00517		not applicable	in vitro	1						976	2524	0	75	9	0007_0000581_0000000	10	4	6/21/12 11:40	4	6/21/12 11:40	4	6/21/12 11:40		
7	815	196	G to A	Ser  to Asn	c.587G>A	c.587G>A	p.Ser196Asn	splicing reporter minigene	not applicable	moderate exon skipping	{PMID22962691:Gaildrat et al. (2012)}		BRCA2_00526		cloned	in vitro	1						992	2568	0	55	9	0007_0000587_0000000	0	4	2/19/14 14:34	4	2/19/14 22:06	4	2/19/14 14:34		
7	845	206	C to G	Ser to Cys	c.617C>G	c.617C>G	p.Ser206Cys	splicing reporter minigene/patient RNA analysis	not applicable	exon skipping ~50%	{PMID22962691:Gaildrat et al. (2012)}		BRCA2_00527		cloned	in vitro	1						993	2569	0	55	9	0007_0000617_0000000	0	4	2/19/14 14:34	4	2/19/14 22:07	4	2/19/14 14:34		
7	847	207	A to G	Thr to Ala	T207A	c.619A>G	p.Thr207Ala	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00038		cloned	in vitro	1						66	1521	0	95	9	0007_0000619_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
7	853	209	C to T	Leu to Phe	c.625C>T	c.625C>T	p.Leu209Phe	splicing reporter minigene	not applicable	No splicing defect	{PMID22962691:Gaildrat et al. (2012)}		BRCA2_00528		cloned	in vitro	1						994	2570	0	55	9	0007_0000625_0000000	0	4	2/19/14 14:34	4	2/19/14 22:07	4	2/19/14 14:34		
7	859	211	G to A	Val to Ile	V211I	c.631G>A	p.Val211Ile	mRNA analysis (RT-PCR)	Not Applicable	Predicted deleterious	{PMID19423647:Colombo et al. (2009)}		BRCA2_00040		cloned	in vitro	1						69	1524	0	95	9	0007_0000631_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
7	859	211	G to A	Val to Ile	V211I	c.631G>A	p.Val211Ile	cDNA analysis	Not Applicable	Predicted deleterious	{PMID19179552:Pensabene et al. 2009}		BRCA2_00040		cloned	in vitro	1						70	1525	0	95	9	0007_0000631_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
7	859	211	G to A	Val to Ile	V211I	c.631G>A	p.Val211Ile	Radiation sensitivity	Not Applicable	As wildtype control	{PMID19179552:Pensabene et al. 2009}		BRCA2_00040		cloned	in vitro	1						71	1526	0	15	9	0007_0000631_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
7	859	211	G to A	Val to Ile	c.631G>A	c.631G>A	p.Val211Ile	splicing reporter minigene	not applicable	major exon skipping	{PMID22962691:Gaildrat et al. (2012)}		BRCA2_00040		cloned	in vitro	1						995	2571	0	75	9	0007_0000631_0000000	0	4	2/19/14 14:34	4	2/19/14 22:08	4	2/19/14 14:34		
7	859		+2 T to G	-	IVS7+2T>G	c.631+2T>G	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID11185744:Pyne et al. (2000)}		BRCA2_00039		cloned	in vitro	1						67	1522	0	55	9	0007_0000631_0000002	1	0	10/3/09 17:15			0	10/3/09 17:15		
7	859		+2 T to G	-	IVS7+2T>G	c.631+2T>G	?	Co-segregation in families	Not Applicable	Predicted deleterious	{PMID11185744:Pyne et al. (2000)}		BRCA2_00039		cloned	in vitro	1						68	1523	0	95	9	0007_0000631_0000002	1	0	10/3/09 17:15			0	10/3/09 17:15		
7	864+2		T>G		IVS7+2T>G	c.631+2T>G	not applicable	"Mouse ES cell assay, RNA analysis"	not applicable	No rescue ES cell lethality	{PMID21719596:Biswas et al.(2011)}	upregulation alternative spliced transcript delta 4-7	BRCA2_00039		not applicable	in vitro	1						977	2525	0	75	9	0007_0000631_0000002	10	4	6/21/12 11:44	4	6/21/12 11:44	4	6/21/12 11:44		
7	860		-1 G to A	G to A	IVS7-1G>A	c.632-1G>A	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID16211554:Tesoriero et al. (2005)}		BRCA2_00041		cloned	in vitro	1						72	1527	0	55	9	0007_0000632_-999999	1	0	10/3/09 17:15			0	10/3/09 17:15		
8	673	225	A to G	Thr to Ala	T225A	c.445A>G	p.Thr225Ala	mRNA analysis (RT-PCR)	Not Applicable	As wildtype control	{PMID15300854:Sharp et al. (2004)}		BRCA2_00042		cloned	in vitro	1						73	1528	0	15	9	0008_0000445_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
8	681		A to T	-	c.681+7T>A	c.681+7T>A	?	mRNA analysis and splicing reporter minigene	Not Applicable	Predicted neutral	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00043		cloned	in vitro	1						74	1529	0	15	9	0008_0000681_0000007	1	0	10/3/09 17:15			0	10/3/09 17:15		
8	909		+56 C to T	-	IVS8+56C/T	c.681+56C>T	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00044		cloned	in vitro	1						75	1530	0	15	9	0008_0000681_0000056	1	0	10/3/09 17:15			0	10/3/09 17:15		
8	909		+56 C to T	-	IVS8+56C/T	c.681+56C>T	?	?	?	?	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00044		cloned	in vitro	1						76	1531	0	55	9	0008_0000681_0000056	1	0	10/3/09 17:15			0	10/3/09 17:15		
8	909		+56 C to T	-	IVS8+56C/T	c.681+56C>T	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00044		cloned	in vitro	1						77	1532	0	55	9	0008_0000681_0000056	1	0	10/3/09 17:15			0	10/3/09 17:15		
9	910		-12delTA	-	IVS8-12delTA	c.682-12_682-11del	?	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00045		cloned	in vitro	1						78	1533	0	15	9	0009_0000682_-999988_0000682_-999989	1	0	10/3/09 17:15			0	10/3/09 17:15		
9		251	C to G	Thr to Arg	p.Thr251Arg	c.752C>G	p.Thr251Arg	LOH analysis	Not applicable	No LOH	{PMID20054658:Beristain et al. (2010)}		BRCA2_00492		Not applicable	in vitro	1						948	2462	0	55	9	0009_0000752_0000000	10	4	9/23/11 13:43	4	9/23/11 13:44	4	9/23/11 13:43		
10	1538	438	del AAGA	Stop458	1538del4	?	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00057		cloned	in vitro	1						124	1579	0	55	9	0010_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1825	533	del A	Stop540	1825delA	?	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00057		cloned	in vitro	1						142	1597	0	55	9	0010_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	2024	599	del CTTAT	Stop599	2024del5	?	?	?	?	?	{PMID12142080:Lapodoulou et al. (2002)}		BRCA2_00057		cloned	in vitro	1						149	1604	0	55	9	0010_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	2024	599	del CTTAT	Stop599	2024del5	?	?	?	?	?	{PMID11504767:Loman et al. (2001)}		BRCA2_00057		cloned	in vitro	1						150	1605	0	55	9	0010_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	2024	599	del CTTAT	Stop599	2024del5	?	?	?	?	?	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00057		cloned	in vitro	1						151	1606	0	55	9	0010_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	2041	605	del A	Stop613	2041delA	?	?	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00057		cloned	in vitro	1						153	1608	0	55	9	0010_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	2041	605	ins A	Stop615	2041insA	?	?	?	?	?	{PMID10699917:Spitzer et al. (2000)}		BRCA2_00057		cloned	in vitro	1						154	1609	0	55	9	0010_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1022		-5 ins T	insT	IVS9-5insT	c.794-5_794-4insT	?	mRNA analysis (RT-PCR)	Not Applicable	As wildtype control	{PMID12759930:Claes et al. (2003)}		BRCA2_00046		cloned	in vitro	1						79	1534	0	15	9	0010_0000794_-999995_0000794_-999996	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1084	286	T to C	Ser to Pro	S286P	c.856T>C	p.Ser286Pro	"HR assay, LOH assay"	not applicable	"predicted neutral, no LOH"	{PMID21671020:Balia et al. (2011)}		BRCA2_00500		not applicable	in vitro	1						959	2507	0	35	9	0010_0000856_0000000	27	0	3/23/12 18:03	4	3/27/12 10:04	0	3/23/12 18:03		
10	1093	289	A to C	Asn to His	1093A/C (N289H)	c.865A>C	p.Asn289His	Allele frequency analysis in controls	Not Applicable	Predicted neutral	{PMID15317758:Freedman et al (2004)}		BRCA2_00047		cloned	in vitro	1						80	1535	0	15	9	0010_0000865_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1093	289	A to C	Asn to His	1093A/C (N289H)	c.865A>C	p.Asn289His	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00047		cloned	in vitro	1						81	1536	0	15	9	0010_0000865_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1093	289	A to C	Asn to His	N289H	c.865A>C	p.Asn289His	?	?	?	{PMID17341484:Johnson et al. (2007)}		BRCA2_00047		cloned	in vitro	1						82	1537	0	55	9	0010_0000865_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1093	289	A to C	Asn to His	N289H	c.865A>C	p.Asn289His	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00047		cloned	in vitro	1						83	1538	0	55	9	0010_0000865_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1093	289	A to C	Asn to His	N289H	c.865A>C	p.Asn289His	Grantham score	Not Applicable	Predicted deleterious	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00047		cloned	in vitro	1						84	1539	0	95	9	0010_0000865_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1093	289	A to C	Asn to His	N289H	c.865A>C	p.Asn289His	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00047		cloned	in vitro	1						85	1540	0	55	9	0010_0000865_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1093	289	A to C	Asn to His	N289H	c.865A>C	p.Asn289His	Evolutionary conservation analysis	Not Applicable	Predicted deleterious	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00047		cloned	in vitro	1						86	1541	0	95	9	0010_0000865_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1184	319	A to C	Asn to Thr	N319T	c.956A>C	p.Asn319Thr	Centrosome amplification	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00048		cloned	in vitro	1						87	1542	0	15	9	0010_0000956_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1184	319	A to C	Asn to Thr	N319T	c.956A>C	p.Asn319Thr	Homology-directed repair assay	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00048		cloned	in vitro	1						88	1543	0	15	9	0010_0000956_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1184	319	A to C	Asn to Thr	N319T	c.956A>C	p.Asn319Thr	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00048		cloned	in vitro	1						89	1544	0	15	9	0010_0000956_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1184	319	A to C	Asn to Thr	N319T	c.956A>C	p.Asn319Thr	LOH analysis	Not Applicable	loss of mutant allele	{PMID20054658:Beristain et al. (2010)}		BRCA2_00048		Not applicable	in vitro	1						943	2462	0	55	9	0010_0000956_0000000	10	4	9/23/11 13:43	4	9/23/11 13:44	4	9/23/11 13:43		
10	1206	326	C to A	Ser to Arg	S326R	c.978C>A	p.Ser326Arg	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00049		cloned	in vitro	1						90	1545	0	15	9	0010_0000978_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1206	326	C to A	Ser to Arg	S326R	c.978C>A	p.Ser326Arg	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00049		cloned	in vitro	1						91	1546	0	55	9	0010_0000978_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1207	327	A to G	Lys to Glu	K327E	c.979A>G	p.Lys327Glu	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00050		cloned	in vitro	1						92	1547	0	15	9	0010_0000979_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1222	332	del A	Stop348	1222delA	c.994del	p.Ile332PhefsX17	?	?	?	{PMID10506595:Turner et al. (1999)}		BRCA2_00051		cloned	in vitro	1						93	1548	0	55	9	0010_0000994_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	His to Asn	1342A/C (H372N)	c.1114A>C	p.His372Asn	Allele frequency analysis in controls	Not Applicable	Predicted neutral	{PMID15317758:Freedman et al (2004)}		BRCA2_00052		cloned	in vitro	1						94	1549	0	15	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	His to Asn	1342A/C (H372N)	c.1114A>C	p.His372Asn	Survival assay with VC8 (after MMC treatment)	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00052		cloned	in vitro	1						95	1550	0	15	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	His to Asn	1342A/C (H372N)	c.1114A>C	p.His372Asn	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00052		cloned	in vitro	1						96	1551	0	15	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	His to Asn	1342A/C (H372N)	c.1114A>C	p.His372Asn	Homology-directed repair assay	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00052		cloned	in vitro	1						97	1552	0	15	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	His to Asn	H372N	c.1114A>C	p.His372Asn	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00052		cloned	in vitro	1						98	1553	0	55	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	Asn to His	N372H	c.1114A>C	p.Asn372His	?	?	?	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00052		cloned	in vitro	1						99	1554	0	55	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	Asn to His	N372H	c.1114A>C	p.Asn372His	Centrosome amplification	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00052		cloned	in vitro	1						100	1555	0	15	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	Asn to His	N372H	c.1114A>C	p.Asn372His	Nuclear localisation	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00052		cloned	in vitro	1						101	1556	0	15	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	Asn to His	N372H	c.1114A>C	p.Asn372His	Homology-directed repair assay	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00052		cloned	in vitro	1						102	1557	0	15	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	Asn to His	N372H	c.1114A>C	p.Asn372His	Survival assay with VC8 (after MMC treatment)	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00052		cloned	in vitro	1						103	1558	0	15	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	Asn to His	N372H	c.1114A>C	p.Asn372His	Evolutionary conservation analysis	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00052		cloned	in vitro	1						104	1559	0	15	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	Asn to His	N372H	c.1114A>C	p.Asn372His	Co-occurrence with deleterious mutation	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00052		cloned	in vitro	1						105	1560	0	15	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	Asn to His	N372H	c.1114A>C	p.Asn372His	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00052		cloned	in vitro	1						106	1561	0	55	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	Asn to His	N372H	c.1114A>C	p.Asn372His	?	?	?	{PMID17341484:Johnson et al. (2007)}		BRCA2_00052		cloned	in vitro	1						107	1562	0	55	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1342	372	A to C	Asn to His	N372H	c.1114A>C	p.Asn372His	?	?	?	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00052		cloned	in vitro	1						108	1563	0	55	9	0010_0001114_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1351	357	C to T	Pro to Ser	P357S	c.1123C>T	p.Pro357Ser	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00053		cloned	in vitro	1						109	1564	0	55	9	0010_0001123_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1351	375	C to T	Pro to Ser	P375S	c.1123C>T	p.Pro375Ser	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00053		cloned	in vitro	1						110	1565	0	15	9	0010_0001123_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1379	384	C to T	Ser to Phe	S384F	c.1151C>T	p.Ser384Phe	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID16168123:Wappenschmidt et al. (2005)}		BRCA2_00054		cloned	in vitro	1						111	1566	0	15	9	0010_0001151_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1379	384	C to T	Ser to Phe	S384F	c.1151C>T	p.Ser384Phe	Co-segregation in families	Not Applicable	Inconclusive	{PMID16168123:Wappenschmidt et al. (2005)}		BRCA2_00054		cloned	in vitro	1						112	1567	0	55	9	0010_0001151_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1379	384	C to T	Ser to Phe	S384F	c.1151C>T	p.Ser384Phe	Loss of Heterozygosity	Not Applicable	Predicted neutral	{PMID16168123:Wappenschmidt et al. (2005)}		BRCA2_00054		cloned	in vitro	1						113	1568	0	15	9	0010_0001151_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1379	384	C to T	Ser to Phe	S384F	c.1151C>T	p.Ser384Phe	Evolutionary conservation analysis	Not Applicable	Predicted neutral	{PMID16168123:Wappenschmidt et al. (2005)}		BRCA2_00054		cloned	in vitro	1						114	1569	0	15	9	0010_0001151_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1379	384	C to T	Ser to Phe	S384F	c.1151C>T	p.Ser384Phe	Grantham score	Not Applicable	Predicted neutral	{PMID16168123:Wappenschmidt et al. (2005)}		BRCA2_00054		cloned	in vitro	1						115	1570	0	15	9	0010_0001151_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1379	384	C to T	Ser to Phe	S384F	c.1151C>T	p.Ser384Phe	Co-occurrence with deleterious mutation	Not Applicable	Predicted neutral	{PMID16168123:Wappenschmidt et al. (2005)}		BRCA2_00054		cloned	in vitro	1						116	1571	0	15	9	0010_0001151_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1379	384	C to T	Ser to Phe	S384F	c.1151C>T	p.Ser384Phe	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00054		cloned	in vitro	1						117	1572	0	15	9	0010_0001151_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1379	384	C to T	Ser to Phe	S384F	c.1151C>T	p.Ser384Phe	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00054		cloned	in vitro	1						118	1573	0	55	9	0010_0001151_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1379	384	C to T	Ser to Phe	S384F	c.1151C>T	p.Ser384Phe	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00054		cloned	in vitro	1						119	1574	0	15	9	0010_0001151_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1379	384	C to T	Ser to Phe	S384F	c.1151C>T	p.Ser384Phe	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00054		cloned	in vitro	1						120	1575	0	55	9	0010_0001151_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1411	395	T to G	Trp to Gly	W395G	c.1183T>G	p.Trp395Gly	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00055		cloned	in vitro	1						121	1576	0	55	9	0010_0001183_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1411	395	T to G	Trp to Gly	W395G	c.1183T>G	p.Trp395Gly	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00055		cloned	in vitro	1						122	1577	0	55	9	0010_0001183_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1515	429	A to G	Leu to Leu	1515A/G (L429L)	c.1287A>G	p.Leu429Leu	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00056		cloned	in vitro	1						123	1578	0	15	9	0010_0001287_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1593	455	A to G	Ser to Ser	1593A/G (S455S)	c.1365A>G	p.Ser455Ser	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00058		cloned	in vitro	1						125	1580	0	15	9	0010_0001365_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1593	455	A to G	Ser to Ser	S455S	c.1365A>G	p.Ser455Ser	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00058		cloned	in vitro	1						126	1581	0	55	9	0010_0001365_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1613	462	A to G	Glu to Gly	E462G	c.1385A>G	p.Glu462Gly	Family history	Not Applicable	Predicted neutral	{PMID19200354:Gomez-Garcia et al. (2009)}		BRCA2_00059		cloned	in vitro	1						127	1582	0	15	9	0010_0001385_0000000	1	0	10/3/09 17:15	4	8/20/10 16:46	0	10/3/09 17:15		
10	1613	462	A to G	Glu to Gly	E462G	c.1385A>G	p.Glu462Gly	Co-segregation in families	Not Applicable	Predicted neutral	{PMID19563646:Mohammadi et al. (2009)}		BRCA2_00059		cloned	in vitro	1						128	1583	0	15	9	0010_0001385_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1613	462	A to G	Glu to Gly	E462G	c.1385A>G	p.Glu462Gly	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00059		cloned	in vitro	1						129	1584	0	15	9	0010_0001385_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1613	462	A to G	Glu to Gly	E462G	c.1385A>G	p.Glu462Gly	Evolutionary conservation analysis	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00059		cloned	in vitro	1						130	1585	0	15	9	0010_0001385_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1613	462	A to G	Glu to Gly	E462G	c.1385A>G	p.Glu462Gly	Nuclear localisation	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00059		cloned	in vitro	1						131	1586	0	15	9	0010_0001385_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1613	462	A to G	Glu to Gly	E462G	c.1385A>G	p.Glu462Gly	Co-occurrence with deleterious mutation	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00059		cloned	in vitro	1						132	1587	0	15	9	0010_0001385_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1613	462	A to G	Glu to Gly	E462G	c.1385A>G	p.Glu462Gly	Co-segregation in families	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00059		cloned	in vitro	1						133	1588	0	15	9	0010_0001385_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1613	462	A to G	Glu to Gly	E462G	c.1385A>G	p.Glu462Gly	Survival assay with VC8 (after MMC treatment)	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00059		cloned	in vitro	1						134	1589	0	15	9	0010_0001385_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1613	462	A to G	Glu to Gly	E462G	c.1385A>G	p.Glu462Gly	Homology-directed repair assay	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00059		cloned	in vitro	1						135	1590	0	15	9	0010_0001385_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1613	462	A to G	Glu to Gly	E462G	c.1385A>G	p.Glu462Gly	Centrosome amplification	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00059		cloned	in vitro	1						136	1591	0	15	9	0010_0001385_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1613	462	A to G	Glu to Gly	E462G	c.1385A>G	p.Glu462Gly	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00059		cloned	in vitro	1						137	1592	0	15	9	0010_0001385_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1623	465	A to C	Val to Val	c.1395A>C	c.1395A>C	p.=	splicing reporter minigene	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00529		cloned	in vitro	1						996	2572	0	55	9	0010_0001395_0000000	0	4	2/19/14 14:34	4	2/19/14 22:08	4	2/19/14 14:34		
10	1742	505	T to C	Ile to Thr	I505T (1742T/C)	c.1514T>C	p.Ile505Thr	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00060		cloned	in vitro	1						138	1593	0	55	9	0010_0001514_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1766	513	A to G	Lys to Arg	K513R	c.1538A>G	p.Lys513Arg	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18375895:Spurdle et al. (2008)}		BRCA2_00061		cloned	in vitro	1						139	1594	0	15	9	0010_0001538_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1766	513	A to G	Lys to Arg	K513R	c.1538A>G	p.Lys513Arg	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00061		cloned	in vitro	1						140	1595	0	15	9	0010_0001538_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1778	517	A to G	Asn to Ser	N517S	c.1550A>G	p.Asn517Ser	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00062		cloned	in vitro	1						141	1596	0	15	9	0010_0001550_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1890	554	T to G	Cys to Trp	C554W	c.1662T>G	p.Cys554Trp	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00063		cloned	in vitro	1						143	1598	0	15	9	0010_0001662_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1972	582	A to C	Thr to Pro	T582P	c.1744A>C	p.Thr582Pro	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00064		cloned	in vitro	1						144	1599	0	15	9	0010_0001744_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1972	582	A to C	Thr to Pro	T582P	c.1744A>C	p.Thr582Pro	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00064		cloned	in vitro	1						145	1600	0	15	9	0010_0001744_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1990	588	A to G	Asn to Asp	N588D	c.1762A>G	p.Asn588Asp	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00065		cloned	in vitro	1						146	1601	0	15	9	0010_0001762_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	1991	588	A to G			c.1763A>G	"p.Asn588_Gly637del, p.N588S"	NNSPLICE and lymphocyte RT-PCR	-	Donor site creation. Deletion of 147 nucleotides	{PMID20215541: Sanz et al. (2010)}		BRCA2_00486	r.1763_1909del	Va481	?	1	Bilateral Breast Cancer. No familial antecedents					925	2383	0	75	9	0010_0001763_0000000	6	0	7/1/10 14:20	4	8/20/10 16:54	0	7/1/10 14:20		
10	2020	598	A to G	Thr to Ala	T598A	c.1792A>G	p.Thr598Ala	Co-occurrence with deleterious mutation	Not Applicable	Predicted neutral	{PMID12215251:Deffenbaugh et al. (2002)}		BRCA2_00066		cloned	in vitro	1						147	1602	0	15	9	0010_0001792_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	2020	598	A to G	Thr to Ala	T598A	c.1792A>G	p.Thr598Ala	Co-segregation in families	Not Applicable	Predicted neutral	{PMID12215251:Deffenbaugh et al. (2002)}		BRCA2_00066		cloned	in vitro	1						148	1603	0	15	9	0010_0001792_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	2032	602	G to A	Gly to Arg	G602R	c.1804G>A	p.Gly602Arg	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00067		cloned	in vitro	1						152	1607	0	15	9	0010_0001804_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	2048	607	A to C	Lys to Thr	K607T	c.1820A>C	p.Lys607Thr	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID18375895:Spurdle et al. (2008)}		BRCA2_00068		cloned	in vitro	1						155	1610	0	55	9	0010_0001820_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	2117	630	C to T	Thr to Ile	T630I	c.1889C>T	p.Thr630Ile	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00069		cloned	in vitro	1						156	1611	0	15	9	0010_0001889_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	2137		+12 del T	-	IVS10+12delT	c.1909+22del	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00070		cloned	in vitro	1						157	1612	0	55	9	0010_0001909_0000022	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	2137		+12 del T	-	IVS10+12delT	c.1909+22del	?	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00070		cloned	in vitro	1						158	1613	0	55	9	0010_0001909_0000022	1	0	10/3/09 17:15			0	10/3/09 17:15		
10	2137	NA	insT	Not applicable	c.1909+22insT	c.1909+22insT	?	splicing reporter minigene	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00540		cloned	in vitro	1						1012	2588	0	55	9	0010_0001909_0000022	0	4	2/19/14 14:34	4	2/19/14 22:08	4	2/19/14 14:34		
11	2558	777	ins A	Stop787	2558insA	?	?	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00057		cloned	in vitro	1						166	1621	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2678	817	del A	Stop824	2678delA	?	?	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00057		cloned	in vitro	1						173	1628	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3034	936	del AAAC	Stop958	3034del4	?	?	?	?	?	{PMID12142080:Lapodoulou et al. (2002)}		BRCA2_00057		cloned	in vitro	1						182	1637	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3036	936	del ACAA	Stop958	3036del4	?	?	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00057		cloned	in vitro	1						183	1638	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3036	936	del ACAA	Stop958	3036del4	?	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00057		cloned	in vitro	1						184	1639	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3036	936	del ACAA	Stop958	3036del4	?	?	?	?	?	{PMID10699917:Spitzer et al. (2000)}		BRCA2_00057		cloned	in vitro	1						185	1640	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3374	1049	del A	Stop1053	3374delA	?	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00057		cloned	in vitro	1						196	1651	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3492	1088	ins T	Stop1098	3492insT	?	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00057		cloned	in vitro	1						199	1654	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4088	1286	del A	Stop1291	4088delA	?	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00057		cloned	in vitro	1						221	1676	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4486	1420	del G	Stop1447	4486delG	?	?	?	?	?	{PMID11504767:Loman et al. (2001)}		BRCA2_00057		cloned	in vitro	1						241	1696	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4708	1494	insA	Stop1513	4708insA	?	?	?	?	?	{PMID10638982:Peelen et al. (2000)}		BRCA2_00057		cloned	in vitro	1						254	1709	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5302	1692	insA	Stop1694	5302insA	?	?	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00057		cloned	in vitro	1						267	1722	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5445	1739	del TTTAA	Stop1739	5445del5	?	?	?	?	?	{PMID11504767:Loman et al. (2001)}		BRCA2_00057		cloned	in vitro	1						270	1725	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5804	1859	del ATTA	Stop1862	5804del4	?	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00057		cloned	in vitro	1						279	1734	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5844	1872	del5	Stop1873	5844del5	?	?	?	?	?	{PMID15533909:Pal et al. (2004)}		BRCA2_00057		cloned	in vitro	1						281	1736	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6079	1951	del 4	Stop1961	6079del4	?	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00057		cloned	in vitro	1						294	1749	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6174	1982	del TGGA	Stop2166	6174del4	?	?	?	?	?	{PMID09665145:Abbott et al. (1998)}		BRCA2_00057		cloned	in vitro	1						296	1751	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6310	2028	del GAAGA	Stop2046	6310del5	?	?	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00057		cloned	in vitro	1						306	1761	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6630	2134	del5	Stop2138	6630del5	?	?	?	?	?	{PMID12142080:Lapodoulou et al. (2002)}		BRCA2_00057		cloned	in vitro	1						324	1779	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6696	2156	del TC	Stop2174	6696delTC	?	?	?	?	?	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00057		cloned	in vitro	1						326	1781	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6714	2162	del ACAA	Stop2166	6714del4	?	?	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00057		cloned	in vitro	1						329	1784	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6714	2162	del ACAA	Stop2166	6714del4	?	?	?	?	?	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00057		cloned	in vitro	1						330	1785	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6857	2210	del AA	Stop2222	6857delAA	?	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00057		cloned	in vitro	1						333	1788	0	55	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	7069		+73 T to A	-	IVS11+73T/A	geen t op positie	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00167		cloned	in vitro	1						338	1793	0	15	9	0011_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2192	655	C to G	Pro to Arg	P655R	c.1964C>G	p.Pro655Arg	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID15290653:Goldgar et al. (2004)}		BRCA2_00071		cloned	in vitro	1						159	1614	0	15	9	0011_0001964_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2192	655	C to G	Pro to Arg	P655R	c.1964C>G	p.Pro655Arg	Histopathology	Not Applicable	Inconclusive	{PMID18824701:Spearman et al. (2008)}		BRCA2_00071		cloned	in vitro	1						160	1615	0	55	9	0011_0001964_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2192	655	C to G	Pro to Arg	P655R	c.1964C>G	p.Pro655Arg	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID15290653:Goldgar et al. (2004)}		BRCA2_00071		cloned	in vitro	1						161	1616	0	15	9	0011_0001964_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2192	655	C to G	Pro to Arg	P655R	c.1964C>G	p.Pro655Arg	Embryonic stem cell assay	Not Applicable	As wildtype	{PMID22678057:Biswas et al. (2012)}		BRCA2_00071		not applicable	in vitro	1						983	2533	0	35	9	0011_0001964_0000000	10	4	2/5/14 21:28	4	2/5/14 21:28	4	2/5/14 21:28		
11	2347	707	G to T	Asp to Tyr	D707Y	c.2119G>T	p.Asp707Tyr	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00072		cloned	in vitro	1						162	1617	0	15	9	0011_0002119_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2366	713	A to T	Gln to Leu	Q713L	c.2138A>T	p.Gln713Leu	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00073		cloned	in vitro	1						163	1618	0	55	9	0011_0002138_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2457	743	T to C	His to His	2457T/C (H743H)	c.2229T>C	p.His743His	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00074		cloned	in vitro	1						164	1619	0	15	9	0011_0002229_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2457	743	T to C	His to His	H743H	c.2229T>C	p.His743His	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00074		cloned	in vitro	1						165	1620	0	55	9	0011_0002229_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2578	784	A to G	Met to Val	M784V	c.2350A>G	p.Met784Val	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00075		cloned	in vitro	1						167	1622	0	15	9	0011_0002350_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2578	784	A to G	Met to Val	M784V	c.2350A>G	p.Met784Val	Peptide binding ability	Not Applicable	Predicted neutral	{PMID15317758:Freedman et al (2004)}		BRCA2_00075		cloned	in vitro	1						168	1623	0	15	9	0011_0002350_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2578	784	A to G	Met to Val	M784V	c.2350A>G	p.Met784Val	Allele frequency analysis in controls	Not Applicable	Predicted neutral	{PMID15317758:Freedman et al (2004)}		BRCA2_00075		cloned	in vitro	1						169	1624	0	15	9	0011_0002350_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2578	784	A to G	Met to Val	M784V	c.2350A>G	p.Met784Val	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00075		cloned	in vitro	1						170	1625	0	15	9	0011_0002350_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2604	792	C to A	Tyr to Stop	Y792X	c.2376C>A	p.Tyr792X	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00076		cloned	in vitro	1						171	1626	0	55	9	0011_0002376_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2644	806	G to C	Asp to His	D806H	c.2416G>C	p.Asp806His	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00077		cloned	in vitro	1						172	1627	0	15	9	0011_0002416_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2778	850	A to G	Gln to Gln	2778A/G (Q850Q)	c.2550A>G	p.Gln850Gln	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00078		cloned	in vitro	1						174	1629	0	15	9	0011_0002550_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2885	886	A to T	Asn to Ile	N886I	c.2657A>T	p.Asn886Ile	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00079		cloned	in vitro	1						175	1630	0	15	9	0011_0002657_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	2908	894	G to A	Val to Ile	V894I	c.2680G>A	p.Val894Ile	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00080		cloned	in vitro	1						176	1631	0	15	9	0011_0002680_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3007	927	A to G	Met to Val	M927V	c.2779A>G	p.Met927Val	"HR assay, LOH assay"	not applicable	"predicted neutral, no LOH"	{PMID21671020:Balia et al. (2011)}		BRCA2_00501		not applicable	in vitro	1						960	2508	0	35	9	0011_0002779_0000000	27	0	3/23/12 18:06	4	3/27/12 10:06	0	3/23/12 18:06		
11	3014	929	T to C	Leu to Ser	L929S	c.2786T>C	p.Leu929Ser	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00081		cloned	in vitro	1						177	1632	0	15	9	0011_0002786_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3031	935	G to A	Asp to Asn	D935N	c.2803G>A	p.Asp935Asn	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00082		cloned	in vitro	1						178	1633	0	55	9	0011_0002803_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3031	935	G to A	Asp to Asn	D935N	c.2803G>A	p.Asp935Asn	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18375895:Spurdle et al. (2008)}		BRCA2_00082		cloned	in vitro	1						179	1634	0	15	9	0011_0002803_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3031	935	G to A	Asp to Asn	D935N	c.2803G>A	p.Asp935Asn	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00082		cloned	in vitro	1						180	1635	0	55	9	0011_0002803_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3031	935	G to A	Asp to Asn	D935N	c.2803G>A	p.Asp935Asn	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00082		cloned	in vitro	1						181	1636	0	15	9	0011_0002803_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3111	961	G to A	Gln to Gln	3111G/A (Q961Q)	c.2883G>A	p.Gln961Gln	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00083		cloned	in vitro	1						186	1641	0	15	9	0011_0002883_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11		934	G to A	p.=	c.2883G>A	c.2883G>A	p.=	LOH analysis	Not applicable	No LOH	{PMID20054658:Beristain et al. (2010)}		BRCA2_00083		Not applicable	in vitro	1						949	2462	0	55	9	0011_0002883_0000000	10	4	9/23/11 13:43	4	9/23/11 13:46	4	9/23/11 13:43		
11		976		del Ser	p.Ser976del	c.2926_2928del	p.Ser976del	LOH analysis	Not applicable	Loss of variant allele	{PMID20054658:Beristain et al. (2010)}		BRCA2_00493		Not applicable	in vitro	1						950	2462	0	55	9	0011_0002926_0000000_0002928_0000000	10	4	9/23/11 13:43	4	9/23/11 13:47	4	9/23/11 13:43		
11	3188	987	A to T	Asn to Ile	N987I	c.2960A>T	p.Asn987Ile	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00084		cloned	in vitro	1						187	1642	0	15	9	0011_0002960_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3199	991	A to G	Asn to Asp	3199A/G (N991D)	c.2971A>G	p.Asn991Asp	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00085		cloned	in vitro	1						188	1643	0	15	9	0011_0002971_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3199	991	A to G	Asn to Asp	3199A/G (N991D)	c.2971A>G	p.Asn991Asp	Allele frequency analysis in controls	Not Applicable	Predicted neutral	{PMID15317758:Freedman et al (2004)}		BRCA2_00085		cloned	in vitro	1						189	1644	0	15	9	0011_0002971_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3199	991	A to G	Asn to Asp	N991D	c.2971A>G	p.Asn991Asp	Grantham score	Not Applicable	Predicted deleterious	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00085		cloned	in vitro	1						190	1645	0	95	9	0011_0002971_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3199	991	A to G	Asn to Asp	N991D	c.2971A>G	p.Asn991Asp	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00085		cloned	in vitro	1						191	1646	0	55	9	0011_0002971_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3199	991	A to G	Asn to Asp	N991D	c.2971A>G	p.Asn991Asp	Cell viability (in BRCA-/- cells)	Not Applicable	As wildtype control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00085		cloned	in vitro	1						192	1647	0	15	9	0011_0002971_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3199	991	A to G	Asn to Asp	N991D	c.2971A>G	p.Asn991Asp	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00085		cloned	in vitro	1						193	1648	0	55	9	0011_0002971_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3260	1011	C to G	Thr to Arg	T1011R	c.3032C>G	p.Thr1011Arg	"HR assay, LOH assay"	not applicable	"predicted neutral, no LOH"	{PMID21671020:Balia et al. (2011)}		BRCA2_00503		not applicable	in vitro	1						962	2510	0	35	9	0011_0003032_0000000	27	0	3/23/12 18:20	4	3/27/12 10:09	0	3/23/12 18:20		
11	3283	1019	C to G	Leu to Val	L1019V	c.3055C>G	p.Leu1019Val	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00086		cloned	in vitro	1						194	1649	0	15	9	0011_0003055_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3283	1019	C to G	Leu to Val	L1019V	c.3055C>G	p.Leu1019Val	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00086		cloned	in vitro	1						195	1650	0	55	9	0011_0003055_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3283	1019	C to G	Leu to Val	L1019V	c.3055C>G	p.Leu1019Val	"HR assay, LOH assay"	not applicable	"predicted neutral, no LOH"	{PMID21671020:Balia et al. (2011)}		BRCA2_00504		not applicable	in vitro	1						963	2511	0	35	9	0011_0003055_0000000	27	0	3/23/12 18:23	4	3/27/12 10:11	0	3/23/12 18:23		
11	3398	1057	A to G	Lys to Arg	K1057R	c.3170A>G	p.Lys1057Arg	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00087		cloned	in vitro	1						197	1652	0	55	9	0011_0003170_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3398	1057	A to G	Lys to Arg	K1057R	c.3170A>G	p.Lys1057Arg	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00087		cloned	in vitro	1						198	1653	0	55	9	0011_0003170_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3532	1102	A to T	Asn to Tyr	N1102Y	c.3304A>T	p.Asn1102Tyr	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00088		cloned	in vitro	1						200	1655	0	15	9	0011_0003304_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3624	1132	A to G	Lys to Lys	3624A/G (K1132K)	c.3396A>G	p.Lys1132Lys	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00089		cloned	in vitro	1						201	1656	0	15	9	0011_0003396_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3624	1132	A to G	Lys to Lys	3624A/G (K1132K)	c.3396A>G	p.Lys1132Lys	Allele frequency analysis in controls	Not Applicable	Predicted neutral	{PMID15317758:Freedman et al (2004)}		BRCA2_00089		cloned	in vitro	1						202	1657	0	15	9	0011_0003396_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3624	1132	A to G	Lys to Lys	K1132K	c.3396A>G	p.Lys1132Lys	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00089		cloned	in vitro	1						203	1658	0	55	9	0011_0003396_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3624	1132	A to G	Lys to Lys	K1132K	c.3396A>G	p.Lys1132Lys	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00089		cloned	in vitro	1						204	1659	0	55	9	0011_0003396_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3737	1170	C to T	Ala to Val	A1170V	c.3509C>T	p.Ala1170Val	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00090		cloned	in vitro	1						205	1660	0	15	9	0011_0003509_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3743	1172	C to T	Ser to Leu	S1172L	c.3515C>T	p.Ser1172Leu	Histopathology	Not Applicable	Inconclusive	{PMID18824701:Spearman et al. (2008)}		BRCA2_00091		cloned	in vitro	1						206	1661	0	55	9	0011_0003515_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3743	1172	C to T	Ser to Leu	S1172L	c.3515C>T	p.Ser1172Leu	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00091		cloned	in vitro	1						207	1662	0	15	9	0011_0003515_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3743	1172	C to T	Ser to Leu	S1172L	c.3515C>T	p.Ser1172Leu	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18375895:Spurdle et al. (2008)}		BRCA2_00091		cloned	in vitro	1						208	1663	0	15	9	0011_0003515_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3796	1190	C to T	Arg to Trp	R1190W	c.3568C>T	p.Arg1190Trp	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00092		cloned	in vitro	1						209	1664	0	15	9	0011_0003568_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3809	1194	G to A	Gly to Asp	G1194D	c.3581G>A	p.Gly1194Asp	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00093		cloned	in vitro	1						210	1665	0	15	9	0011_0003581_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	3910	1228	A to G	Asn to Asp	N1228D	c.3682A>G	p.Asn1228Asp	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00094		cloned	in vitro	1						211	1666	0	15	9	0011_0003682_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4021	1265	T to A	Cys to Ser	C1265S	c.3793T>A	p.Cys1265Ser	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00095		cloned	in vitro	1						212	1667	0	15	9	0011_0003793_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4035	1269	C to T	Val to Val	V1269V	c.3807C>T	p.Val1269Val	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00097		cloned	in vitro	1						214	1669	0	55	9	0011_0003807_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4035	1269	C to T	Val to Val	V1269V	c.3807C>T	p.Val1269Val	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00097		cloned	in vitro	1						215	1670	0	55	9	0011_0003807_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4035	1269	T to C	Val to Val	4035T/C (V1269V)	c.3807T>C	p.Val1269Val	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00096		cloned	in vitro	1						213	1668	0	15	9	0011_0003807_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4053	1275	A to G	Ile to Met	I1275M	c.3825A>G	p.Ile1275Met	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00098		cloned	in vitro	1						216	1671	0	55	9	0011_0003825_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4064	1279	A to G	Asn to Ser	N1279S	c.3836A>G	p.Asn1279Ser	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00099		cloned	in vitro	1						217	1672	0	55	9	0011_0003836_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4067	1280	A to T	Asp to Val	D1280V	c.3839A>T	p.Asp1280Val	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00100		cloned	in vitro	1						218	1673	0	15	9	0011_0003839_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4084	1286	A to G	Lys to Glu	K1286E	c.3856A>G	p.Lys1286Glu	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00102		cloned	in vitro	1						220	1675	0	55	9	0011_0003856_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4084	1286	del AAA	del Lys	K1286del	c.3858_3860del	p.Lys1286del	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00101		cloned	in vitro	1						219	1674	0	15	9	0011_0003858_0000000_0003860_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4097	1290	G to A	Cys to Tyr	C1290Y	c.3869G>A	p.Cys1290Tyr	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00103		cloned	in vitro	1						222	1677	0	15	9	0011_0003869_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4132	1302	del ACT	del Thr	T1302del	c.3904_3906del	p.Thr1302del	Nuclear localisation	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00104		cloned	in vitro	1						223	1678	0	15	9	0011_0003904_0000000_0003906_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4132	1302	del ACT	del Thr	T1302del	c.3904_3906del	p.Thr1302del	Homology-directed repair assay	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00104		cloned	in vitro	1						224	1679	0	15	9	0011_0003904_0000000_0003906_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4132	1302	del ACT	del Thr	T1302del	c.3904_3906del	p.Thr1302del	Evolutionary conservation analysis	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00104		cloned	in vitro	1						225	1680	0	15	9	0011_0003904_0000000_0003906_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4132	1302	del ACT	del Thr	T1302del	c.3904_3906del	p.Thr1302del	Centrosome amplification	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00104		cloned	in vitro	1						226	1681	0	55	9	0011_0003904_0000000_0003906_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4132	1302	del ACT	del Thr	T1302del	c.3904_3906del	p.Thr1302del	Survival assay with VC8 (after MMC treatment)	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00104		cloned	in vitro	1						227	1682	0	55	9	0011_0003904_0000000_0003906_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4144	1306	G to A	Val to Ile	V1306I	c.3916G>A	p.Val1306Ile	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00105		cloned	in vitro	1						228	1683	0	15	9	0011_0003916_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4150	1308	G to T	Phe to Stop	E1308X	c.3922G>T	p.Phe1308X	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00106		cloned	in vitro	1						229	1684	0	55	9	0011_0003922_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4194	1322	C to T	Asn to Asn	4194C/T (N1322N)	c.3966C>T	p.Asn1322Asn	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00107		cloned	in vitro	1						230	1685	0	15	9	0011_0003966_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4282	1352	G to T	Asp to Tyr	D1352Y	c.4054G>T	p.Asp1352Tyr	Histopathology	Not Applicable	Inconclusive	{PMID18824701:Spearman et al. (2008)}		BRCA2_00108		cloned	in vitro	1						231	1686	0	55	9	0011_0004054_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4289	1354	C to T	Thr to Met	T1354M	c.4061C>T	p.Thr1354Met	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00109		cloned	in vitro	1						232	1687	0	15	9	0011_0004061_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4322	1365	G to A	Cys to Tyr	C1365Y	c.4094G>A	p.Cys1365Tyr	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00110		cloned	in vitro	1						233	1688	0	15	9	0011_0004094_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4374	1382	del AGA	del Glu	E1382del	c.4146_4148delAGA	p.1383delGlu	Homology-directed repair assay	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00111		cloned	in vitro	1						234	1689	0	55	9	0011_0004146_0000000_0004148_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4374	1382	del AGA	del Glu	E1382del	c.4146_4148delAGA	p.1383delGlu	Centrosome amplification	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00111		cloned	in vitro	1						235	1690	0	15	9	0011_0004146_0000000_0004148_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4374	1382	del AGA	del Glu	E1382del	c.4146_4148delAGA	p.1383delGlu	Nuclear localisation	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00111		cloned	in vitro	1						236	1691	0	15	9	0011_0004146_0000000_0004148_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4374	1382	del AGA	del Glu	E1382del	c.4146_4148delAGA	p.1383delGlu	Evolutionary conservation analysis	Not Applicable	Predicted deleterious	{PMID15695382:Wu et al. (2005)}		BRCA2_00111		cloned	in vitro	1						237	1692	0	95	9	0011_0004146_0000000_0004148_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4374	1382	del AGA	del Glu	E1382del	c.4146_4148delAGA	p.1383delGlu	Survival assay with VC8 (after MMC treatment)	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00111		cloned	in vitro	1						238	1693	0	55	9	0011_0004146_0000000_0004148_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4415	1396	A to G	Gln to Arg	Q1396R	c.4187A>G	p.Gln1396Arg	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00112		cloned	in vitro	1						239	1694	0	15	9	0011_0004187_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4469	1414	C to T	Thr to Met	T1414M	c.4241C>T	p.Thr1414Met	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00113		cloned	in vitro	1						240	1695	0	15	9	0011_0004241_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4486	1420	G to A	Asp to Tyr	D1420Y (G>A)	c.4258G>A	p.Asp1420Tyr	Co-occurrence with deleterious mutation	Not Applicable	Predicted neutral	{PMID12215251:Deffenbaugh et al. (2002)}		BRCA2_00114		cloned	in vitro	1						242	1697	0	15	9	0011_0004258_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4486	1420	G to A	Asp to Tyr	D1420Y (G>A)	c.4258G>A	p.Asp1420Tyr	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00114		cloned	in vitro	1						243	1698	0	15	9	0011_0004258_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4486	1420	G to A	Asp to Tyr	D1420Y (G>A)	c.4258G>A	p.Asp1420Tyr	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID12215251:Deffenbaugh et al. (2002)}		BRCA2_00114		cloned	in vitro	1						244	1699	0	15	9	0011_0004258_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4486	1420	G to A	Asp to Tyr	D1420Y (G>A)	c.4258G>A	p.Asp1420Tyr	?	?	?	{PMID10699917:Spitzer et al. (2000)}		BRCA2_00114		cloned	in vitro	1						245	1700	0	55	9	0011_0004258_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4486	1420	G to A	Asp to Tyr	D1420Y (G>A)	c.4258G>A	p.Asp1420Tyr	LOH analysis	Not Applicable	Loss of variant allele	{PMID20054658:Beristain et al. (2010)}		BRCA2_00114		Not applicable	in vitro	1						944	2462	0	55	9	0011_0004258_0000000	10	4	9/23/11 13:43	4	9/23/11 13:47	4	9/23/11 13:43		
11	4486	1420	G to T	Asp to Tyr	D1420Y (G>T)	c.4258G>T	p.Asp1420Tyr	?	?	?	Personal communication		BRCA2_00115		cloned	in vitro	1						246	1701	0	55	9	0011_0004258_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4486	1420	G to T	Asp to Tyr	D1420Y (G>T)	c.4258G>T	p.Asp1420Tyr	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00115		cloned	in vitro	1						247	1702	0	15	9	0011_0004258_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4486	1420	G to T	Asp to Tyr	D1420Y (G>T)	c.4258G>T	p.Asp1420Tyr	Bayesian statistics	Not Applicable	Predicted deleterious	{PMID12601471:Scott et al. (2003)}		BRCA2_00115		cloned	in vitro	1						248	1703	0	95	9	0011_0004258_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4499	1424	C to G	Ser to Cys	S1424C	c.4271C>G	p.Ser1424Cys	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00116		cloned	in vitro	1						249	1704	0	15	9	0011_0004271_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4516	1430	A to G	Thr to Ala	T1430A	c.4288A>G	p.Thr1430Ala	?	?	?	{PMID11239456:Davies et al. (2001)}		BRCA2_00117		cloned	in vitro	1						250	1705	0	55	9	0011_0004288_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4529	1434	A to T	Lys to Ile	K1434I	c.4301A>T	p.Lys1434Ile	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00118		cloned	in vitro	1						251	1706	0	15	9	0011_0004301_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4542	1438	del C	Stop1447	4542delC	c.4314delC	p.Val1438fs	?	?	?	{PMID10638982:Peelen et al. (2000)}		BRCA2_00119		cloned	in vitro	1						252	1707	0	55	9	0011_0004314_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4599	1457	G to C	Leu to Phe	L1457F	c.4371G>C	p.Leu1457Phe	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00120		cloned	in vitro	1						253	1708	0	55	9	0011_0004371_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4765	1513	G to A	Asp to Asn	4765G/A (D1513N)	c.4537G>A	p.Asp1513Asn	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00121		cloned	in vitro	1						255	1710	0	15	9	0011_0004537_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4789	1521	G to A	Leu to leu	L1521L	c.4561G>A	p.Leu1521leu	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00122		cloned	in vitro	1						256	1711	0	55	9	0011_0004561_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4791	1521	G to A	Leu to Leu	4791G/A (L1521L)	c.4563G>A	p.Leu1521Leu	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00123		cloned	in vitro	1						257	1712	0	15	9	0011_0004563_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4798	1524	T to G	Phe to Val	F1524V	c.4570T>G	p.Phe1524Val	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00124		cloned	in vitro	1						258	1713	0	15	9	0011_0004570_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4812	1528	C to T	Ser to Ser	S1528S	c.4584C>T	p.Ser1528Ser	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00125		cloned	in vitro	1						259	1714	0	55	9	0011_0004584_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4813	1529	G to A	Gly to Arg	G1529R	c.4585G>A	p.Gly1529Arg	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00126		cloned	in vitro	1						260	1715	0	15	9	0011_0004585_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4813	1529	G to A	Gly to Arg	G1529R	c.4585G>A	p.Gly1529Arg	Yeast two-hybrid	BRCA2-BRC4/RAD51	Inconclusive	{PMID10551859:Chen et al. (1999)}		BRCA2_00126		cloned	in vitro	1						261	1716	0	55	9	0011_0004585_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4813	1529	G to A	Gly to Arg	G1529R	c.4585G>A	p.Gly1529Arg	Structure-based prediction (crystallography etc)	Not Applicable	Predicted deleterious	{PMID12442171:Pellegrini et al. (2002)}		BRCA2_00126		cloned	in vitro	1						262	1717	0	95	9	0011_0004585_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	4946	1573	G to A	Cys to Tyr	C1573Y	c.4718G>A	p.Cys1573Tyr	?	?	?	{PMID10699917:Spitzer et al. (2000)}		BRCA2_00127		cloned	in vitro	1						263	1718	0	55	9	0011_0004718_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5007	1593	A to C	Glu to Asp	E1593D	c.4779A>C	p.Glu1593Asp	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00128		cloned	in vitro	1						264	1719	0	15	9	0011_0004779_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5156	1643	T to C	Val to Ala	V1643A	c.4928T>C	p.Val1643Ala	Histopathology	Not Applicable	Inconclusive	{PMID18824701:Spearman et al. (2008)}		BRCA2_00129		cloned	in vitro	1						265	1720	0	55	9	0011_0004928_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5298	1690	A to C	Lys to Asn	K1690N	c.5070A>C	p.Lys1690Asn	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00130		cloned	in vitro	1						266	1721	0	15	9	0011_0005070_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5426	1733	C to T	Ser to Phe	S1733F	c.5198C>T	p.Ser1733Phe	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00131		cloned	in vitro	1						268	1723	0	15	9	0011_0005198_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5427	1733	T to C	Ser to Ser	5427T/C (S1733S)	c.5199T>C	p.Ser1733Ser	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00132		cloned	in vitro	1						269	1724	0	15	9	0011_0005199_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5506	1760	T to G	Ser to Ala	S1760A	c.5278T>G	p.Ser1760Ala	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID18375895:Spurdle et al. (2008)}		BRCA2_00133		cloned	in vitro	1						271	1726	0	55	9	0011_0005278_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5540	1771	G to A	Gly to Asp	G1771D	c.5312G>A	p.Gly1771Asp	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00134		cloned	in vitro	1						272	1727	0	55	9	0011_0005312_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5540	1771	G to A	Gly to Asp	G1771D	c.5312G>A	p.Gly1771Asp	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00134		cloned	in vitro	1						273	1728	0	15	9	0011_0005312_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5540	1771	G to A	Gly to Asp	G1771D	c.5312G>A	p.Gly1771Asp	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00134		cloned	in vitro	1						274	1729	0	15	9	0011_0005312_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5579	1784	ins A	Stop1786	5579insA	c.5351dupA	p.Asn1784fs	?	?	?	{PMID10638982:Peelen et al. (2000)}		BRCA2_00135		cloned	in vitro	1						275	1730	0	55	9	0011_0005351_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5642	1805	A to G	Asn to Ser	N1805S	c.5414A>G	p.Asn1805Ser	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00136		cloned	in vitro	1						276	1731	0	15	9	0011_0005414_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5683	1819	C to T	Pro to Ser	P1819S	c.5455C>T	p.Pro1819Ser	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00137		cloned	in vitro	1						277	1732	0	15	9	0011_0005455_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5683	1819	C to T	Pro to Ser	P1819S	c.5455C>T	p.Pro1819Ser	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00137		cloned	in vitro	1						278	1733	0	15	9	0011_0005455_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5840	1871	G to A	Ser to Asn	S1871N	c.5612G>A	p.Ser1871Asn	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00138		cloned	in vitro	1						280	1735	0	55	9	0011_0005612_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5862	1878	C to G	Asn to Lys	N1878K	c.5634C>G	p.Asn1878Lys	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00139		cloned	in vitro	1						282	1737	0	15	9	0011_0005634_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5862	1878	C to G	Asn to Lys	N1878K	c.5634C>G	p.Asn1878Lys	"HR assay, LOH assay"	not applicable	"predicted pathogenic, no LOH"	{PMID21671020:Balia et al. (2011)}		BRCA2_00505		not applicable	in vitro	1						964	2512	0	75	9	0011_0005634_0000000	27	0	3/23/12 18:26	4	3/27/12 10:15	0	3/23/12 18:26		
11	5868	1880	T to G	Asn to Lys	N1880K	c.5640T>G	p.Asn1880Lys	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00140		cloned	in vitro	1						283	1738	0	15	9	0011_0005640_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5873	1882	C to A	Ser to Stop	S1882X	c.5645C>A	p.Ser1882X	?	?	?	{PMID10638982:Peelen et al. (2000)}		BRCA2_00141		cloned	in vitro	1						284	1739	0	55	9	0011_0005645_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5932	1902	G to A	Asp to Asn	D1902N	c.5704G>A	p.Asp1902Asn	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00142		cloned	in vitro	1						285	1740	0	15	9	0011_0005704_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5938	1904	C to G	Leu to Val	L1904V	c.5710C>G	p.Leu1904Val	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00143		cloned	in vitro	1						286	1741	0	15	9	0011_0005710_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11		1910	A to T	Asn to Ile	p.Asn1910Ile	c.5729A>T	p.Asn1910Ile	LOH analysis	Not applicable	Loss of variant allele	{PMID20054658:Beristain et al. (2010)}		BRCA2_00494		Not applicable	in vitro	1						951	2462	0	55	9	0011_0005729_0000000	10	4	9/23/11 13:43	4	9/23/11 13:47	4	9/23/11 13:43		
11	5967	1913	T to A	Cys to Stop	C1913X	c.5739T>A	p.Cys1913X	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00144		cloned	in vitro	1						287	1742	0	55	9	0011_0005739_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5972	1915	C to T	Thr to Met	5972C/T (T1915M)	c.5744C>T	p.Thr1915Met	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00145		cloned	in vitro	1						288	1743	0	15	9	0011_0005744_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5972	1915	C to T	Thr to Met	T1915M	c.5744C>T	p.Thr1915Met	?	?	?	{PMID10699917:Spitzer et al. (2000)}		BRCA2_00145		cloned	in vitro	1						289	1744	0	55	9	0011_0005744_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5972	1915	C to T	Thr to Met	T1915M	c.5744C>T	p.Thr1915Met	?	?	?	{PMID17341484:Johnson et al. (2007)}		BRCA2_00145		cloned	in vitro	1						290	1745	0	55	9	0011_0005744_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5972	1915	C to T	Thr to Met	T1915M	c.5744C>T	p.Thr1915Met	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00145		cloned	in vitro	1						291	1746	0	55	9	0011_0005744_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	5972	1915	C to T	Thr to Met	p.Thr1915Met	c.5744C>T	p.Thr1915Met	LOH analysis	Not Applicable	partial loss of wild type allele	{PMID20054658:Beristain et al. (2010)}		BRCA2_00145		Not applicable	in vitro	1						945	2462	0	55	9	0011_0005744_0000000	10	4	9/23/11 13:43	4	9/23/11 13:48	4	9/23/11 13:43		
11	5980	1918	C to T	His to Tyr	H1918Y	c.5752C>T	p.His1918Tyr	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00146		cloned	in vitro	1						292	1747	0	15	9	0011_0005752_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6013	1929	A to G	Ile to Val	I1929V	c.5785A>G	p.Ile1929Val	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00147		cloned	in vitro	1						293	1748	0	15	9	0011_0005785_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6124	1966	C to T	His to Tyr	H1966Y	c.5896C>T	p.His1966Tyr	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00148		cloned	in vitro	1						295	1750	0	15	9	0011_0005896_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6174	1982	del T	Stop2003	6174delT	c.5946delT	p.Ser1982fs	Radiation sensitivity	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00149		cloned	in vitro	1						297	1752	0	55	9	0011_0005946_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6174	1982	del T	Stop2003	6174delT	c.5946delT	p.Ser1982fs	Nuclear localisation	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00149		cloned	in vitro	1						298	1753	0	55	9	0011_0005946_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6174	1982	del T	Stop2003	6174delT	c.5946delT	p.Ser1982fs	Centrosome amplification	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00149		cloned	in vitro	1						299	1754	0	55	9	0011_0005946_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6174	1982	del T	Stop2003	6174delT	c.5946delT	p.Ser1982fs	Homology-directed repair assay	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00149		cloned	in vitro	1						300	1755	0	55	9	0011_0005946_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6174	1982	del T	Stop2003	6174delT	c.5946delT	p.Ser1982fs	Survival assay with VC8 (after MMC treatment)	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00149		cloned	in vitro	1						301	1756	0	55	9	0011_0005946_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6174	1982	del T	Stop2003	6174delT	c.5946delT	p.Ser1982fs	Co-segregation in families	Not Applicable	Predicted deleterious	{PMID15695382:Wu et al. (2005)}		BRCA2_00149		cloned	in vitro	1						302	1757	0	95	9	0011_0005946_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6174	1982	del T	Stop2003	6174delT	c.5946delT	p.Ser1982fs	Cell viability (in BRCA-/- cells)	Not Applicable	As mutant control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00149		cloned	in vitro	1						303	1758	0	55	9	0011_0005946_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6208	1994	C to T	Gln to Stop	Q1994X	c.5980C>T	p.Gln1994X	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00150		cloned	in vitro	1						304	1759	0	55	9	0011_0005980_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6242	2005	A to T	Asp to Val	D2005V	c.6014A>T	p.Asp2005Val	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00151		cloned	in vitro	1						305	1760	0	55	9	0011_0006014_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6246	2006	T to A	Ser to Arg	S2006R	c.6018T>A	p.Ser2006Arg	HR assay	not applicable	predicted pathogenic	{PMID21671020:Balia et al. (2011)}		BRCA2_00506		not applicable	in vitro	1						965	2513	0	75	9	0011_0006018_0000000	27	0	3/23/12 18:29	4	3/29/12 8:50	0	3/23/12 18:29		
11		2034	C to T	Arg to Cys	R2034C	c.6100 C>T	p.Arg2034Cys	coocurrence	Not applicable	neutral	"{PMID22144684:Caputo et al., 2011}"		BRCA2_00498		not applicable	in vitro	1						955	2503	0	35	9	0011_0006100_0000000	26	0	3/23/12 17:17	4	4/6/12 9:30	0	3/23/12 17:17		
11	6328	2034	C to T	Arg to Cys	R2034C	c.6100C>T	p.Arg2034Cys	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00152		cloned	in vitro	1						307	1762	0	55	9	0011_0006100_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6328	2034	C to T	Arg to Cys	R2034C	c.6100C>T	p.Arg2034Cys	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00152		cloned	in vitro	1						308	1763	0	15	9	0011_0006100_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6328	2034	C to T	Arg to Cys	R2034C	c.6100C>T	p.Arg2034Cys	Co-segregation in families	Not Applicable	Predicted neutral	{PMID12215251:Deffenbaugh et al. (2002)}		BRCA2_00152		cloned	in vitro	1						309	1764	0	15	9	0011_0006100_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6328	2034	C to T	Arg to Cys	R2034C	c.6100C>T	p.Arg2034Cys	Co-occurrence with deleterious mutation	Not Applicable	Predicted neutral	{PMID12215251:Deffenbaugh et al. (2002)}		BRCA2_00152		cloned	in vitro	1						310	1765	0	15	9	0011_0006100_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6328	2034	C to T	Arg to Cys	R2034C	c.6100C>T	p.Arg2034Cys	Histopathology	Not Applicable	Inconclusive	{PMID18824701:Spearman et al. (2008)}		BRCA2_00152		cloned	in vitro	1						311	1766	0	55	9	0011_0006100_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6328	2034	C to T	Arg to Cys	R2034C	c.6100C>T	p.Arg2034Cys	?	?	?	{PMID17341484:Johnson et al. (2007)}		BRCA2_00152		cloned	in vitro	1						312	1767	0	55	9	0011_0006100_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6328	2034	C to T	Arg to Cys	R2034C	c.6100C>T	p.Arg2034Cys	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00152		cloned	in vitro	1						313	1768	0	55	9	0011_0006100_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6328	2034	C to T	Arg to Cys	R2034C	c.6100C>T	p.Arg2034Cys	LOH analysis	Not applicable	Loss of wild type allele	{PMID20054658:Beristain et al. (2010)}		BRCA2_00152		Not applicable	in vitro	1						946	2462	0	55	9	0011_0006100_0000000	10	4	9/23/11 13:43	4	9/23/11 13:49	4	9/23/11 13:43		
11	6359	2044	G to C	Gly to Ala	G2044A	c.6131G>C	p.Gly2044Ala	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00153		cloned	in vitro	1						314	1769	0	55	9	0011_0006131_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6371	2048	A to T	Asn to Ile	N2048I	c.6143A>T	p.Asn2048Ile	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00154		cloned	in vitro	1						315	1770	0	15	9	0011_0006143_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6448	2074	C to A	His to Asn	H2074N	c.6220C>A	p.His2074Asn	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00155		cloned	in vitro	1						316	1771	0	15	9	0011_0006220_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6448	2074	C to A	His to Asn	H2074N	c.6220C>A	p.His2074Asn	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00155		cloned	in vitro	1						317	1772	0	15	9	0011_0006220_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6503	2092	del TT	Stop2098	6503delTT	c.6275_6276delTT	p.Leu2092fs	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00156		cloned	in vitro	1						318	1773	0	55	9	0011_0006275_0000000_0006276_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6518	2097	C to T	Thr to Met	T2097M	c.6290C>T	p.Thr2097Met	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00157		cloned	in vitro	1						319	1774	0	55	9	0011_0006290_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6545	2106	T to C	Leu to Pro	L2106P	c.6317T>C	p.Leu2106Pro	Histopathology	Not Applicable	Inconclusive	{PMID18824701:Spearman et al. (2008)}		BRCA2_00158		cloned	in vitro	1						320	1775	0	55	9	0011_0006317_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6550	2108	C to T	Arg to Cys	R2108C	c.6322C>T	p.Arg2108Cys	"HR assay, LOH assay"	not applicable	"predicted pathogenic, no LOH"	{PMID21671020:Balia et al. (2011)}		BRCA2_00508		not applicable	in vitro	1						967	2515	0	75	9	0011_0006322_0000000	27	0	3/23/12 18:37	4	3/29/12 8:47	0	3/23/12 18:37		
11	6551	2108	G to A	Arg to His	R2108H	c.6323G>A	p.Arg2108His	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00159		cloned	in vitro	1						321	1776	0	15	9	0011_0006323_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6551	2108	G to A	Arg to His	R2108H	c.6323G>A	p.Arg2108His	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00159		cloned	in vitro	1						322	1777	0	55	9	0011_0006323_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6551	2108	G to A	Arg to His	R2108H	c.6323G>A	p.Arg2108His	Embryonic stem cell assay	Not Applicable	As wildtype	{PMID22678057:Biswas et al. (2012)}		BRCA2_00159		not applicable	in vitro	1						984	2534	0	35	9	0011_0006323_0000000	10	4	2/5/14 21:32	4	2/5/14 21:32	4	2/5/14 21:32		
11	6566	2113	A to G	Asn to Ser	N2113S	c.6338A>G	p.Asn2113Ser	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00160		cloned	in vitro	1						323	1778	0	15	9	0011_0006338_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6640	2138	G to T	Val to Phe	V2138F	c.6412G>T	p.Val2138Phe	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00161		cloned	in vitro	1						325	1780	0	15	9	0011_0006412_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6710	2161	del ACAA	Stop2166	6710del4	c.6486_6489del	p.Lys2162AsnfsX5	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00162		cloned	in vitro	1						327	1782	0	55	9	0011_0006486_0000000_0006489_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6710	2161	del ACAA	Stop2166	6710del4	c.6486_6489del	p.Lys2162AsnfsX5	Loss of Heterozygosity	Not Applicable	As mutant control	{PMID10969800:Gayther et al. (2000)}		BRCA2_00162		cloned	in vitro	1						328	1783	0	55	9	0011_0006486_0000000_0006489_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6741	2171	C to G	Val to Val	6741C/G (V2171V)	c.6513C>G	p.Val2171Val	Allele frequency analysis in controls	Not Applicable	Predicted neutral	{PMID15317758:Freedman et al (2004)}		BRCA2_00163		cloned	in vitro	1						331	1786	0	15	9	0011_0006513_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6741	2171	C to G	Val to Val	6741C/G (V2171V)	c.6513C>G	p.Val2171Val	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00163		cloned	in vitro	1						332	1787	0	15	9	0011_0006513_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6893	2222	A to G	Tyr to Cys	Y2222C	c.6665A>G	p.Tyr2222Cys	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00164		cloned	in vitro	1						334	1789	0	55	9	0011_0006665_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	6976	2250	A to G	Thr to Ala	T2250A	c.6748A>G	p.Thr2250Ala	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00165		cloned	in vitro	1						335	1790	0	15	9	0011_0006748_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	7049	2274	G to T	Gly to Val	G2274V	c.6821G>T	p.Gly2274Val	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00166		cloned	in vitro	1						336	1791	0	15	9	0011_0006821_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	7049	2274	G to T	Gly to Val	G2274V	c.6821G>T	p.Gly2274Val	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00166		cloned	in vitro	1						337	1792	0	15	9	0011_0006821_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
11	7069		+80 del TTAA	-	IVS11+80del4	c.6841+80_6841+83del	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00168		cloned	in vitro	1						339	1794	0	15	9	0011_0006841_0000080_0006841_0000083	1	0	10/3/09 17:15			0	10/3/09 17:15		
12	7084		delAAAAG	Stop2291	7084delAAAAG	?	?	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00057		cloned	in vitro	1						344	1799	0	55	9	0012_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
12	7070		-51 G to T	-	IVS11-51G>T	unclear	?	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00027		cloned	in vitro	1						341	1796	0	55	9	0012_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
12	7070		-20 T to A	-	IVS11-20T/A	c.6842-20T>A	?	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00169		cloned	in vitro	1						340	1795	0	15	9	0012_0006842_-999980	1	0	10/3/09 17:15			0	10/3/09 17:15		
12	7081	2285	A to G	Ile to Val	I2285V	c.6853A>G	p.Ile2285Val	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00170		cloned	in vitro	1						342	1797	0	15	9	0012_0006853_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
12	7081	2285	A to G	Ile to Val	I2285V	c.6853A>G	p.Ile2285Val	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00170		cloned	in vitro	1						343	1798	0	15	9	0012_0006853_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
12		2285		Ile to Val		c.6853A>G	p.Ile2285Val	cell survival by crystal violet staining and CDDE	Not applicable	neutral	{PMID21741379:Warren et al. (2011)}		BRCA2_00170		not applicable	in vitro	1						952	2501	0	35	9	0012_0006853_0000000	26	0	3/21/12 11:47	4	6/21/12 8:34	0	3/21/12 11:47		
12	7105	2293	T to C	Phe to Leu	7105	c.6877T>C	p.Phe2293Leu	Cell survival and apoptosis	not applicable	no functional effect	{PMID21741379:Warren et al. (2011)}		BRCA2_00516		not applicable	in vitro	1						975	2523	0	35	9	0012_0006877_0000000	10	4	6/21/12 8:50	4	6/21/12 8:50	4	6/21/12 8:50		
12	7163	2312	A to T	Asp to Val	D2312V	c.6935A>T	p.Asp2312Val	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00171		cloned	in vitro	1						345	1800	0	15	9	0012_0006935_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
13	7166		-9 del4	-	IVS12-9del4	c.6938-8_6938-5del	?	mRNA analysis (RT-PCR)	Not Applicable	As wildtype control	{PMID17011978:Bonatti et al. (2006)}		BRCA2_00172		cloned	in vitro	1						346	1801	0	15	9	0013_0006938_-999992_0006938_-999995	1	0	10/3/09 17:15			0	10/3/09 17:15		
13	7181	2318	G to A	Arg to Gln	R2318Q	c.6953G>A	p.Arg2318Gln	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00173		cloned	in vitro	1						347	1802	0	55	9	0013_0006953_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
13	7181	2318	G to A	Arg to Gln	7181 G>A	c.6953G>A	p.Arg2318Gln	cell survival by crystal violet staining and CDDE	Not applicable	predicted pathogenic	{PMID21741379:Warren et al. (2011)}		BRCA2_00496		not applicable	in vitro	1						954	2503	0	75	9	0013_0006953_0000000	26	0	3/23/12 17:17	4	6/21/12 8:39	0	3/23/12 17:17		
13	7235	2336	G to A	Arg to His	R2336H	c.7007G>A	p.Arg2336His	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00175		cloned	in vitro	1						349	1804	0	95	9	0013_0007007_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
13	7235	2336	G to A	Arg to His	R2336H	c.7007G>A	p.Arg2336His	mRNA analysis (RT-PCR)	Not Applicable	Predicted deleterious	{PMID16792514:Thomassen et al. (2006)}		BRCA2_00175		cloned	in vitro	1						350	1805	0	95	9	0013_0007007_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
13	7235	2336	G to A	Arg to His	R2336H	c.7007G>A	p.Arg2336His	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00175		cloned	in vitro	1						351	1806	0	95	9	0013_0007007_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
13	7235	2336	G to A	Arg to His		c.7007G>A	p.Gly2313AlafsX40	NNSPLICE and lymphocyte RT-PCR	-	Donor site disruption. Exon 13 skipping	{PMID20215541: Sanz et al. (2010)}		BRCA2_00175	r.6938_7007del	Va785	?	1	"Bilateral breast cancer, three or more BC cases in the family"					928	2387	0	95	9	0013_0007007_0000000	6	0	7/2/10 10:08	4	10/9/10 22:44	0	7/2/10 10:08		
13	7235	2336	G to A	Arg to His	R2336H	c.7007G>A	p.Arg2336His	"Embryonic stem cell assay, RNA analysis"	not applicable	"aberrant splicing, HR deficient"	{PMID21719596:Biswas et al.(2011)}		BRCA2_00510		not applicable	in vitro	1						969	2517	0	75	9	0013_0007007_0000000	27	0	3/24/12 16:22	4	6/21/12 11:11	0	3/24/12 16:22		
13	7235		+5 G to C	-	IVS13+5G>C	c.7007+5G>C	?	Histopathology	Not Applicable	Inconclusive	{PMID18824701:Spearman et al. (2008)}		BRCA2_00174		cloned	in vitro	1						348	1803	0	55	9	0013_0007007_0000005	1	0	10/3/09 17:15			0	10/3/09 17:15		
13						c.7008-62A>G	IVS13-62A>G	coocurrence	Not applicable	neutral	"{PMID22144684:Caputo et al., 2011}"		BRCA2_00178		not applicable	in vitro	1						956	2503	0	35	9	0013_0007008_-999938	26	0	3/23/12 17:17	4	4/6/12 9:33	0	3/23/12 17:17		
14	7252	2342	del20insTG	del2342-2348insLeu	7252_7272delinsTG	?	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID17011978:Bonatti et al. (2006)}		BRCA2_00057		cloned	in vitro	1						357	1812	0	55	9	0014_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7236		-62 A to G	-	IVS13-62A/G	c.7008-62A>G	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00178		cloned	in vitro	1						355	1810	0	15	9	0014_0007008_-999938	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7236		-62 A to G	-	IVS13-62A/G	c.7008-62A>G	?	?	?	?	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00178		cloned	in vitro	1						356	1811	0	55	9	0014_0007008_-999938	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7236		-2 A to G	-	IVS13-2A>G	c.7008-2A>G	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID17011978:Bonatti et al. (2006)}		BRCA2_00176		cloned	in vitro	1						352	1807	0	55	9	0014_0007008_-999998	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7236		-2 A to T	-	IVS13-2A>T	c.7008-2A>T	?	mRNA analysis (RT-PCR)	Not Applicable	Inconclusive	{PMID19423647:Colombo et al. (2009)}		BRCA2_00177		cloned	in vitro	1						353	1808	0	55	9	0014_0007008_-999998	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7236		-2 A to T	-	IVS13-2A>T	c.7008-2A>T	?	cDNA analysis	Not Applicable	Predicted deleterious	{PMID19179552:Pensabene et al. 2009}		BRCA2_00177		cloned	in vitro	1						354	1809	0	95	9	0014_0007008_-999998	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7280	2351	C to G	Ala to Gly	A2351G	c.7052C>G	p.Ala2351Gly	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00179		cloned	in vitro	1						358	1813	0	15	9	0014_0007052_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7285	2353	G to C	Gly to Arg	G2353R	c.7057G>C	p.Gly2353Arg	"HR assay, LOH assay"	not applicable	"predicted pathogenic, no LOH"	{PMID21671020:Balia et al. (2011)}		BRCA2_00507		not applicable	in vitro	1						966	2514	0	75	9	0014_0007057_0000000	27	0	3/23/12 18:33	4	3/27/12 10:17	0	3/23/12 18:33		
14	7378	2384	C to A	Gln to Lys	Q2384K	c.7150C>A	p.Gln2384Lys	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00180		cloned	in vitro	1						359	1814	0	15	9	0014_0007150_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7416	2396	G to T or C	Leu to Phe	L2396F	c.7188G>T?C	p.Leu2396Phe	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00181		cloned	in vitro	1						360	1815	0	15	9	0014_0007188_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14		2406	T to G		Phe to Leu	c.7218T>G	p.Phe2406Leu	Embryonic stem cell assay	not applicable	As wildtype	{PMID22678057:Biswas et al. (2012)}		BRCA2_00548		not applicable	in vitro	1						1025	2638	0	35	9	0014_0007218_0000000	10	4	2/19/14 21:52	4	2/19/14 22:09	4	2/19/14 21:52		
14	7460	2411	A to C	Lys to Thr	K2411T	c.7232A>C	p.Lys2411Thr	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00182		cloned	in vitro	1						361	1816	0	15	9	0014_0007232_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7470	2414	A to G	Ser to Ser	7470A/G (S2414S)	c.7242A>G	p.Ser2414Ser	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00183		cloned	in vitro	1						362	1817	0	15	9	0014_0007242_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7470	2414	A to G	Ser to Ser	7470A/G (S2414S)	c.7242A>G	p.Ser2414Ser	Allele frequency analysis in controls	Not Applicable	Predicted neutral	{PMID15317758:Freedman et al (2004)}		BRCA2_00183		cloned	in vitro	1						363	1818	0	15	9	0014_0007242_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7470	2414	A to G	Ser to Ser	S2414S	c.7242A>G	p.Ser2414Ser	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00183		cloned	in vitro	1						364	1819	0	55	9	0014_0007242_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7470	2414	A to G	Ser to Ser	S2414S	c.7242A>G	p.Ser2414Ser	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00183		cloned	in vitro	1						365	1820	0	55	9	0014_0007242_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7480	2418	A to G	Arg to Gly	R2418G	c.7252A>G	p.Arg2418Gly	Histopathology	Not Applicable	Inconclusive	{PMID18824701:Spearman et al. (2008)}		BRCA2_00184		cloned	in vitro	1						366	1821	0	55	9	0014_0007252_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7535	2436	A to T	Asn to Ile	N2436I	c.7307A>T	p.Asn2436Ile	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00185		cloned	in vitro	1						367	1822	0	15	9	0014_0007307_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14		2446	A>G	Lys to Gly	c.7336A>G	c.7336A>G	p.Lys2446Gly	RNA analysis	not applicable	Normal RNA splicing	{PMID20513136:Walker et al. (2010)}		BRCA2_00489		not applicable	in vitro	1						939	2437	0	35	9	0014_0007336_0000000	10	4	6/30/11 18:35	4	6/30/11 18:42	4	6/30/11 18:35		
14		2452	A to G	Asn to Asp		c.7351A>G	p.Asn2452Asp	cell survival by crystal violet staining and CDDE	Not applicable	neutral	{PMID21741379:Warren et al. (2011)}		BRCA2_00495		not applicable	in vitro	1						953	2502	0	35	9	0014_0007351_0000000	26	0	3/23/12 16:21	4	6/21/12 8:28	0	3/23/12 16:21		
14	7625	2466	C to T	Ala to Val	A2466V	c.7397C>T	p.Ala2466Val	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00186		cloned	in vitro	1						368	1823	0	15	9	0014_0007397_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7625	2466	C to T	Ala to Val	A2466V	c.7397C>T	p.Ala2466Val	Allele frequency analysis in controls	Not Applicable	Predicted neutral	{PMID15317758:Freedman et al (2004)}		BRCA2_00186		cloned	in vitro	1						369	1824	0	15	9	0014_0007397_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7625	2466	C to T	Ala to Val	c.7397C>T	c.7397C>T	p.Ala2466Val	splicing reporter minigene	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00186		cloned	in vitro	1						997	2573	0	55	9	0014_0007397_0000000	0	4	2/19/14 14:34	4	2/19/14 22:10	4	2/19/14 14:34		
14	7643	2472	A to C	Lys to Thr	K2472T	c.7415A>C	p.Lys2472Thr	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18375895:Spurdle et al. (2008)}		BRCA2_00187		cloned	in vitro	1						370	1825	0	15	9	0014_0007415_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7663		+53 C to T	-	IVS14+53C/T	c.7435+53C>T	?	?	?	?	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00188		cloned	in vitro	1						371	1826	0	55	9	0014_0007435_0000053	1	0	10/3/09 17:15			0	10/3/09 17:15		
14	7663		+53 C to T	-	IVS14+53C/T	c.7435+53C>T	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00188		cloned	in vitro	1						372	1827	0	15	9	0014_0007435_0000053	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7772		insA	Stop2536	7772insA	?	?	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00057		cloned	in vitro	1						401	1856	0	55	9	0015_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7845		+15 C to T	-	IVS15+7C\\\\T	unclear	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00027		cloned	in vitro	1						423	1878	0	55	9	0015_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7666	2480	T to G	Leu to Val	L2480V	c.7438T>G	p.Leu2480Val	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00189		cloned	in vitro	1						373	1828	0	15	9	0015_0007438_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7666	2480	T to G	Leu to Val	L2480V	c.7438T>G	p.Leu2480Val	?	?	?	Personal communication		BRCA2_00189		cloned	in vitro	1						374	1829	0	55	9	0015_0007438_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7666	2480	T to G	Leu to Val	L2480V	c.7438T>G	p.Leu2480Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00189		cloned	in vitro	1						375	1830	0	15	9	0015_0007438_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7675	2483	A to G	Ser to Gly	S2483G	c.7447A>G	p.Ser2483Gly	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00190		cloned	in vitro	1						376	1831	0	15	9	0015_0007447_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7675	2483	A to G	Ser to Gly	S2483G	c.7447A>G	p.Ser2483Gly	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00190		cloned	in vitro	1						377	1832	0	55	9	0015_0007447_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7676	2483	G to A	Ser to Asn	S2483N	c.7448G>A	p.Ser2483Asn	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00191		cloned	in vitro	1						378	1833	0	15	9	0015_0007448_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7676	2483	G to A	Ser to Asn	S2483N	c.7448G>A	p.Ser2483Asn	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00191		cloned	in vitro	1						379	1834	0	15	9	0015_0007448_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7691	2488	G to A	Arg to Lys	c.7463G>A	7463G>A	p.Arg2488Lys	splicing reporter minigene/patient RNA analysis	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00530		cloned	in vitro	1						998	2574	0	55	9	0015_0007463_0000000	0	4	2/19/14 14:34	4	2/19/14 22:10	4	2/19/14 14:34		
15	7691	2488	G to A	Arg to Lys	R2488K	c.7463G>A	p.Arg2488Lys	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00192		cloned	in vitro	1						380	1835	0	15	9	0015_0007463_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7692	2488	A to C	Arg to Ser	R2488S	c.7464A>C	p.Arg2488Ser	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00193		cloned	in vitro	1						381	1836	0	55	9	0015_0007464_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7694	2489	A to G	Asp to Gly	D2489G	c.7466A>G	p.Asp2489Gly	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00194		cloned	in vitro	1						382	1837	0	15	9	0015_0007466_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7697	2490	T to C	Ile to Thr	I2490T	c.7469T>C	p.Ile2490Thr	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00195		cloned	in vitro	1						383	1838	0	15	9	0015_0007469_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7697	2490	T to C	Ile to Thr	I2490T	c.7469T>C	p.Ile2490Thr	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00195		cloned	in vitro	1						384	1839	0	95	9	0015_0007469_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7697	2490	T to C	Ile to Thr	I2490T	c.7469T>C	p.Ile2490Thr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00195		cloned	in vitro	1						385	1840	0	15	9	0015_0007469_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7697	2490	T to C	Ile to Thr	I2490T	c.7469T>C	p.Ile2490Thr	Allele frequency analysis in controls	Not Applicable	Predicted neutral	{PMID15317758:Freedman et al (2004)}		BRCA2_00195		cloned	in vitro	1						386	1841	0	15	9	0015_0007469_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7697	2490	T to C	Ile to Thr	I2490T	c.7469T>C	p.Ile2490Thr	Embryonic stem cell assay	DSS1 interaction not affected	As wild type	{PMID21719596:Biswas et al.(2011)}		BRCA2_00195		not applicable	in vitro	1						970	2518	0	35	9	0015_0007469_0000000	27	0	3/24/12 16:28	2	2/2/14 10:11	0	3/24/12 16:28		
15	7699	2491	C to T	Gln to Stop	Q2491X	c.7471C>T	p.Gln2491X	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00196		cloned	in vitro	1						387	1842	0	95	9	0015_0007471_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7709	2494	G to A	Arg to Gln	R2494Q	c.7481G>A	p.Arg2494Gln	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00197		cloned	in vitro	1						388	1843	0	95	9	0015_0007481_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7715	2496	A to C	Lys to Thr	K2496T	c.7487A>C	p.Lys2496Thr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00198		cloned	in vitro	1						389	1844	0	15	9	0015_0007487_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7727	2500	G to C	Arg to Thr	R2500T	c.7499G>C	p.Arg2500Thr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00199		cloned	in vitro	1						390	1845	0	15	9	0015_0007499_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7732	2502	C to T	Arg to Cys	R2502C	c.7504C>T	p.Arg2502Cys	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00200		cloned	in vitro	1						391	1846	0	95	9	0015_0007504_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7732	2502	C to T	Arg to Cys	R2502C	c.7504C>T	p.Arg2502Cys	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00200		cloned	in vitro	1						392	1847	0	15	9	0015_0007504_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7733	2502	G to A	Arg to His	R2502H	c.7505G>A	p.Arg2502His	Histopathology	Not Applicable	Inconclusive	{PMID18824701:Spearman et al. (2008)}		BRCA2_00201		cloned	in vitro	1						393	1848	0	55	9	0015_0007505_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7733	2502	G to A	Arg to His	R2502H	c.7505G>A	p.Arg2502His	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00201		cloned	in vitro	1						394	1849	0	15	9	0015_0007505_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7733	2502	G to C	Arg to Pro	R2502P	c.7505G>C	p.Arg2502Pro	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00202		cloned	in vitro	1						395	1850	0	15	9	0015_0007505_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7740	2504	T to G	Phe to Leu	F2504L	c.7512T>G	p.Phe2504Leu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00203		cloned	in vitro	1						396	1851	0	15	9	0015_0007512_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7750	2508	G to A	Gly to Ser	G2508S	c.7522G>A	p.Gly2508Ser	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00204		cloned	in vitro	1						397	1852	0	15	9	0015_0007522_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7750	2508	G to A	Gly to Ser	G2508S	c.7522G>A	p.Gly2508Ser	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00204		cloned	in vitro	1						398	1853	0	95	9	0015_0007522_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7757	2510	T to C	Leu to Pro	L2510P	c.7529T>C	p.Leu2510Pro	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00205		cloned	in vitro	1						399	1854	0	55	9	0015_0007529_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7757	2510	T to C	Leu to Pro	L2510P	c.7529T>C	p.Leu2510Pro	Embryonic stem cell assay	Reduced DSS1 binding	"Reduced complementation, HR deficient"	{PMID21719596:Biswas et al.(2011)}		BRCA2_00512		not applicable	in vitro	1						971	2519	0	75	9	0015_0007529_0000000	27	0	3/24/12 16:35	4	6/21/12 11:19	0	3/24/12 16:35		
15	7762	2512	C to T	Leu to Phe	L2512F	c.7534C>T	p.Leu2512Phe	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00206		cloned	in vitro	1						400	1855	0	15	9	0015_0007534_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7772	2515	C to T	Thr to Ile	T2515I	c.7544C>T	p.Thr2515Ile	Centrosome amplification	Not Applicable	Inconclusive	{PMID15695382:Wu et al. (2005)}		BRCA2_00207		cloned	in vitro	1						402	1857	0	55	9	0015_0007544_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7772	2515	C to T	Thr to Ile	T2515I	c.7544C>T	p.Thr2515Ile	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18375895:Spurdle et al. (2008)}		BRCA2_00207		cloned	in vitro	1						403	1858	0	15	9	0015_0007544_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7772	2515	C to T	Thr to Ile	T2515I	c.7544C>T	p.Thr2515Ile	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00207		cloned	in vitro	1						404	1859	0	15	9	0015_0007544_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7772	2515	C to T	Thr to Ile	T2515I	c.7544C>T	p.Thr2515Ile	Nuclear localisation	Not Applicable	Inconclusive	{PMID15695382:Wu et al. (2005)}		BRCA2_00207		cloned	in vitro	1						405	1860	0	55	9	0015_0007544_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7772	2515	C to T	Thr to Ile	T2515I	c.7544C>T	p.Thr2515Ile	Homology-directed repair assay	Not Applicable	Inconclusive	{PMID15695382:Wu et al. (2005)}		BRCA2_00207		cloned	in vitro	1						406	1861	0	55	9	0015_0007544_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7772	2515	C to T	Thr to Ile	T2515I	c.7544C>T	p.Thr2515Ile	Survival assay with VC8 (after MMC treatment)	Not Applicable	Predicted deleterious	{PMID15695382:Wu et al. (2005)}		BRCA2_00207		cloned	in vitro	1						407	1862	0	95	9	0015_0007544_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7772	2515	C to T	Thr to Ile	T2515I	c.7544C>T	p.Thr2515Ile	Co-segregation in families	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00207		cloned	in vitro	1						408	1863	0	15	9	0015_0007544_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7772	2515	C to T	Thr to Ile	T2515I	c.7544C>T	p.Thr2515Ile	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00207		cloned	in vitro	1						409	1864	0	15	9	0015_0007544_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7772	2515	C to T	Thr to Ile	T2515I	c.7544C>T	p.Thr2515Ile	cDNA analysis	Not Applicable	Predicted neutral	{PMID12955719:Campos et al. (2003)}		BRCA2_00207		cloned	in vitro	1						410	1865	0	15	9	0015_0007544_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7772	2515	C to T	Thr to Ile	T2515I	c.7544C>T	p.Thr2515Ile	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00207		cloned	in vitro	1						411	1866	0	55	9	0015_0007544_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7787	2520	G to A	Arg to Gln	R2520Q	c.7559G>A	p.Arg2520Gln	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00208		cloned	in vitro	1						412	1867	0	55	9	0015_0007559_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7787	2520	G to A	Arg to Gln	R2520Q	c.7559G>A	p.Arg2520Gln	Centrosome amplification	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00208		cloned	in vitro	1						413	1868	0	15	9	0015_0007559_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7787	2520	G to A	Arg to Gln	R2520Q	c.7559G>A	p.Arg2520Gln	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00208		cloned	in vitro	1						414	1869	0	15	9	0015_0007559_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7787	2520	G to A	Arg to Gln	R2520Q	c.7559G>A	p.Arg2520Gln	Homology-directed repair assay	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00208		cloned	in vitro	1						415	1870	0	15	9	0015_0007559_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7789	2521	A to G	Ile to Val	I2521V	c.7561A>G	p.Ile2521Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00209		cloned	in vitro	1						416	1871	0	15	9	0015_0007561_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7790	2521	T to C	Ile to Thr	I2521T	c.7562T>C	p.Ile2521Thr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00210		cloned	in vitro	1						417	1872	0	15	9	0015_0007562_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7793	2522	C to T	Ser to Phe	S2522F	c.7565C>T	p.Ser2522Phe	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00211		cloned	in vitro	1						418	1873	0	95	9	0015_0007565_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7811	2528	G to A	Gly to Glu	G2528E	c.7583G>A	p.Gly2528Glu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00212		cloned	in vitro	1						419	1874	0	15	9	0015_0007583_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7826	2533	C to G	Ser to Cys	S2533C	c.7598C>G	p.Ser2533Cys	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00213		cloned	in vitro	1						420	1875	0	55	9	0015_0007598_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7829	2534	C to T	Ala to Val	A2534V	c.7601C>T	p.Ala2534Val	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00214		cloned	in vitro	1						421	1876	0	55	9	0015_0007601_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
15	7845		+2 T to G	-	IVS15+2T>G	c.7617+2T>G	?	cDNA analysis	Not Applicable	As mutant control	{PMID18693280:Vreeswijk et al. (2008)}		BRCA2_00215		cloned	in vitro	1						422	1877	0	55	9	0015_0007617_0000002	1	0	10/3/09 17:15	4	5/23/14 15:53	0	10/3/09 17:15		
16	7838	2537	A to G	His to Arg	H2537R	c.7610A>G	p.His2537Arg	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00217		cloned	in vitro	1						425	1880	0	15	9	0016_0007610_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7846		-27 T to A	-	IVS15-27T/A	c.7618-27T>A	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00218		cloned	in vitro	1						426	1881	0	15	9	0016_0007618_-999973	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7853	2542	C to G	Thr to Arg	T2542R	c.7625C>G	p.Thr2542Arg	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00219		cloned	in vitro	1						427	1882	0	95	9	0016_0007625_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7853	2542	C to G	Thr to Arg	T2542R	c.7625C>G	p.Thr2542Arg	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00219		cloned	in vitro	1						428	1883	0	15	9	0016_0007625_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7861	2545	G to A	Val to Ile	V2545I	c.7633G>A	p.Val2545Ile	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00220		cloned	in vitro	1						429	1884	0	55	9	0016_0007633_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7867	2547	A to G	Lys to Glu	K2547E	c.7639A>G	p.Lys2547Glu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00221		cloned	in vitro	1						430	1885	0	15	9	0016_0007639_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7911	2561	G to A	Glu to Glu	c.7683G>A	c.7683G>A	p.=	splicing reporter minigene/patient RNA analysis	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00531		cloned	in vitro	1						999	2575	0	55	9	0016_0007683_0000000	0	4	2/19/14 14:34	4	2/19/14 22:11	4	2/19/14 14:34		
16	7912	2562	T to C	Phe to Leu	F2562L	c.7684T>C	p.Phe2562Leu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00222		cloned	in vitro	1						431	1886	0	15	9	0016_0007684_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7924	2566	G to T	Asp to Tyr	D2566Y	c.7696G>T	p.Asp2566Tyr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00223		cloned	in vitro	1						432	1887	0	15	9	0016_0007696_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7940	2571	A to G	Glu to Gly	E2571G	c.7712A>G	p.Glu2571Gly	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00224		cloned	in vitro	1						433	1888	0	15	9	0016_0007712_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7970	2581	T to G	Leu to Trp	L2581W	c.7742T>G	p.Leu2581Trp	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00225		cloned	in vitro	1						434	1889	0	55	9	0016_0007742_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7979	2584	G to A	Gly to Asp	G2584D	c.7751G>A	p.Gly2584Asp	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00226		cloned	in vitro	1						435	1890	0	55	9	0016_0007751_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7981	2585	G to A	Gly to Arg	G2585R	c.7753G>A	p.Gly2585Arg	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00227		cloned	in vitro	1						436	1891	0	55	9	0016_0007753_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7994	2589	C to A	Pro to His	P2589H	c.7766C>A	p.Pro2589His	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00228		cloned	in vitro	1						437	1892	0	55	9	0016_0007766_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	8000	2591	A to G	Asn to Ser	N2591S	c.7772A>G	p.Asn2591Ser	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00229		cloned	in vitro	1						438	1893	0	15	9	0016_0007772_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	8011	2595	G to T	Ala to Ser	A2595S	c.7783G>T	p.Ala2595Ser	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00230		cloned	in vitro	1						439	1894	0	15	9	0016_0007783_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
16	7805	2602	G to C	Arg to Thr	p.Arg2602Thr	c.7805G>C	p.Arg2602Thr	mRNA analysis and splicing reporter minigene	Not Applicable	Predicted deleterious	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00216		cloned	in vitro	1						424	1879	0	95	9	0016_0007805_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8138	2637	delCCTTT	Stop2638	8138del5	?	?	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00057		cloned	in vitro	1						459	1914	0	55	9	0017_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17			G to C			c.5075-1G>C	?	mRNA analysis	not applicable	Aberrant splicing	{PMID16211554:Tesoriero et al. (2005)}		BRCA2_00521		not applicable	in vitro	1						982	2532	0	75	9	0017_0005075_-999999	10	4	2/5/14 20:43	4	2/5/14 20:44	4	2/5/14 20:43		
17	8034		-14 T to C	-	IVS16-14T/C	c.7806-14T>C	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00233		cloned	in vitro	1						442	1897	0	55	9	0017_0007806_-999986	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8034		-14 T to C	-	IVS16-14T/C	c.7806-14T>C	?	?	?	?	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00233		cloned	in vitro	1						443	1898	0	55	9	0017_0007806_-999986	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8034		-14 T to C	-	IVS16-14T/C	c.7806-14T>C	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00233		cloned	in vitro	1						444	1899	0	15	9	0017_0007806_-999986	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	7806		T to G	-	7806-9T>G	c.7806-9T>G	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID17657584:Kwong et al. (2007)}		BRCA2_00231		cloned	in vitro	1						440	1895	0	55	9	0017_0007806_-999991	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8047	2607	A to C	Thr to Pro	T2607P	c.7819A>C	p.Thr2607Pro	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00234		cloned	in vitro	1						445	1900	0	95	9	0017_0007819_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8054	2609	G to A	Gly to Asp	G2609D	c.7826G>A	p.Gly2609Asp	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00235		cloned	in vitro	1						446	1901	0	95	9	0017_0007826_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8054	2609	G to A	Gly to Asp	G2609D	c.7826G>A	p.Gly2609Asp	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00235		cloned	in vitro	1						447	1902	0	95	9	0017_0007826_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8060	2611	A to G	Asp to Gly	D2611G	c.7832A>G	p.Asp2611Gly	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00236		cloned	in vitro	1						448	1903	0	95	9	0017_0007832_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8060	2611	A to G	Asp to Gly	D2611G	c.7832A>G	p.Asp2611Gly	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00236		cloned	in vitro	1						449	1904	0	15	9	0017_0007832_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8096	2623	A to G	His to Arg	H2623R	c.7868A>G	p.His2623Arg	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00237		cloned	in vitro	1						450	1905	0	95	9	0017_0007868_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8106	2626	G to C	Trp to Cys	W2626C	c.7878G>C	p.Trp2626Cys	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00238		cloned	in vitro	1						451	1906	0	95	9	0017_0007878_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8106	2626	G to C	Trp to Cys	W2626C	c.7878G>C	p.Trp2626Cys	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00238		cloned	in vitro	1						452	1907	0	95	9	0017_0007878_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8106	2626	G to C	Trp to Cys	W2626C	c.7878G>C	p.Trp2626Lys	Embryonic stem cell assay	DSS1 interaction not affected	"Reduced complementation, HR deficient"	{PMID21719596:Biswas et al.(2011)}		BRCA2_00513		not applicable	in vitro	1						972	2520	0	75	9	0017_0007878_0000000	27	0	3/24/12 16:39	4	5/23/14 14:41	0	3/24/12 16:39		
17	8107	2627	A to T	Ile to Phe	I2627F	c.7879A>T	p.Ile2627Phe	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00239		cloned	in vitro	1						453	1908	0	95	9	0017_0007879_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8107	2627	A to T	Ile to Phe	I2627F	c.7879A>T	p.Ile2627Phe	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00239		cloned	in vitro	1						454	1909	0	95	9	0017_0007879_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8107	2627	A to T	Ile to Phe	I2627F	c.7879A>T	p.Ile2627Phe	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00239		cloned	in vitro	1						455	1910	0	55	9	0017_0007879_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8107	2627	A to T	Ile to Phe	I2627F	c.7879A>T	p.Ile2627Phe	Centrosome amplification	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00239		cloned	in vitro	1						456	1911	0	55	9	0017_0007879_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8107	2627	A to T	Ile to Phe	I2627F	c.7879A>T	p.Ile2627Phe	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00239		cloned	in vitro	1						457	1912	0	95	9	0017_0007879_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8107	2627	A to T	Ile to Phe	I2627F	c.7879A>T	p.Ile2627Phe	?	?	?	{PMID10699917:Spitzer et al. (2000)}		BRCA2_00239		cloned	in vitro	1						458	1913	0	55	9	0017_0007879_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8143	2639	C to G	Pro to Ala	P2639A	c.7915C>G	p.Pro2639Ala	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00240		cloned	in vitro	1						460	1915	0	55	9	0017_0007915_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8156	2643	C to G	Ala to Gly	A2643G	c.7928C>G	p.Ala2643Gly	Centrosome amplification	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00241		cloned	in vitro	1						461	1916	0	15	9	0017_0007928_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8156	2643	C to G	Ala to Gly	A2643G	c.7928C>G	p.Ala2643Gly	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00241		cloned	in vitro	1						462	1917	0	15	9	0017_0007928_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8156	2643	C to G	Ala to Gly	A2643G	c.7928C>G	p.Ala2643Gly	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00241		cloned	in vitro	1						463	1918	0	15	9	0017_0007928_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8156	2643	C to G	Ala to Gly	A2643G	c.7928C>G	p.Ala2643Gly	Homology-directed repair assay	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00241		cloned	in vitro	1						464	1919	0	15	9	0017_0007928_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8156	2643	C to G	Ala to Gly	c.7928C>G	c.7928C>G	p.Ala2643Gly	splicing reporter minigene/patient RNA analysis	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00241		cloned	in vitro	1						1000	2576	0	55	9	0017_0007928_0000000	0	4	2/19/14 14:34	4	2/19/14 22:11	4	2/19/14 14:34		
17	8156	2643	C to T	Ala to Val	A2643V	c.7928C>T	p.Ala2643Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00242		cloned	in vitro	1						465	1920	0	15	9	0017_0007928_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8159	2644	A to G	Asn to Ser	N2644S	c.7931A>G	p.Asn2644Ser	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00243		cloned	in vitro	1						466	1921	0	15	9	0017_0007931_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8168	2647	T to C	Leu to Pro	L2647P	c.7940T>C	p.Leu2647Pro	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00244		cloned	in vitro	1						467	1922	0	55	9	0017_0007940_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8168	2647	T to C	Leu to Pro	L2647P	c.7940T>C	p.Leu2647Pro	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00244		cloned	in vitro	1						468	1923	0	95	9	0017_0007940_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8168	2647	T to C	Leu to Pro	L2647P	c.7940T>C	p.Leu2647Pro	Centrosome amplification	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00244		cloned	in vitro	1						469	1924	0	55	9	0017_0007940_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8168	2647	T to C	Leu to Pro	L2647P	c.7940T>C	p.Leu2647Pro	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00244		cloned	in vitro	1						470	1925	0	95	9	0017_0007940_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8186	2653	T to C	Leu to Pro	L2653P	c.7958T>C	p.Leu2653Pro	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00245		cloned	in vitro	1						471	1926	0	95	9	0017_0007958_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8186	2653	T to C	Leu to Pro	L2653P	c.7958T>C	p.Leu2653Pro	Centrosome amplification	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00245		cloned	in vitro	1						472	1927	0	55	9	0017_0007958_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8186	2653	T to C	Leu to Pro	L2653P	c.7958T>C	p.Leu2653Pro	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00245		cloned	in vitro	1						473	1928	0	55	9	0017_0007958_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8186	2653	T to C	Leu to Pro	L2653P	c.7958T>C	p.Leu2653Pro	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00245		cloned	in vitro	1						474	1929	0	95	9	0017_0007958_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8186	2653	T to C	Leu to Pro	L2653P	c.7958T>C	p.Leu2653Pro	Embryonic stem cell assay	Not Applicable	"reduced complementation, sensitive, HR deficient"	{PMID22678057:Biswas et al. (2012)}		BRCA2_00245		not applicable	in vitro	1						1018	2631	0	75	9	0017_0007958_0000000	10	4	2/19/14 21:29	4	2/19/14 22:12	4	2/19/14 21:29		
17	8189	2654	T to C	Leu to Pro	L2654P	c.7961T>C	p.Leu2654Pro	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00246		cloned	in vitro	1						475	1930	0	95	9	0017_0007961_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8192	2655	A to G	Gln to Arg	Q2655R	c.7964A>G	p.Gln2655Arg	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00247		cloned	in vitro	1						476	1931	0	95	9	0017_0007964_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8199	2657	A to G	Lys2657Lys	c.7971A>G	c.7971A>G	p.=	splicing reporter minigene/patient RNA analysis	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00532		cloned	in vitro	1						1001	2577	0	55	9	0017_0007971_0000000	0	4	2/19/14 14:34	4	2/19/14 22:12	4	2/19/14 14:34		
17	8203	2659	A to G	Arg to Gly	R2659G	c.7975A>G	p.Arg2659Gly	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00248		cloned	in vitro	1						477	1932	0	95	9	0017_0007975_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8204	2659	G to A	Del2602-2659	8204G>A (R2659K)	c.7976G>A	p.Ala2603_Arg2659del	mRNA analysis	?	in frame deletion exon 17	{PMID12624152:Hofmann et al. (2003)}		BRCA2_00249		cloned	in vitro	1						479	1934	0	55	9	0017_0007976_0000000	1	0	10/3/09 17:15	4	6/25/14 12:10	0	10/3/09 17:15		
17	8204	2659	G to A	Del2602-2659	8204G>A (R2659K)	c.7976G>A	p.Ala2603_Arg2659del	Homology-directed repair assay	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00249		cloned	in vitro	1						480	1935	0	55	9	0017_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8204	2659	G to A	Arg to Lys	R2659K	c.7976G>A	p.Arg2659Lys	Centrosome amplification	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00249		cloned	in vitro	1						483	1938	0	55	9	0017_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8204	2659	G to A	Arg to Lys	R2659K	c.7976G>A	p.Arg2659Lys	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00249		cloned	in vitro	1						484	1939	0	55	9	0017_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8204	2659	G to A	Arg to Lys	R2659K	c.7976G>A	p.Arg2659Lys	Evolutionary conservation analysis	Not Applicable	Predicted deleterious	{PMID15695382:Wu et al. (2005)}		BRCA2_00249		cloned	in vitro	1						485	1940	0	95	9	0017_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8204	2659	G to A	Arg to Lys	R2659K	c.7976G>A	p.Arg2659Lys	Homology-directed repair assay	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00249		cloned	in vitro	1						486	1941	0	55	9	0017_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8204	2659	G to A	Arg to Lys	R2659K	c.7976G>A	p.Arg2659Lys	Nuclear localisation	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00249		cloned	in vitro	1						487	1942	0	55	9	0017_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8204	2659	G to A	Arg to Lys	R2659K	c.7976G>A	p.Arg2659Lys	Centrosome amplification	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00249		cloned	in vitro	1						488	1943	0	55	9	0017_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8204	2659	G to A	Arg to Lys	R2659K	c.7976G>A	p.Arg2659Lys	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00249		cloned	in vitro	1						489	1944	0	55	9	0017_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8204	2659	G to A	Arg to Lys	R2659K	c.7976G>A	p.Arg2659Lys	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00249		cloned	in vitro	1						490	1945	0	95	9	0017_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8204	2659	G to A	Arg to Lys	R2659K	c.7976G>A	p.Arg2659Lys	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00249		cloned	in vitro	1						491	1946	0	95	9	0017_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8204	2659	G to A	Arg to Lys	R2659K	c.7976G>A	p.Arg2659Lys	Survival assay with VC8 (after MMC treatment)	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00249		cloned	in vitro	1						492	1947	0	55	9	0017_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	8204		+12 G to A	-	IVS17+12G/A	c.7976+12G>A	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00250		cloned	in vitro	1						482	1937	0	15	9	0017_0007976_0000012	1	0	10/3/09 17:15			0	10/3/09 17:15		
17	7976		C to A	-	c.7976+35C>A	c.7976+35C>A	?	mRNA analysis and splicing reporter minigene	Not Applicable	Predicted neutral	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00232		cloned	in vitro	1						441	1896	0	15	9	0017_0007976_0000035	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8238	2670	del GGCTATAAAAAAGATAATGGA	Stop2672	8238del23	?	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00057		cloned	in vitro	1						517	1972	0	55	9	0018_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8525	2766	del C	Stop2776	8525delC	?	?	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00057		cloned	in vitro	1						607	2062	0	55	9	0018_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8204	2659	G to C	Arg to Thr	R2659T	c.7976G>C	p.Arg2659Thr	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00253		cloned	in vitro	1						495	1950	0	95	9	0018_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8204	2659	G to C	Arg to Thr	R2659T	c.7976G>C	p.Arg2659Thr	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00253		cloned	in vitro	1						496	1951	0	95	9	0018_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8204	2659	G to C	Arg to Thr	R2659T	c.7976G>C	p.Arg2659Thr	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00253		cloned	in vitro	1						497	1952	0	55	9	0018_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8204	2659	G to C	Arg to Thr	R2659T	c.7976G>C	p.Arg2659Thr	Centrosome amplification	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00253		cloned	in vitro	1						498	1953	0	55	9	0018_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8204	2659	G to C	Arg to Thr	R2659T	c.7976G>C	p.Arg2659Thr	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00253		cloned	in vitro	1						499	1954	0	55	9	0018_0007976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8205	NA	 C to G	Not applicable	c.7977-7 C>G	c.7977-7 C>G	?	splicing reporter minigene/patient RNA analysis	not applicable	Insertion of 6 nt from 3\' of intron 17	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00541		cloned	in vitro	1						1013	2589	0	55	9	0018_0007977_-999993	0	4	2/19/14 14:34	4	2/19/14 22:21	4	2/19/14 14:34		
18	8205		-4 delTT	-	IVS17-4delTT	c.7977-4_7977-3del	?	mRNA analysis (RT-PCR)	Not Applicable	As wildtype control	{PMID16619214:Chen et al. (2006)}		BRCA2_00254		cloned	in vitro	1						500	1955	0	15	9	0018_0007977_-999996_0007977_-999997	1	0	10/3/09 17:15			0	10/3/09 17:15		
18			G to C		c.7977-1G>C	c.7977-1G>C	-	Multifactorial likelihood model	not applicable	likelihood score 29389:1	{PMID20020529:Spurdle et al. (2010)}		BRCA2_00488		not applicable	in vitro	1						935	2431	0	95	9	0018_0007977_-999999	10	4	4/26/11 10:21	4	4/26/11 10:22	4	4/26/11 10:21		
18	8206	2660	T to G	Tyr to Asp	Y2660D	c.7978T>G	p.Tyr2660Asp	Family history	Not Applicable	Predicted deleterious	{PMID19200354:Gomez-Garcia et al. (2009)}		BRCA2_00255		cloned	in vitro	1						501	1956	0	95	9	0018_0007978_0000000	1	0	10/3/09 17:15	4	8/20/10 16:47	0	10/3/09 17:15		
18	8206	2660	T to G	Tyr to Asp	Y2660D	c.7978T>G	p.Tyr2660Asp	Co-segregation in families	Not Applicable	Predicted deleterious	{PMID19563646:Mohammadi et al. (2009)}		BRCA2_00255		cloned	in vitro	1						502	1957	0	95	9	0018_0007978_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8206	2660	T to G	Tyr to Asp	Y2660D	c.7978T>G	p.Tyr2660Asp	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00255		cloned	in vitro	1						503	1958	0	95	9	0018_0007978_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8215	2663	G to A	Glu to Lys	E2663K	c.7987G>A	p.Glu2663Lys	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00256		cloned	in vitro	1						504	1959	0	95	9	0018_0007987_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8216	2663	A to T	Glu to Val	E2663V	c.7988A>T	p.Glu2663Val	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00257		cloned	in vitro	1						505	1960	0	95	9	0018_0007988_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8216	2663	A to T	Glu to Val	E2663V	c.7988A>T	p.Glu2663Val	Cell viability (in BRCA-/- cells)	Not Applicable	As mutant control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00257		cloned	in vitro	1						506	1961	0	55	9	0018_0007988_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8216	2663	A to T	Glu to Val	E2663V	c.7988A>T	p.Glu2663Val	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00257		cloned	in vitro	1						507	1962	0	95	9	0018_0007988_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8216	2663	A to T	Glu to Val	E2663V	c.7988A>T	p.Glu2663Val	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00257		cloned	in vitro	1						508	1963	0	95	9	0018_0007988_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8216	2663	A to T	Glu to Val	E2663V	c.7988A>T	p.Glu2663Val	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00257		cloned	in vitro	1						509	1964	0	55	9	0018_0007988_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8216	2663	A to T	Glu to Val	E2663V	c.7988A>T	p.Glu2663Val	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID20513136:Walker et al. (2010)}		BRCA2_00257		not applicable	in vitro	1						937	2435	0	95	9	0018_0007988_0000000	10	4	6/30/11 18:28	4	6/30/11 18:42	4	6/30/11 18:28		
18	8222	2665	A to G	Asp to Gly	D2665G	c.7994A>G	p.Asp2665Gly	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00258		cloned	in vitro	1						510	1965	0	15	9	0018_0007994_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8222	2665	A to G	Asp to Gly	D2665G	c.7994A>G	p.Asp2665Gly	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00258		cloned	in vitro	1						511	1966	0	55	9	0018_0007994_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8222	2665	A to G	Asp to Gly	D2665G	c.7994A>G	p.Asp2665Gly	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00258		cloned	in vitro	1						512	1967	0	15	9	0018_0007994_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8222	2665	A to G	Asp to Gly	D2665G	c.7994A>G	p.Asp2665Gly	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00258		cloned	in vitro	1						513	1968	0	15	9	0018_0007994_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8225	2666	G to C	Arg to Thr	R2666T	c.7997G>C	p.Arg2666Thr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00259		cloned	in vitro	1						514	1969	0	15	9	0018_0007997_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8237	2670	C to T	Ser to Leu	S2670L	c.8009C>T	p.Ser2670Leu	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00260		cloned	in vitro	1						515	1970	0	95	9	0018_0008009_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8237	2670	C to T	Ser to Leu	S2670L	c.8009C>T	p.Ser2670Leu	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00260		cloned	in vitro	1						516	1971	0	55	9	0018_0008009_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8242	2672	A to G	Ile to Val	I2672V	c.8014A>G	p.Ile2672Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00261		cloned	in vitro	1						518	1973	0	15	9	0018_0008014_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8023	2675	A to G	Ile to Val	p.Ile2675Val	c.8023A>G	p.Ile2675Val	mRNA analysis and splicing reporter minigene	Not Applicable	Predicted deleterious	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00251		cloned	in vitro	1						493	1948	0	95	9	0018_0008023_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8255	2676	T to C	Met to Thr	M2676T	c.8027T>C	p.Met2676Thr	Histopathology	Not Applicable	Inconclusive	{PMID18824701:Spearman et al. (2008)}		BRCA2_00262		cloned	in vitro	1						519	1974	0	55	9	0018_0008027_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8255	2676	T to C	Met to Thr	M2676T	c.8027T>C	p.Met2676Thr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00262		cloned	in vitro	1						520	1975	0	15	9	0018_0008027_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8260	2678	A to G	Arg to Gly	R2678G	c.8032A>G	p.Arg2678Gly	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00264		cloned	in vitro	1						522	1977	0	95	9	0018_0008032_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8263	2679	G to T	Asp to Tyr	D2679Y	c.8035G>T	p.Asp2679Tyr	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00265		cloned	in vitro	1						523	1978	0	95	9	0018_0008035_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8264	2679	A to G	Asp to Gly	D2679G	c.8036A>G	p.Asp2679Gly	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00266		cloned	in vitro	1						524	1979	0	95	9	0018_0008036_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8267	2680	A to G	Asp to Gly	D2680G	c.8039A>G	p.Asp2680Gly	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00267		cloned	in vitro	1						525	1980	0	15	9	0018_0008039_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8270	2681	C to G	Thr to Arg	T2681R	c.8042C>G	p.Thr2681Arg	Histopathology	Not Applicable	Inconclusive	{PMID18824701:Spearman et al. (2008)}		BRCA2_00268		cloned	in vitro	1						526	1981	0	55	9	0018_0008042_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8279	2684	A to G	Lys to Arg	K2684R	c.8051A>G	p.Lys2684Arg	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00269		cloned	in vitro	1						527	1982	0	15	9	0018_0008051_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8285	2686	T to C	Leu to Pro	L2686P	c.8057T>C	p.Leu2686Pro	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00270		cloned	in vitro	1						528	1983	0	95	9	0018_0008057_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8287	2687	G to T	Val to Phe	V2687F	c.8059G>T	p.Val2687Phe	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00271		cloned	in vitro	1						529	1984	0	95	9	0018_0008059_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8291	2688	T to C	Leu to Pro	L2688P	c.8063T>C	p.Leu2688Pro	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00272		cloned	in vitro	1						530	1985	0	95	9	0018_0008063_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8295	2689	T to A	Cys to Stop	C2689X	c.8067T>A	p.Cys2689X	?	?	?	{PMID10638982:Peelen et al. (2000)}		BRCA2_00273		cloned	in vitro	1						531	1986	0	55	9	0018_0008067_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8300	2691	C to T	Ser to Phe	S2691F	c.8072C>T	p.Ser2691Phe	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00274		cloned	in vitro	1						532	1987	0	95	9	0018_0008072_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8312	2695	C to T	Ser to Leu	S2695L	c.8084C>T	p.Ser2695Leu	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00275		cloned	in vitro	1						533	1988	0	55	9	0018_0008084_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8312	2695	C to T	Ser to Leu	S2695L	c.8084C>T	p.Ser2695Leu	Embryonic stem cell assay	Not Applicable	As wildtype	{PMID22678057:Biswas et al. (2012)}		BRCA2_00275		not applicable	in vitro	1						985	2535	0	35	9	0018_0008084_0000000	10	4	2/5/14 21:35	4	2/5/14 21:35	4	2/5/14 21:35		
18	8318	2697	G to A	Ser to Asn	S2697N	c.8090G>A	p.Ser2697Asn	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00276		cloned	in vitro	1						534	1989	0	15	9	0018_0008090_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8320	2698	G to A	Arg to His	R2698H	c.8092G>A	p.Arg2698His	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00277		cloned	in vitro	1						535	1990	0	15	9	0018_0008092_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8326	2700	A to C	Ile to Leu	I2700L	c.8098A>C	p.Ile2700Leu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00278		cloned	in vitro	1						536	1991	0	15	9	0018_0008098_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8339	2704	C to T	Ser to Phe	S2704F	c.8111C>T	p.Ser2704Phe	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00281		cloned	in vitro	1						539	1994	0	55	9	0018_0008111_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8339	2704	C to T	Ser to Phe	S2704F	c.8111C>T	p.Ser2704Phe	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00281		cloned	in vitro	1						540	1995	0	15	9	0018_0008111_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8345	2706	A to G	Asn to Ser	N2706S	c.8117A>G	p.Asn2706Ser	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00282		cloned	in vitro	1						541	1996	0	15	9	0018_0008117_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8362	2712	G to A	Asp to Asn	D2712N	c.8134G>A	p.Asp2712Asn	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00283		cloned	in vitro	1						542	1997	0	15	9	0018_0008134_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8363	2712	A to T	Asp to Val	D2712V	c.8135A>T	p.Asp2712Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00284		cloned	in vitro	1						543	1998	0	15	9	0018_0008135_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8369	2714	A to G	Gln to Arg	Q2714R	c.8141A>G	p.Gln2714Arg	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00285		cloned	in vitro	1						544	1999	0	15	9	0018_0008141_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8377	2717	G to T	Ala to Ser	A2717S	c.8149G>T	p.Ala2717Ser	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00286		cloned	in vitro	1						545	2000	0	15	9	0018_0008149_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8377	2717	G to T	Ala to Ser	A2717S	c.8149G>T	p.Ala2717Ser	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00286		cloned	in vitro	1						546	2001	0	55	9	0018_0008149_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8377	2717	G to T	Ala to Ser	A2717S	c.8149G>T	p.Ala2717Ser	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00286		cloned	in vitro	1						547	2002	0	55	9	0018_0008149_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8377	2717	G to T	Ala to Ser	A2717S	c.8149G>T	p.Ala2717Ser	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18375895:Spurdle et al. (2008)}		BRCA2_00286		cloned	in vitro	1						548	2003	0	15	9	0018_0008149_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8377	2717	G to T	Ala to Ser	A2717S	c.8149G>T	p.Ala2717Ser	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00286		cloned	in vitro	1						549	2004	0	55	9	0018_0008149_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8381	2718	T to C	Ile to Thr	I2718T	c.8153T>C	p.Ile2718Thr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00287		cloned	in vitro	1						550	2005	0	15	9	0018_0008153_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8390	2721	T to A	Leu to His	L2721H	c.8162T>A	p.Leu2721His	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00288		cloned	in vitro	1						551	2006	0	95	9	0018_0008162_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8162	2721	T to G	Leu to Arg	p.Leu2721Arg	c.8162T>G	p.Leu2721Arg	mRNA analysis and splicing reporter minigene	Not Applicable	Inconclusive	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00252		cloned	in vitro	1						494	1949	0	55	9	0018_0008162_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8393	2722	C to G	Thr to Arg	T2722R	c.8165C>G	p.Thr2722Arg	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00289		cloned	in vitro	1						552	2007	0	55	9	0018_0008165_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8393	2722	C to G	Thr to Arg	T2722R	c.8165C>G	p.Thr2722Arg	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00289		cloned	in vitro	1						553	2008	0	95	9	0018_0008165_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8393	2722	C to G	Thr to Arg	T2722R	c.8165C>G	p.Thr2722Arg	Centrosome amplification	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00289		cloned	in vitro	1						554	2009	0	55	9	0018_0008165_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8393	2722	C to G	Thr to Arg	T2722R	c.8165C>G	p.Thr2722Arg	cDNA analysis	Not Applicable	As mutant control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00289		cloned	in vitro	1						555	2010	0	55	9	0018_0008165_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8393	2722	C to G	Thr to Arg	T2722R	c.8165C>G	p.Thr2722Arg	Cell viability (in BRCA-/- cells)	Not Applicable	As mutant control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00289		cloned	in vitro	1						556	2011	0	55	9	0018_0008165_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8393	2722	C to G	Thr to Arg	T2722R	c.8165C>G	p.Thr2722Arg	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00289		cloned	in vitro	1						557	2012	0	95	9	0018_0008165_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8393	2722	C to G	Thr to Arg	T2722R	c.8165C>G	p.Thr2722Arg	mRNA analysis (RT-PCR)	Not Applicable	Predicted deleterious	{PMID12145750:Fackenthal et al. (2002)}		BRCA2_00289		cloned	in vitro	1						558	2013	0	95	9	0018_0008165_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8393	2722	C to G	Thr to Arg	T2722R	c.8165C>G	p.Thr2722Arg	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00289		cloned	in vitro	1						559	2014	0	95	9	0018_0008165_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00290		cloned	in vitro	1						560	2015	0	95	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID15290653:Goldgar et al. (2004)}		BRCA2_00290		cloned	in vitro	1						561	2016	0	15	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00290		cloned	in vitro	1						562	2017	0	95	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Nuclear localisation	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00290		cloned	in vitro	1						563	2018	0	55	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Centrosome amplification	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00290		cloned	in vitro	1						564	2019	0	55	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	?	?	?	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00290		cloned	in vitro	1						565	2020	0	55	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00290		cloned	in vitro	1						566	2021	0	55	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Homology-directed repair assay	Not Applicable	As mutant control	{PMID15695382:Wu et al. (2005)}		BRCA2_00290		cloned	in vitro	1						567	2022	0	55	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Survival assay with VC8 (after MMC treatment)	Not Applicable	Predicted deleterious	{PMID15695382:Wu et al. (2005)}		BRCA2_00290		cloned	in vitro	1						568	2023	0	95	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Co-segregation in families	Not Applicable	Predicted deleterious	{PMID15695382:Wu et al. (2005)}		BRCA2_00290		cloned	in vitro	1						569	2024	0	95	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID15290653:Goldgar et al. (2004)}		BRCA2_00290		cloned	in vitro	1						570	2025	0	95	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Centrosome amplification	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00290		cloned	in vitro	1						571	2026	0	55	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Nuclear localisation	Not Applicable	As mutant control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00290		cloned	in vitro	1						572	2027	0	55	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Evolutionary conservation analysis	Not Applicable	Predicted deleterious	{PMID15695382:Wu et al. (2005)}		BRCA2_00290		cloned	in vitro	1						573	2028	0	95	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8395	2723	G to C	Asp to His	D2723H	c.8167G>C	p.Asp2723His	Cell viability (in BRCA-/- cells)	Not Applicable	As mutant control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00290		cloned	in vitro	1						574	2029	0	55	9	0018_0008167_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8396	2723	A to G	Asp2723Gly	c.8168 A>G	c.8168 A>G	p.Asp2723Gly	splicing reporter minigene	not applicable	deletion of 164 nt from 3\' end of exon 18	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00533		cloned	in vitro	1						1002	2578	0	75	9	0018_0008168_0000000	0	4	2/19/14 14:34	4	2/19/14 22:21	4	2/19/14 14:34		
18	8396	2723	A to C	Asp to Ala	D2723A	c.8168A>C	p.Asp2723Ala	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00291		cloned	in vitro	1						575	2030	0	95	9	0018_0008168_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8396	2723	A to C	Asp to Ala	D2723A	c.8168A>C	p.Asp2723Ala	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00291		cloned	in vitro	1						576	2031	0	55	9	0018_0008168_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8396	2723	A to C	Asp to Ala	D2723A	c.8168A>C	p.Asp2723Ala	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00291		cloned	in vitro	1						577	2032	0	55	9	0018_0008168_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8396	2723	A to C	Asp to Ala	D2723A	c.8168A>C	p.Asp2723Ala	Centrosome amplification	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00291		cloned	in vitro	1						578	2033	0	55	9	0018_0008168_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8396	2723	A to G	Asp to Gly	D2723G	c.8168A>G	p.Asp2723Gly	Centrosome amplification	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00292		cloned	in vitro	1						579	2034	0	55	9	0018_0008168_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8396	2723	A to G	Asp to Gly	D2723G	c.8168A>G	p.Asp2723Gly	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00292		cloned	in vitro	1						580	2035	0	55	9	0018_0008168_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8396	2723	A to G	Asp to Gly	D2723G	c.8168A>G	p.Asp2723Gly	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00292		cloned	in vitro	1						581	2036	0	95	9	0018_0008168_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8396	2723	A to G	Asp to Gly	D2723G	c.8168A>G	p.Asp2723Gly	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00292		cloned	in vitro	1						582	2037	0	95	9	0018_0008168_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8396	2723	A to G	Asp to Gly	D2723G	c.8168A>G	p.Asp2723Gly	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00292		cloned	in vitro	1						583	2038	0	95	9	0018_0008168_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8396	2723	A to G	Asp to Gly	D2723G	c.8168A>G	p.Asp2723Gly	Multifactorial likelihood model	Not Applicable	Predicted deleterious	{PMID20513136:Walker et al. (2010)}		BRCA2_00292		not applicable	?	1						936	2434	0	95	9	0018_0008168_0000000	10	4	6/30/11 18:26	4	6/30/11 18:44	4	6/30/11 18:26		
18	8399	2724	G to T	Gly to Val	G2724V	c.8171G>T	p.Gly2724Val	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00293		cloned	in vitro	1						584	2039	0	95	9	0018_0008171_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8405	2726	A to G	Tyr to Cys	Y2726C	c.8177A>G	p.Tyr2726Cys	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00294		cloned	in vitro	1						585	2040	0	95	9	0018_0008177_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8410	2728	G to A	Val to Ile	V2728I	c.8182G>A	p.Val2728Ile	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00295		cloned	in vitro	1						586	2041	0	15	9	0018_0008182_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8410	2728	G to A	Val to Ile	V2728I	c.8182G>A	p.Val2728Ile	Cell viability (in BRCA-/- cells)	Not Applicable	As wildtype control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00295		cloned	in vitro	1						587	2042	0	15	9	0018_0008182_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8410	2728	G to A	Val to Ile	V2728I	c.8182G>A	p.Val2728Ile	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00295		cloned	in vitro	1						588	2043	0	55	9	0018_0008182_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8410	2728	G to A	Val to Ile	V2728I	c.8182G>A	p.Val2728Ile	Co-occurrence with deleterious mutation	Not Applicable	Predicted neutral	{PMID12215251:Deffenbaugh et al. (2002)}		BRCA2_00295		cloned	in vitro	1						589	2044	0	15	9	0018_0008182_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8410	2728	G to A	Val to Ile	V2728I	c.8182G>A	p.Val2728Ile	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID12215251:Deffenbaugh et al. (2002)}		BRCA2_00295		cloned	in vitro	1						590	2045	0	15	9	0018_0008182_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8410	2728	G to C	Val to Leu	V2728L	c.8182G>C	p.Val2728Leu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00296		cloned	in vitro	1						591	2046	0	15	9	0018_0008182_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8410	2728	G to C	Val to Leu	V2728L	c.8182G>C	p.Val2728Leu	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00296		cloned	in vitro	1						592	2047	0	55	9	0018_0008182_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8415	2729	G to T	Lys to Asn	K2729N	c.8187G>T	p.Lys2729Asn	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00297		cloned	in vitro	1						593	2048	0	15	9	0018_0008187_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8415	2729	G to T	Lys to Asn	K2729N	c.8187G>T	p.Lys2729Asn	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00297		cloned	in vitro	1						594	2049	0	55	9	0018_0008187_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8415	2729	G to T	Lys to Asn	K2729N	c.8187G>T	p.Lys2729Asn	Homology-directed repair assay	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00297		cloned	in vitro	1						595	2050	0	15	9	0018_0008187_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8415	2729	G to T	Lys to Asn	K2729N	c.8187G>T	p.Lys2729Asn	Centrosome amplification	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00297		cloned	in vitro	1						596	2051	0	15	9	0018_0008187_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8415	2729	G to T	Lys to Asn	K2729N	c.8187G>T	p.Lys2729Asn	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00297		cloned	in vitro	1						597	2052	0	15	9	0018_0008187_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8187	2729	G to T	Lys to Asn	K2729N	c.8187G>T	p.Lys2729Asn	Embryonis stem cell assay	DSS1 interaction not affected	As wild type	{PMID21719596:Biswas et al.(2011)}		BRCA2_00514		not applicable	in vitro	1						973	2521	0	35	9	0018_0008187_0000000	27	0	3/24/12 16:43	4	5/23/14 15:44	0	3/24/12 16:43		
18	8416	2730	G to C	Ala to Pro	A2730P	c.8188G>C	p.Ala2730Pro	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00298		cloned	in vitro	1						598	2053	0	95	9	0018_0008188_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8417	2730	C to T	Ala to Val	A2730V	c.8189C>T	p.Ala2730Val	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00299		cloned	in vitro	1						599	2054	0	95	9	0018_0008189_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8443	2739	G to A	Val to Ile	V2739I	c.8215G>A	p.Val2739Ile	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00300		cloned	in vitro	1						600	2055	0	15	9	0018_0008215_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8471	2748	G to A	Gly to Asp	G2748D	c.8243G>A	p.Gly2748Asp	Centrosome amplification	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00301		cloned	in vitro	1						601	2056	0	55	9	0018_0008243_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8471	2748	G to A	Gly to Asp	G2748D	c.8243G>A	p.Gly2748Asp	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00301		cloned	in vitro	1						602	2057	0	55	9	0018_0008243_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8471	2748	G to A	Gly to Asp	G2748D	c.8243G>A	p.Gly2748Asp	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00301		cloned	in vitro	1						603	2058	0	95	9	0018_0008243_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8471	2748	G to A	Gly to Asp	G2748D	c.8243G>A	p.Gly2748Asp	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00301		cloned	in vitro	1						604	2059	0	95	9	0018_0008243_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8471	2748	G to A	Gly to Asp	G2748D	c.8243G>A	p.Gly2748Asp	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00301		cloned	in vitro	1						605	2060	0	95	9	0018_0008243_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8482	2752	A to T	Ile to Phe	I2752F	c.8254A>T	p.Ile2752Phe	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00302		cloned	in vitro	1						606	2061	0	15	9	0018_0008254_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8257	2753	delCTT	Leu to del	p.Leu2753del	c.8257_8259delCTT	p.Leu2753del	mRNA analysis and splicing reporter minigene	Not Applicable	Inconclusive	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00263		cloned	in vitro	1						521	1976	0	55	9	0018_0008257_0000000_0008259_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8536	2770	G to A	Ala to Thr	A2770T	c.8308G>A	p.Ala2770Thr	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00303		cloned	in vitro	1						608	2063	0	55	9	0018_0008308_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8536	2770	G to A	Ala to Thr	A2770T	c.8308G>A	p.Ala2770Thr	mRNA analysis	Not Applicable	No evidence for aberrant splicing	{PMID20507642:Whiley et al. (2010)}		BRCA2_00303		not applicable	in vitro	1						930	2392	0	15	9	0018_0008308_0000000	10	4	10/26/10 13:09	4	10/29/10 9:52	4	10/26/10 13:09		
18	8552	2775	T to C	Met to Thr	M2775T	c.8324T>C	p.Met2775Thr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00305		cloned	in vitro	1						610	2065	0	15	9	0018_0008324_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8552	2775	T to G	Met to Arg	M2775R	c.8324T>G	p.Met2775Arg	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00304		cloned	in vitro	1						609	2064	0	15	9	0018_0008324_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8559	NA	 C to G	Not applicable	c.8331+16 C>G	c.8331+16 C>G	?	splicing reporter minigene	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00542		cloned	in vitro	1						1014	2590	0	55	9	0018_0008331_0000016	0	4	2/19/14 14:34	4	2/19/14 22:22	4	2/19/14 14:34		
18	8331		G to C	-	c.8331+22G>C	c.8331+22G>C	?	mRNA analysis and splicing reporter minigene	Not Applicable	Predicted neutral	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00279		cloned	in vitro	1						537	1992	0	15	9	0018_0008331_0000022	1	0	10/3/09 17:15			0	10/3/09 17:15		
18	8332		T to G	-	c.8332-54T>G	c.8332-54T>G	?	mRNA analysis and splicing reporter minigene	Not Applicable	Predicted neutral	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00280		cloned	in vitro	1						538	1993	0	15	9	0018_0008332_-999946	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	5416	1730	A to T	Asn to Tyr	N1730Y	c.5188A>T	p.Asn1730Tyr	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00306		cloned	in vitro	1						611	2066	0	55	9	0019_0005188_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8560		-66 T to C	-	IVS18-66T/C	c.8332-66T>C	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00308		cloned	in vitro	1						613	2068	0	15	9	0019_0008332_-999934	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8560		-64 A to G	-	IVS18-64A/G	c.8332-64A>G	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00307		cloned	in vitro	1						612	2067	0	15	9	0019_0008332_-999936	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8714	2778	A to G	del2788-2829 (in frame)	del exon 19	c.8332_8487del	p.Ile2778_Gln2829del	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00333		cloned	in vitro	1						644	2099	0	55	9	0019_0008332_0000000_0008487_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8578	2784	C to T	Arg to Trp	R2784W	c.8350C>T	p.Arg2784Trp	Family history	Not Applicable	Inconclusive	{PMID19200354:Gomez-Garcia et al. (2009)}		BRCA2_00309		cloned	in vitro	1						614	2069	0	55	9	0019_0008350_0000000	1	0	10/3/09 17:15	4	8/20/10 16:47	0	10/3/09 17:15		
19	8578	2784	C to T	Arg to Trp	R2784W	c.8350C>T	p.Arg2784Trp	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00309		cloned	in vitro	1						615	2070	0	95	9	0019_0008350_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8578	2784	C to T	Arg to Trp	R2784W	c.8350C>T	p.Arg2784Trp	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00309		cloned	in vitro	1						616	2071	0	55	9	0019_0008350_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8578	2784	C to T	Arg to Trp	R2784W	c.8350C>T	p.Arg2784Trp	Centrosome amplification	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00309		cloned	in vitro	1						617	2072	0	15	9	0019_0008350_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8578	2784	C to T	Arg to Trp	R2784W	c.8350C>T	p.Arg2784Trp	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00309		cloned	in vitro	1						618	2073	0	55	9	0019_0008350_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8579	2784	G to A	Arg to Gln	R2784Q	c.8351G>A	p.Arg2784Gln	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00310		cloned	in vitro	1						619	2074	0	95	9	0019_0008351_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8579	2784	G to A	Arg to Gln	R2784Q	c.8351G>A	p.Arg2784Gln	Co-segregation in families	Not Applicable	Predicted deleterious	{PMID19563646:Mohammadi et al. (2009)}		BRCA2_00310		cloned	in vitro	1						620	2075	0	95	9	0019_0008351_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8579	2784	G to A	Arg to Gln	R2784Q	c.8351G>A	p.Arg2784Gln	Family history	Not Applicable	Predicted deleterious	{PMID19200354:Gomez-Garcia et al. (2009)}		BRCA2_00310		cloned	in vitro	1						621	2076	0	95	9	0019_0008351_0000000	1	0	10/3/09 17:15	4	8/20/10 16:48	0	10/3/09 17:15		
19	8584	2786	G to C	Ala to Pro	A2786P	c.8356G>C	p.Ala2786Pro	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00311		cloned	in vitro	1						622	2077	0	95	9	0019_0008356_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8587	2787	C to T	Arg to Cys	R2787C	c.8359C>T	p.Arg2787Cys	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00312		cloned	in vitro	1						623	2078	0	95	9	0019_0008359_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8588	2787	G to A	Arg to His	R2787H	c.8360G>A	p.Arg2787His	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00313		cloned	in vitro	1						624	2079	0	15	9	0019_0008360_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8590	2788	T to C	Trp to Arg	W2788R	c.8362T>C	p.Trp2788Arg	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00314		cloned	in vitro	1						625	2080	0	95	9	0019_0008362_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8591	2788	G to C	Trp to Ser	W2788S	c.8363G>C	p.Trp2788Ser	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00315		cloned	in vitro	1						626	2081	0	95	9	0019_0008363_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8596	2790	A to T	Thr to Ser	T2790S	c.8368A>T	p.Thr2790Ser	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00316		cloned	in vitro	1						627	2082	0	55	9	0019_0008368_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8603	2792	T to C	Leu to Pro	L2792P	c.8375T>C	p.Leu2792Pro	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00317		cloned	in vitro	1						628	2083	0	95	9	0019_0008375_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8605	2793	G to A	Gly to Arg	G2793R	c.8377G>A	p.Gly2793Arg	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00318		cloned	in vitro	1						629	2084	0	95	9	0019_0008377_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8606	2793	G to A	Gly to Glu	G2793E	c.8378G>A	p.Gly2793Glu	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00319		cloned	in vitro	1						630	2085	0	95	9	0019_0008378_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8610	2794	C to G	Phe to Leu	F2794L	c.8382C>G	p.Phe2794Leu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00320		cloned	in vitro	1						631	2086	0	15	9	0019_0008382_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8626	2800	C to T	Pro to Ser	P2800S	c.8398C>T	p.Pro2800Ser	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00321		cloned	in vitro	1						632	2087	0	15	9	0019_0008398_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8627	2800	C to G	Pro to Arg	P2800R	c.8399C>G	p.Pro2800Arg	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00322		cloned	in vitro	1						633	2088	0	15	9	0019_0008399_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8648	2807	C to T	Ser to Leu	S2807L	c.8420C>T	p.Ser2807Leu	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00323		cloned	in vitro	1						634	2089	0	55	9	0019_0008420_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8656	2810	A to G	Ser to Gly	S2810G	c.8428A>G	p.Ser2810Gly	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00324		cloned	in vitro	1						635	2090	0	15	9	0019_0008428_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8660	2811	A to G	Asp to Gly	D2811G	c.8432A>G	p.Asp2811Gly	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00325		cloned	in vitro	1						636	2091	0	15	9	0019_0008432_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8663	2812	G to A	Gly to Glu	G2812E	c.8435G>A	p.Gly2812Glu	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00326		cloned	in vitro	1						637	2092	0	95	9	0019_0008435_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8666	2813	G to A	Gly to Glu	G2813E	c.8438G>A	p.Gly2813Glu	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00327		cloned	in vitro	1						638	2093	0	95	9	0019_0008438_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8671	2815	G to A	Val to Ile	V2815I	c.8443G>A	p.Val2815Ile	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00328		cloned	in vitro	1						639	2094	0	55	9	0019_0008443_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8680	2818	G to A	Val to Ile	V2818I	c.8452G>A	p.Val2818Ile	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00329		cloned	in vitro	1						640	2095	0	15	9	0019_0008452_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8686	2820	G to T	Val to Leu	V2820L	c.8458G>T	p.Val2820Leu	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00330		cloned	in vitro	1						641	2096	0	95	9	0019_0008458_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8688	2820	A to C	Val to Val	c.8460A>C	c.8460A>C	p.=	splicing reporter minigene/patient RNA analysis	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00534		cloned	in vitro	1						1003	2579	0	55	9	0019_0008460_0000000	0	4	2/19/14 14:34	4	2/19/14 22:22	4	2/19/14 14:34		
19	8690	2821	T to C	Ile to Thr	I2821T	c.8462T>C	p.Ile2821Thr	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00331		cloned	in vitro	1						642	2097	0	55	9	0019_0008462_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8710	2828	A to G	Ile to Val	I2828V	c.8482A>G	p.Ile2828Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00332		cloned	in vitro	1						643	2098	0	15	9	0019_0008482_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8714	2829	A to T	Gln to Leu	Q2829L	c.8486A>T	p.Gln2829Leu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00334		cloned	in vitro	1						645	2100	0	15	9	0019_0008486_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8715		+1 G to A	-	IVS19+1G>A	c.8487+1G>A	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID12606139:Agata et al. (2003)}		BRCA2_00336		cloned	in vitro	1						647	2102	0	55	9	0019_0008487_0000001	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8715		+1 G to A	-	IVS19+1G>A	c.8487+1G>A	?	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00336		cloned	in vitro	1						648	2103	0	95	9	0019_0008487_0000001	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8715		+1 G to A	-	IVS19+1G>A	c.8487+1G>A	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID16619214:Chen et al. (2006)}		BRCA2_00336		cloned	in vitro	1						649	2104	0	55	9	0019_0008487_0000001	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8715		+19 A to G	-	IVS19+19A>G	c.8487+19A>G	?	mRNA analysis (RT-PCR)	Not Applicable	As wildtype control	{PMID16619214:Chen et al. (2006)}		BRCA2_00335		cloned	in vitro	1						646	2101	0	15	9	0019_0008487_0000019	1	0	10/3/09 17:15			0	10/3/09 17:15		
19	8715		+47 C to T	-	IVS19+47C/T	c.8487+47C>T	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00337		cloned	in vitro	1						650	2105	0	15	9	0019_0008487_0000047	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8803	2859	del C	Stop2862	8803delC	?	?	?	?	?	{PMID11504767:Loman et al. (2001)}		BRCA2_00057		cloned	in vitro	1						674	2129	0	55	9	0020_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8731	2835	T to C	Ser to Pro	S2835P	c.8503T>C	p.Ser2835Pro	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00338		cloned	in vitro	1						651	2106	0	15	9	0020_0008503_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8731	2835	T to C	Ser to Pro	S2835P	c.8503T>C	p.Ser2835Pro	?	?	?	{PMID17341484:Johnson et al. (2007)}		BRCA2_00338		cloned	in vitro	1						652	2107	0	55	9	0020_0008503_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8746	2840	A to G	Ile to Val	I2840V	c.8518A>G	p.Ile2840Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00339		cloned	in vitro	1						653	2108	0	15	9	0020_0008518_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8752	2842	C to T	Arg to Cys	R2842C	c.8524C>T	p.Arg2842Cys	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00340		cloned	in vitro	1						654	2109	0	95	9	0020_0008524_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8753	2842	G to A	Arg to His	R2842H	c.8525G>A	p.Arg2842His	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00341		cloned	in vitro	1						655	2110	0	55	9	0020_0008525_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8753	2842	G to A	Arg to His	R2842H	c.8525G>A	p.Arg2842His	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00341		cloned	in vitro	1						656	2111	0	15	9	0020_0008525_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8753	2842	G to T	Arg to Leu	R2842L	c.8525G>T	p.Arg2842Leu	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00342		cloned	in vitro	1						657	2112	0	95	9	0020_0008525_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8756	2843	A to G	Asn to Ser	N2843S	c.8528A>G	p.Asn2843Ser	?	?	?	{PMID18992264:Carvalho et al. (2009)}		BRCA2_00343		cloned	in vitro	1						658	2113	0	55	9	0020_0008528_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8767	2847	G to A	Glu to Lys	E2847K	c.8539G>A	p.Glu2847Lys	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00344		cloned	in vitro	1						659	2114	0	55	9	0020_0008539_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8773	2849	A to G	Lys to Glu	K2849E	c.8545A>G	p.Lys2849Glu	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00345		cloned	in vitro	1						660	2115	0	55	9	0020_0008545_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8776	2850	G to A	Glu to Lys	E2850K	c.8548G>A	p.Glu2850Lys	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00346		cloned	in vitro	1						661	2116	0	15	9	0020_0008548_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8795	2856	A to C	Glu to Ala	E2856A	c.8567A>C	p.Glu2856Ala	Cell viability (in BRCA-/- cells)	Not Applicable	As wildtype control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00347		cloned	in vitro	1						662	2117	0	15	9	0020_0008567_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8795	2856	A to C	Glu to Ala	E2856A	c.8567A>C	p.Glu2856Ala	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00347		cloned	in vitro	1						663	2118	0	15	9	0020_0008567_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8795	2856	A to C	Glu to Ala	E2856A	c.8567A>C	p.Glu2856Ala	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00347		cloned	in vitro	1						664	2119	0	15	9	0020_0008567_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8795	2856	A to C	Glu to Ala	E2856A	c.8567A>C	p.Glu2856Ala	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00347		cloned	in vitro	1						665	2120	0	15	9	0020_0008567_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8795	2856	A to C	Glu to Ala	E2856A	c.8567A>C	p.Glu2856Ala	?	?	?	{PMID10699917:Spitzer et al. (2000)}		BRCA2_00347		cloned	in vitro	1						666	2121	0	55	9	0020_0008567_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8795	2856	A to C	Glu to Ala	E2856A	c.8567A>C	p.Glu2856Ala	?	?	?	{PMID17341484:Johnson et al. (2007)}		BRCA2_00347		cloned	in vitro	1						667	2122	0	55	9	0020_0008567_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8795	2856	A to C	Glu to Ala	E2856A	c.8567A>C	p.Glu2856Ala	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00347		cloned	in vitro	1						668	2123	0	55	9	0020_0008567_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8795	2856	A to C	Glu to Ala	E2856A	c.8567A>C	p.Glu2856Ala	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00347		cloned	in vitro	1						669	2124	0	95	9	0020_0008567_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8795	2856	A to C	Glu to Ala	E2856A	c.8567A>C	p.Glu2856Ala	?	?	?	{PMID16489001:Chenevix-Trench et al. (2006)}		BRCA2_00347		cloned	in vitro	1						670	2125	0	55	9	0020_0008567_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8800	2858	C to A	Gln to Lys	Q2858K	c.8572C>A	p.Gln2858Lys	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00348		cloned	in vitro	1						671	2126	0	55	9	0020_0008572_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8801	2858	A to G	Gln to Arg	Q2858R	c.8573A>G	p.Gln2858Arg	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00349		cloned	in vitro	1						672	2127	0	15	9	0020_0008573_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8801	2858	A to G	Gln to Arg	Q2858R	c.8573A>G	p.Gln2858Arg	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID18375895:Spurdle et al. (2008)}		BRCA2_00349		cloned	in vitro	1						673	2128	0	55	9	0020_0008573_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8819	2864	C to T	Ala to Val	A2864V	c.8591C>T	p.Ala2864Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00350		cloned	in vitro	1						675	2130	0	15	9	0020_0008591_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8821	2865	T to G	Leu to Val	L2865V	c.8593T>G	p.Leu2865Val	Homology-directed repair assay	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00351		cloned	in vitro	1						676	2131	0	15	9	0020_0008593_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8821	2865	T to G	Leu to Val	L2865V	c.8593T>G	p.Leu2865Val	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00351		cloned	in vitro	1						677	2132	0	15	9	0020_0008593_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8821	2865	T to G	Leu to Val	L2865V	c.8593T>G	p.Leu2865Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00351		cloned	in vitro	1						678	2133	0	15	9	0020_0008593_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8821	2865	T to G	Leu to Val	L2865V	c.8593T>G	p.Leu2865Val	Centrosome amplification	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00351		cloned	in vitro	1						679	2134	0	15	9	0020_0008593_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8822	2865	T to A	Leu to Stop	L2865X	c.8594T>A	p.Leu2865X	?	?	?	{PMID10506595:Turner et al. (1999)}		BRCA2_00352		cloned	in vitro	1						680	2135	0	55	9	0020_0008594_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8827	2867	A to C	Thr to Pro	T2867P	c.8599A>C	p.Thr2867Pro	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00353		cloned	in vitro	1						681	2136	0	15	9	0020_0008599_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8846	2873	T to G	Phe to Cys	F2873C	c.8618T>G	p.Phe2873Cys	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00354		cloned	in vitro	1						682	2137	0	55	9	0020_0008618_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
20	8860		+1 G to A	-	IVS20+1G>A	c.8632+1G>A	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID16211554:Tesoriero et al. (2005)}		BRCA2_00355		cloned	in vitro	1						683	2138	0	55	9	0020_0008632_0000001	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8873	2882	del4	p.Lys2882fs	8873del4	?	?	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00057		cloned	in vitro	1						686	2141	0	55	9	0021_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8861		-16 C to G	-	IVS20-16C/G	c.8633-16C>G	?	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00356		cloned	in vitro	1						684	2139	0	15	9	0021_0008633_-999984	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8861		-2 A to G	-	IVS20-2A>G	c.8633-2A>G	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID16619214:Chen et al. (2006)}		BRCA2_00357		cloned	in vitro	1						685	2140	0	55	9	0021_0008633_-999998	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8875	2883	C to T	Pro to Ser	P2883S	c.8647C>T	p.Pro2883Ser	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00358		cloned	in vitro	1						687	2142	0	15	9	0021_0008647_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8890	2888	C to T	Arg to Cys	R2888C	c.8662C>T	p.Arg2888Cys	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00359		cloned	in vitro	1						688	2143	0	15	9	0021_0008662_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8890	2888	C to T	Arg to Cys	R2888C	c.8662C>T	p.Arg2888Cys	Family history	Not Applicable	Predicted neutral	{PMID19200354:Gomez-Garcia et al. (2009)}		BRCA2_00359		cloned	in vitro	1						689	2144	0	15	9	0021_0008662_0000000	1	0	10/3/09 17:15	4	8/20/10 16:48	0	10/3/09 17:15		
21	8890	2888	C to T	Arg to Cys	R2888C	c.8662C>T	p.Arg2888Cys	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00359		cloned	in vitro	1						690	2145	0	15	9	0021_0008662_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8890	2888	C to T	Arg to Cys	c.8662C>T	c.8662C>T	p.Arg2888Cys	splicing reporter minigene	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00359		cloned	in vitro	1						1004	2580	0	55	9	0021_0008662_0000000	0	4	2/19/14 14:34	4	2/19/14 22:23	4	2/19/14 14:34		
21	8891	2888	G to C	Arg to Pro	R2888P	c.8663G>C	p.Arg2888Pro	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00361		cloned	in vitro	1						692	2147	0	15	9	0021_0008663_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8891	2888	G to T	Arg to Leu	R2888L	c.8663G>T	p.Arg2888Leu	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00360		cloned	in vitro	1						691	2146	0	55	9	0021_0008663_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8893	2889	G to T	Ala to Ser	A2889S	c.8665G>T	p.Ala2889Ser	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00362		cloned	in vitro	1						693	2148	0	15	9	0021_0008665_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8896	2890	C to A	Leu to Ile	L2890I	c.8668C>A	p.Leu2890Ile	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00363		cloned	in vitro	1						694	2149	0	15	9	0021_0008668_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8915	2896	G to A	Arg to His	R2896H	c.8687G>A	p.Arg2896His	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00364		cloned	in vitro	1						695	2150	0	15	9	0021_0008687_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8930	2901	G to A	Gly to Asp	G2901D	c.8702G>A	p.Gly2901Asp	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00365		cloned	in vitro	1						696	2151	0	55	9	0021_0008702_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8930	2901	G to A	Gly to Asp	G2901D	c.8702G>A	p.Gly2901Asp	Cell viability (in BRCA-/- cells)	Not Applicable	As wildtype control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00365		cloned	in vitro	1						697	2152	0	15	9	0021_0008702_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8951	2908	T to G	Val to Gly	V2908G	c.8723T>G	p.Val2908Gly	Centrosome amplification	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00366		cloned	in vitro	1						698	2153	0	15	9	0021_0008723_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8951	2908	T to G	Val to Gly	V2908G	c.8723T>G	p.Val2908Gly	Homology-directed repair assay	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00366		cloned	in vitro	1						699	2154	0	15	9	0021_0008723_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8951	2908	T to G	Val to Gly	V2908G	c.8723T>G	p.Val2908Gly	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00366		cloned	in vitro	1						700	2155	0	15	9	0021_0008723_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8951	2908	T to G	Val to Gly	V2908G	c.8723T>G	p.Val2908Gly	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00366		cloned	in vitro	1						701	2156	0	55	9	0021_0008723_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8951	2908	T to G	Val to Gly	V2908G	c.8723T>G	p.Val2908Gly	Nuclear localisation	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00366		cloned	in vitro	1						702	2157	0	15	9	0021_0008723_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8951	2908	T to G	Val to Gly	V2908G	c.8723T>G	p.Val2908Gly	Centrosome amplification	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00366		cloned	in vitro	1						703	2158	0	15	9	0021_0008723_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8951	2908	T to G	Val to Gly	V2908G	c.8723T>G	p.Val2908Gly	Homology-directed repair assay	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00366		cloned	in vitro	1						704	2159	0	15	9	0021_0008723_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8951	2908	T to G	Val to Gly	V2908G	c.8723T>G	p.Val2908Gly	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00366		cloned	in vitro	1						705	2160	0	15	9	0021_0008723_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8951	2908	T to G	Val to Gly	V2908G	c.8723T>G	p.Val2908Gly	Survival assay with VC8 (after MMC treatment)	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00366		cloned	in vitro	1						706	2161	0	15	9	0021_0008723_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8951	2908	T to G	Val to Gly	V2908G	c.8723T>G	p.Val2908Gly	Evolutionary conservation analysis	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00366		cloned	in vitro	1						707	2162	0	15	9	0021_0008723_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8960	2911	C to T	Ala to Val	A2911V	c.8732C>T	p.Ala2911Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00367		cloned	in vitro	1						708	2163	0	15	9	0021_0008732_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8982+1		G>A			c.8754+1G>A	?	Aberant splicing	Not applicable	Predicted to be deleterious	{PMID18597679: Hansen et al. (2008)}		BRCA2_00491		Not applicable	in vitro	1						941	2453	0	75	9	0021_0008754_0000001	21	0	9/14/11 14:38	4	6/21/12 10:50	0	9/14/11 14:38		
21	8982		+4 A to G	-	IVS21+4A>G	c.8754+4A>G	?	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00368		cloned	in vitro	1						709	2164	0	95	9	0021_0008754_0000004	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8982		+4 A to G	-	IVS21+4A>G	c.8754+4A>G	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID17011978:Bonatti et al. (2006)}		BRCA2_00368		cloned	in vitro	1						710	2165	0	55	9	0021_0008754_0000004	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	8982		+5 G to A	-	IVS21+5G>A	c.8754+5G>A	?	cDNA analysis	Not Applicable	As mutant control	{PMID18693280:Vreeswijk et al. (2008)}		BRCA2_00369		cloned	in vitro	1						711	2166	0	55	9	0021_0008754_0000005	1	0	10/3/09 17:15			0	10/3/09 17:15		
21	9191	2988	c.8963G>A	Ser to Asn	c.8963G>A	c.8963G>A	p.Ser2988Asn	splicing reporter minigene	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00535		cloned	in vitro	1						1005	2581	0	55	9	0021_0008963_0000000	0	4	2/19/14 14:34	4	2/19/14 22:23	4	2/19/14 14:34		
22	8984	2919	del G	Stop2926	8984delG	?	?	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00057		cloned	in vitro	1						715	2170	0	55	9	0022_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9017	2930	del A	Stop2936	9017delA	?	?	?	?	?	{PMID15533909:Pal et al. (2004)}		BRCA2_00057		cloned	in vitro	1						720	2175	0	55	9	0022_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	8983		-66 T to C	-	IVS21-66C/T	unclear	?	?	?	?	{PMID18694767:Tommasi et al. (2008)}		BRCA2_00027		cloned	in vitro	1						712	2167	0	55	9	0022_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	8983		-66 T to C	-	IVS21-66C/T	unclear	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00027		cloned	in vitro	1						713	2168	0	15	9	0022_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	8983		-79 G to A	-	IVS21-79G/A	c.8755-79G>A	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00370		cloned	in vitro	1						714	2169	0	15	9	0022_0008755_-999921	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	8984	2919	G to T	Gly to Val	G2919V	c.8756G>T	p.Gly2919Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00371		cloned	in vitro	1						716	2171	0	15	9	0022_0008756_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	8992	2922	A to G	Ser to Gly	S2922G	c.8764A>G	p.Ser2922Gly	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00372		cloned	in vitro	1						717	2172	0	55	9	0022_0008764_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9002	2925	A to G	Gln to Arg	Q2925R	c.8774A>G	p.Gln2925Arg	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00373		cloned	in vitro	1						718	2173	0	95	9	0022_0008774_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9003	2925	G to C	Gln to His	Q2925H	c.8775G>C	p.Gln2925His	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00374		cloned	in vitro	1						719	2174	0	55	9	0022_0008775_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9034	2936	T to A	Leu to Met	L2936M	c.8806T>A	p.Leu2936Met	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00375		cloned	in vitro	1						721	2176	0	15	9	0022_0008806_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9036	2936	G to C	Leu to Phe	L2936F	c.8808G>C	p.Leu2936Phe	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00376		cloned	in vitro	1						722	2177	0	15	9	0022_0008808_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9052	2942	G to A	Ala to Thr	A2942T	c.8824G>A	p.Ala2942Thr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00377		cloned	in vitro	1						723	2178	0	15	9	0022_0008824_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9058	2944	A to T	Ile to Phe	I2944F	c.8830A>T	p.Ile2944Phe	?	?	?	{PMID15533909:Pal et al. (2004)}		BRCA2_00378		cloned	in vitro	1						724	2179	0	55	9	0022_0008830_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9058	2944	A to T	Ile to Phe	I2944F	c.8830A>T	p.Ile2944Phe	?	?	?	{PMID17341484:Johnson et al. (2007)}		BRCA2_00378		cloned	in vitro	1						725	2180	0	55	9	0022_0008830_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9058	2944	A to T	Ile to Phe	I2944F	c.8830A>T	p.Ile2944Phe	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00378		cloned	in vitro	1						726	2181	0	15	9	0022_0008830_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9058	2944	A to T	Ile to Phe	I2944F	c.8830A>T	p.Ile2944Phe	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00378		cloned	in vitro	1						727	2182	0	15	9	0022_0008830_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9058	2944	A to T	Ile to Phe	I2944F	c.8830A>T	p.Ile2944Phe	Embryonic stem cell assay	Not Applicable	As wildtype	{PMID22678057:Biswas et al. (2012)}		BRCA2_00378		not applicable	in vitro	1						986	2536	0	35	9	0022_0008830_0000000	10	4	2/5/14 21:38	4	2/5/14 21:38	4	2/5/14 21:38		
22		2947	G to A	Glu to Lys	c.8839 G>A	c.8839 G>A	p.Glu2947Lys	RNA analysis	not applicable	Normal RNA splicing	{PMID20513136: Walker et al. (2010)}		BRCA2_00490		not applicable	in vitro	1						940	2438	0	35	9	0022_0008839_0000000	10	4	6/30/11 18:38	4	6/30/11 18:45	4	6/30/11 18:38		
22	9078	2950	G to T	Lys to Asn	K2950N	c.8850G>T	p.Lys2950Asn	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00379		cloned	in vitro	1						728	2183	0	55	9	0022_0008850_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9078	2950	G to T	Lys to Asn	K2950N	c.8850G>T	p.Lys2950Asn	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18375895:Spurdle et al. (2008)}		BRCA2_00379		cloned	in vitro	1						729	2184	0	15	9	0022_0008850_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9078	2950	G to T	Lys to Asn	K2950N	c.8850G>T	p.Lys2950Asn	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID12955716:Diez et al. (2003)}		BRCA2_00379		cloned	in vitro	1						730	2185	0	15	9	0022_0008850_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9078	2950	G to T	Lys to Asn	K2950N	c.8850G>T	p.Lys2950Asn	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00379		cloned	in vitro	1						731	2186	0	15	9	0022_0008850_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9078	2950	G to T	Lys to Asn	K2950N	c.8850G>T	p.Lys2950Asn	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00379		cloned	in vitro	1						732	2187	0	15	9	0022_0008850_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9078	2950	G to T	Lys to Asn	K2950N	c.8850G>T	p.Lys2950Asn	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID10969800:Gayther et al. (2000)}		BRCA2_00379		cloned	in vitro	1						733	2188	0	15	9	0022_0008850_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9078	2950	G to T	Lys to Asn	K2950N	c.8850G>T	p.Lys2950Asn	LOH analysis	Not applicable	No LOH	{PMID20054658:Beristain et al. (2010)}		BRCA2_00379		Not applicable	in vitro	1						947	2462	0	55	9	0022_0008850_0000000	10	4	9/23/11 13:43	4	9/23/11 13:49	4	9/23/11 13:43		
22	9079	2951	G to A	Ala to Thr	9079G/A (A2951T)	c.8851G>A	p.Ala2951Thr	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00380		cloned	in vitro	1						734	2189	0	15	9	0022_0008851_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9079	2951	G to A	Ala to Thr	9079G/A (A2951T)	c.8851G>A	p.Ala2951Thr	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00380		cloned	in vitro	1						735	2190	0	55	9	0022_0008851_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9079	2951	G to A	Ala to Thr	A2951T	c.8851G>A	p.Ala2951Thr	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00380		cloned	in vitro	1						736	2191	0	55	9	0022_0008851_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9079	2951	G to A	Ala to Thr	A2951T	c.8851G>A	p.Ala2951Thr	Co-segregation in families	Not Applicable	Predicted neutral	{PMID12215251:Deffenbaugh et al. (2002)}		BRCA2_00380		cloned	in vitro	1						737	2192	0	15	9	0022_0008851_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9079	2951	G to A	Ala to Thr	A2951T	c.8851G>A	p.Ala2951Thr	Co-occurrence with deleterious mutation	Not Applicable	Predicted neutral	{PMID12215251:Deffenbaugh et al. (2002)}		BRCA2_00380		cloned	in vitro	1						738	2193	0	15	9	0022_0008851_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9079	2951	G to A	Ala to Thr	A2951T	c.8851G>A	p.Ala2951Thr	?	?	?	{PMID10699917:Spitzer et al. (2000)}		BRCA2_00380		cloned	in vitro	1						739	2194	0	55	9	0022_0008851_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9079	2951	G to A	Ala to Thr	A2951T	c.8851G>A	p.Ala2951Thr	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID12215251:Deffenbaugh et al. (2002)}		BRCA2_00380		cloned	in vitro	1						740	2195	0	15	9	0022_0008851_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9079	2951	G to A	Ala to Thr	A2951T	c.8851G>A	p.Ala2951Thr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00380		cloned	in vitro	1						741	2196	0	15	9	0022_0008851_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9079	2951	G to A	Ala to Thr	A2951T	c.8851G>A	p.Ala2951Thr	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID17549625:Hammet et al. (2007)}		BRCA2_00380		cloned	in vitro	1						742	2197	0	55	9	0022_0008851_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9121	2965	G to C	Asp to His	D2965H	c.8893G>C	p.Asp2965His	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00381		cloned	in vitro	1						743	2198	0	15	9	0022_0008893_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9133	2969	G to A	Val to Met	V2969M	c.8905G>A	p.Val2969Met	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00382		cloned	in vitro	1						744	2199	0	15	9	0022_0008905_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9133	2969	G to A	Val to Met	V2969M	c.8905G>A	p.Val2969Met	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00382		cloned	in vitro	1						745	2200	0	15	9	0022_0008905_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9133	2969	G to A	Val to Met	V2969M	c.8905G>A	p.Val2969Met	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00382		cloned	in vitro	1						746	2201	0	95	9	0022_0008905_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9143	2972	T to G	Leu to Trp	L2972W	c.8915T>G	p.Leu2972Trp	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00383		cloned	in vitro	1						747	2202	0	95	9	0022_0008915_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9145	2973	C to T	Arg to Cys	R2973C	c.8917C>T	p.Arg2973Cys	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00384		cloned	in vitro	1						748	2203	0	15	9	0022_0008917_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9145	2973	C to T	Arg to Cys	R2973C	c.8917C>T	p.Arg2973Cys	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00384		cloned	in vitro	1						749	2204	0	95	9	0022_0008917_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9145	2973	C to T	Arg to Cys	R2973C	c.8917C>T	p.Arg2973Cys	Homology-directed repair assay	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00384		cloned	in vitro	1						750	2205	0	15	9	0022_0008917_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9145	2973	C to T	Arg to Cys	R2973C	c.8917C>T	p.Arg2973Cys	Centrosome amplification	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00384		cloned	in vitro	1						751	2206	0	15	9	0022_0008917_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9145	2973	C to T	Arg to Cys	R2973C	c.8917C>T	p.Arg2973Cys	Histopathology	Not Applicable	Inconclusive	{PMID18824701:Spearman et al. (2008)}		BRCA2_00384		cloned	in vitro	1						752	2207	0	55	9	0022_0008917_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9145	2973	C to T	Arg to Cys	R2973C	c.8917C>T	p.Arg2973Cys	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00384		cloned	in vitro	1						753	2208	0	15	9	0022_0008917_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9146	2973	G to A	Arg to His	R2973H	c.8918G>A	p.Arg2973His	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00385		cloned	in vitro	1						754	2209	0	15	9	0022_0008918_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9172	2982	A to C	Lys to Gln	K2982Q	c.8944A>C	p.Lys2982Gln	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00386		cloned	in vitro	1						755	2210	0	15	9	0022_0008944_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9181		+16 C to T	-	IVS22+16C/T	c.8953+16C>T	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00387		cloned	in vitro	1						756	2211	0	15	9	0022_0008953_0000016	1	0	10/3/09 17:15			0	10/3/09 17:15		
22	9181		+98 T to C	-	IVS22+98T/C	c.8953+98T>C	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00388		cloned	in vitro	1						757	2212	0	15	9	0022_0008953_0000098	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9243	3005	del AT	Stop3016	9243delAT	?	?	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00057		cloned	in vitro	1						767	2222	0	55	9	0023_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9254	3009	del ATCAT	Stop3015	9254del5	?	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00057		cloned	in vitro	1						769	2224	0	55	9	0023_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9190	2988	A to G	Ser to Gly	S2988G	c.8962A>G	p.Ser2988Gly	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00389		cloned	in vitro	1						758	2213	0	95	9	0023_0008962_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9190	2988	A to G	Ser to Gly	S2988G	c.8962A>G	p.Ser2988Gly	Cell viability (in BRCA-/- cells)	Not Applicable	As wildtype control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00389		cloned	in vitro	1						759	2214	0	15	9	0023_0008962_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9190	2988	A to G	Ser to Gly	S2988G	c.8962A>G	p.Ser2988Gly	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00389		cloned	in vitro	1						760	2215	0	95	9	0023_0008962_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9190	2988	A to G	Ser to Gly	S2988G	c.8962A>G	p.Ser2988Gly	splicing reporter minigene assay	Not Applicable	No evidence for aberrant splicing	{PMID20507642: Whiley et al. (2010)}		BRCA2_00389		not applicable	in vitro	1						931	2393	0	15	9	0023_0008962_0000000	10	4	10/26/10 13:18	4	10/29/10 9:52	4	10/26/10 13:18		
23	9197	2990	G to A	Trp to Stop	W2990X	c.8969G>A	p.Trp2990X	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00390		cloned	in vitro	1						761	2216	0	95	9	0023_0008969_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9200	2991	G to A	Arg to His	R2991H	c.8972G>A	p.Arg2991His	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00391		cloned	in vitro	1						762	2217	0	95	9	0023_0008972_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9200	2991	G to A	Arg to His	R2991H	c.8972G>A	p.Arg2991His	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00391		cloned	in vitro	1						763	2218	0	15	9	0023_0008972_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9200	2991	G to A	Arg to His	R2991H	c.8972G>A	p.Arg2991His	splicing reporter minigene assay	Not Applicable	No evidence for aberrant splicing	{PMID20507642:Whiley et al. (2010)}		BRCA2_00391		not applicable	in vitro	1						932	2394	0	15	9	0023_0008972_0000000	10	4	10/26/10 13:22	4	10/29/10 9:53	4	10/26/10 13:22		
23	9232	3002	G to A	Glu to Lys	E3002K	c.9004G>A	p.Glu3002Lys	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00392		cloned	in vitro	1						764	2219	0	55	9	0023_0009004_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9232	3002	G to A	Glu to Lys	E3002K	c.9004G>A	p.Glu3002Lys	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00392		cloned	in vitro	1						765	2220	0	95	9	0023_0009004_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9232	3002	G to A	Glu to Lys	E3002K	c.9004G>A	p.Glu3002Lys	Embryonic stem cell assay	not applicable	No rescue ES cell lethality	{PMID22678057:Biswas et al. (2012)}		BRCA2_00392		Not applicable	in vitro	1						1019	2632	0	75	9	0023_0009004_0000000	10	4	2/19/14 21:32	4	2/19/14 22:23	4	2/19/14 21:32		
23	9234	3002	A to T	Glu to Asp	E3002D	c.9006A>T	p.Glu3002Asp	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00393		cloned	in vitro	1						766	2221	0	95	9	0023_0009006_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9246	3006	C to A	Tyr to Stop	Y3006X	c.9018C>A	p.Tyr3006X	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00394		cloned	in vitro	1						768	2223	0	95	9	0023_0009018_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9260	3011	T to C	Leu to Pro	L3011P	c.9032T>C	p.Leu3011Pro	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00395		cloned	in vitro	1						770	2225	0	95	9	0023_0009032_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9266	3013	C to T	Thr to Ile	T3013I	c.9038C>T	p.Thr3013Ile	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00396		cloned	in vitro	1						771	2226	0	15	9	0023_0009038_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9266	3013	C to T	Thr to Ile	T3013I	c.9038C>T	p.Thr3013Ile	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00396		cloned	in vitro	1						772	2227	0	55	9	0023_0009038_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9287	3020	C to G	Ser to Cys	S3020C	c.9059C>G	p.Ser3020Cys	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00397		cloned	in vitro	1						773	2228	0	15	9	0023_0009059_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9304	3026	C to G	Gln to Glu	Q3026E	c.9076C>G	p.Gln3026Glu	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00398		cloned	in vitro	1						774	2229	0	55	9	0023_0009076_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9310	3028	G to C	Ala to Pro	A3028P	c.9082G>C	p.Ala3028Pro	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00399		cloned	in vitro	1						775	2230	0	15	9	0023_0009082_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9313	3029	G to A	Ala to Thr	A3029T	c.9085G>A	p.Ala3029Thr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00400		cloned	in vitro	1						776	2231	0	15	9	0023_0009085_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9314	3029	C to T	Ala to Val	A3029V	c.9086C>T	p.Ala3029Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00401		cloned	in vitro	1						777	2232	0	15	9	0023_0009086_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9315	3029	G to A	Ala to Ala	c.9087G>A	c.9087G>A	p.=	splicing reporter minigene	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00536		cloned	in vitro	1						1006	2582	0	55	9	0023_0009087_0000000	0	4	2/19/14 14:34	4	2/19/14 22:24	4	2/19/14 14:34		
23	9329	3034	A to G	Gln to Arg	Q3034R	c.9101A>G	p.Gln3034Arg	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00402		cloned	in vitro	1						778	2233	0	15	9	0023_0009101_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9332	3035	A to C	Tyr to Ser	Y3035S	c.9104A>C	p.Tyr3035Ser	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00404		cloned	in vitro	1						780	2235	0	95	9	0023_0009104_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9332	3035	A to C	Tyr to Ser	c.9104A>C	c.9104A>C	p.Tyr3035Ser	splicing reporter minigene	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00404		cloned	in vitro	1						1007	2583	0	55	9	0023_0009104_0000000	0	4	2/19/14 14:34	4	2/19/14 22:24	4	2/19/14 14:34		
23	9332	3035	A to G	Tyr to Cys	Y3035C	c.9104A>G	p.Tyr3035Cys	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00403		cloned	in vitro	1						779	2234	0	95	9	0023_0009104_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9344	3039	C to T	Pro to Leu	P3039L	c.9116C>T	p.Pro3039Leu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00405		cloned	in vitro	1						781	2236	0	15	9	0023_0009116_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9345		G to A	Val to Gly	9345G>A	c.9117G>A	p.Val2985GlyfsX4	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID18375895:Spurdle et al. (2008)}		BRCA2_00406		cloned	in vitro	1						782	2237	0	55	9	0023_0009117_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9345	3039	G to A	splicing	P3039P	c.9117G>A	p.Pro3039Pro	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00406		cloned	in vitro	1						784	2239	0	95	9	0023_0009117_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9345	3039	G to A	splicing	P3039P	c.9117G>A	p.Pro3039Pro	?	?	?	{PMID10638982:Peelen et al. (2000)}		BRCA2_00406		cloned	in vitro	1						785	2240	0	55	9	0023_0009117_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9345	3039	G to A	splicing	P3039P	c.9117G>A	p.Pro3039Pro	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID17011978:Bonatti et al. (2006)}		BRCA2_00406		cloned	in vitro	1						786	2241	0	55	9	0023_0009117_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
23	9345		+9 C to T	-	IVS23+9C>T	c.9256+9C>A	?	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00407		cloned	in vitro	1						783	2238	0	15	9	0023_0009256_0000009	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9346		-2 A to G	-	IVS23-2A>G	c.9118-2A>G	?	?	?	?	{PMID11504767:Loman et al. (2001)}		BRCA2_00410		cloned	in vitro	1						789	2244	0	55	9	0024_0009118_-999998	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9346		-2 A to G	-	IVS23-2A>G	c.9118-2A>G	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID12759930:Claes et al. (2003)}		BRCA2_00410		cloned	in vitro	1						790	2245	0	55	9	0024_0009118_-999998	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9346	3040	G to A	Val to Ile	V3040I	c.9118G>A	p.Val3040Ile	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00411		cloned	in vitro	1						791	2246	0	15	9	0024_0009118_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9382	3052	C to T	Arg to Trp	R3052W	c.9154C>T	p.Arg3052Trp	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00412		cloned	in vitro	1						792	2247	0	95	9	0024_0009154_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9382	3052	C to T	Arg to Trp	R3052W	c.9154C>T	p.Arg3052Trp	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00412		cloned	in vitro	1						793	2248	0	95	9	0024_0009154_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9382	3052	C to T	Arg to Trp	R3052W	c.9154C>T	p.Arg3052Trp	Family history	Not Applicable	Predicted deleterious	{PMID19200354:Gomez-Garcia et al. (2009)}		BRCA2_00412		cloned	in vitro	1						794	2249	0	95	9	0024_0009154_0000000	1	0	10/3/09 17:15	4	8/20/10 16:49	0	10/3/09 17:15		
24	9382	3052	C to T	Arg to Trp	R3052W	c.9154C>T	p.Arg3052Trp	Co-segregation in families	Not Applicable	Predicted deleterious	{PMID19563646:Mohammadi et al. (2009)}		BRCA2_00412		cloned	in vitro	1						795	2250	0	95	9	0024_0009154_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9382	3052	C to T	Arg to Trp	R3052W	c.9154C>T	p.Arg3052Trp	Cell viability (in BRCA-/- cells)	Not Applicable	As mutant control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00412		cloned	in vitro	1						796	2251	0	55	9	0024_0009154_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9382	3052	C to T	Arg to Trp	R3052W	c.9154C>T	p.Arg3052Trp	Centrosome amplification	Not Applicable	As wildtype control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00412		cloned	in vitro	1						797	2252	0	15	9	0024_0009154_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9382	3052	C to T	Arg to Trp	R3052W	c.9154C>T	p.Arg3052Trp	Structure-based prediction (crystallography etc)	Not Applicable	Predicted deleterious	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00412		cloned	in vitro	1						798	2253	0	95	9	0024_0009154_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9382	3052	C to T	Arg to Trp	R3052W	c.9154C>T	p.Arg3052Trp	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00412		cloned	in vitro	1						799	2254	0	55	9	0024_0009154_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9382	3052	C to T	Arg to Trp	R3052W	c.9154C>T	p.Arg3052Trp	Multifactorial likelihood model	Not Applicable	Predicted deleterious	{PMID20513136:Walker et al. (2010)}		BRCA2_00412		not applicable	in vitro	1						938	2436	0	95	9	0024_0009154_0000000	10	4	6/30/11 18:30	4	6/30/11 18:45	4	6/30/11 18:30		
24	9383	3052	G to A	Arg to Gln	R3052Q	c.9155G>A	p.Arg3052Gln	Family history	Not Applicable	Predicted neutral	{PMID19200354:Gomez-Garcia et al. (2009)}		BRCA2_00413		cloned	in vitro	1						800	2255	0	15	9	0024_0009155_0000000	1	0	10/3/09 17:15	4	8/20/10 16:49	0	10/3/09 17:15		
24	9383	3052	G to A	Arg to Gln	R3052Q	c.9155G>A	p.Arg3052Gln	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00413		cloned	in vitro	1						801	2256	0	15	9	0024_0009155_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9383	3052	G to A	Arg to Gln	R3052Q	c.9155G>A	p.Arg3052Gln	Structure-based prediction (crystallography etc)	Not Applicable	Inconclusive	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00413		cloned	in vitro	1						802	2257	0	55	9	0024_0009155_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9383	3052	G to A	Arg to Gln	R3052Q	c.9155G>A	p.Arg3052Gln	Co-segregation in families	Not Applicable	Predicted neutral	{PMID19563646:Mohammadi et al. (2009)}		BRCA2_00413		cloned	in vitro	1						803	2258	0	15	9	0024_0009155_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9383	3052	G to A	Arg to Gln	R3052Q	c.9155G>A	p.Arg3052Gln	Sensitivity to DNA damaging agents	Not Applicable	Inconclusive	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00413		cloned	in vitro	1						804	2259	0	55	9	0024_0009155_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9383	3052	G to A	Arg to Gln	R3052Q	c.9155G>A	p.Arg3052Gln	Cell viability (in BRCA-/- cells)	Not Applicable	As wildtype control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00413		cloned	in vitro	1						805	2260	0	15	9	0024_0009155_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9383	3052	G to A	Arg to Gln	R3052Q	c.9155G>A	p.Arg3052Gln	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00413		cloned	in vitro	1						806	2261	0	55	9	0024_0009155_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9389	3054	C to A	Pro to His	P3054H	c.9161C>A	p.Pro3054His	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00414		cloned	in vitro	1						807	2262	0	55	9	0024_0009161_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9400	3058	A to G	Ser to Gly	S3058G	c.9172A>G	p.Ser3058Gly	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00415		cloned	in vitro	1						808	2263	0	95	9	0024_0009172_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9400	3058	A to G	Ser to Gly	S3058G	c.9172A>G	p.Ser3058Gly	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00415		cloned	in vitro	1						809	2264	0	15	9	0024_0009172_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9400	3058	A to G	Ser to Gly	S3058G	c.9172A>G	p.Ser3058Gly	splicing reporter minigene assay	Not Applicable	No evidence for aberrant splicing	{PMID20507642:Whiley et al. (2010)}		BRCA2_00415		not applicable	in vitro	1						933	2395	0	15	9	0024_0009172_0000000	10	4	10/26/10 13:26	4	10/29/10 9:53	4	10/26/10 13:26		
24	9403	3059	A to G	Lys to Glu	K3059E	c.9175A>G	p.Lys3059Glu	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00416		cloned	in vitro	1						810	2265	0	55	9	0024_0009175_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9415	3063	C to T	Pro to Ser	P3063S	c.9187C>T	p.Pro3063Ser	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00417		cloned	in vitro	1						811	2266	0	15	9	0024_0009187_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9418	3064	G to A	Asp to Asn	D3064N	c.9190G>A	p.Asp3064Asn	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00418		cloned	in vitro	1						812	2267	0	15	9	0024_0009190_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9418	3064	G to T	Asp to Tyr	D3064Y	c.9190G>T	p.Asp3064Tyr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00419		cloned	in vitro	1						813	2268	0	15	9	0024_0009190_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9423	3065	T to A	Phe to Leu	F3065L	c.9195T>A	p.Phe3065Leu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00420		cloned	in vitro	1						814	2269	0	15	9	0024_0009195_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9424	3066	C to G	Gln to Glu	Q3066E	c.9196C>G	p.Gln3066Glu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00421		cloned	in vitro	1						815	2270	0	15	9	0024_0009196_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9441	3071	G to T	Glu to Asp	E3071D	c.9213G>T	p.Glu3071Asp	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00422		cloned	in vitro	1						816	2271	0	55	9	0024_0009213_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9441	3071	G to T	Glu to Asp	E3071D	c.9213G>T	p.Glu3071Asp	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00422		cloned	in vitro	1						817	2272	0	95	9	0024_0009213_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9441	3071	G to T	Glu to Asp	E3071D	c.9213G>T	p.Glu3071Asp	splicing reporter minigene assay	Not Applicable	No evidence for aberrant splicing	{PMID20507642:Whiley et al. (2010)}		BRCA2_00422		not applicable	in vitro	1						934	2396	0	15	9	0024_0009213_0000000	10	4	10/26/10 13:28	4	10/29/10 9:53	4	10/26/10 13:28		
24	9443	3072	T to A	Val to Glu	V3072E	c.9215T>A	p.Val3072Glu	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00423		cloned	in vitro	1						818	2273	0	95	9	0024_0009215_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9443	3072	T to A	Val to Glu	V3072E	c.9215T>A	p.Val3072Glu	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00423		cloned	in vitro	1						819	2274	0	95	9	0024_0009215_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9446	3073	A to G	Asp to Gly	D3073G	c.9218A>G	p.Asp3073Gly	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00424		cloned	in vitro	1						820	2275	0	95	9	0024_0009218_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9455	3076	G to A	Gly to Glu	G3076E	c.9227G>A	p.Gly3076Glu	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00425		cloned	in vitro	1						821	2276	0	95	9	0024_0009227_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9455	3076	G to T	Gly to Val	G3076V	c.9227G>T	p.Gly3076Val	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00426		cloned	in vitro	1						822	2277	0	55	9	0024_0009227_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9463	3079	G to A	Val to Ile	V3079I	c.9235G>A	p.Val3079Ile	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00427		cloned	in vitro	1						823	2278	0	15	9	0024_0009235_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9463	3079	G to A	Val to Ile	V3079I	c.9235G>A	p.Val3079Ile	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00427		cloned	in vitro	1						824	2279	0	15	9	0024_0009235_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9465	3079	T to C	Val to Val	9465T/C (V3079V)	c.9237T>C	p.Val3079Val	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00428		cloned	in vitro	1						825	2280	0	15	9	0024_0009237_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9470	3081	T to C	Val to Ala	V3081A	c.9242T>C	p.Val3081Ala	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00429		cloned	in vitro	1						826	2281	0	15	9	0024_0009242_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9475	3083	A to G	Lys to Glu	K3083E	c.9247A>G	p.Lys3083Glu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00430		cloned	in vitro	1						827	2282	0	15	9	0024_0009247_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9477	3083	A to T	Lys to Asn	K3083N	c.9249A>T	p.Lys3083Asn	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00431		cloned	in vitro	1						828	2283	0	15	9	0024_0009249_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9484		+1 G to A	Stop3103	IVS24+1G>A	c.9256+1G>A	?	mRNA analysis (RT-PCR)	Not Applicable	As mutant control	{PMID12759930:Claes et al. (2003)}		BRCA2_00432		cloned	in vitro	1						829	2284	0	55	9	0024_0009256_0000001	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9257		T to G	-	c.9257-113T>G	c.9257-113T>G	?	mRNA analysis and splicing reporter minigene	Not Applicable	Predicted neutral	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00408		cloned	in vitro	1						787	2242	0	15	9	0024_0009257_-999887	1	0	10/3/09 17:15			0	10/3/09 17:15		
24	9257		T to C	-	c.9257-16T>C	c.9257-16T>C	?	mRNA analysis and splicing reporter minigene	Not Applicable	Predicted neutral	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00409		cloned	in vitro	1						788	2243	0	15	9	0024_0009257_-999984	1	0	10/3/09 17:15			0	10/3/09 17:15		
24						c.9257-16T>C	IVS24-16T>C	coocurrence	Not applicable	neutral	"{PMID22144684:Caputo et al., 2011}"		BRCA2_00409		not applicable	in vitro	1						957	2504	0	35	9	0024_0009257_-999984	26	0	3/23/12 17:24	4	4/6/12 9:34	0	3/23/12 17:24		
25	9538	3104	del AA	Stop3109	9538delAA	?	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00057		cloned	in vitro	1						857	2312	0	55	9	0025_0000000_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9485	NA	G to A	Not applicable	c.9257-83G>A	c.9257-83G>A	?	splicing reporter minigene/patient RNA analysis	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00543		cloned	in vitro	1						1015	2591	0	55	9	0025_0009257_-999917	0	4	2/19/14 14:34	4	2/19/14 22:25	4	2/19/14 14:34		
25	9485		-18 C to A	-	IVS24-18C/A	c.9257-18C>A	?	mRNA analysis (RT-PCR)	Not Applicable	As wildtype control	{PMID16619214:Chen et al. (2006)}		BRCA2_00433		cloned	in vitro	1						834	2289	0	15	9	0025_0009257_-999982	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9485		-16 T to C	-	IVS24-16T/C	c.9257-16T>C	?	mRNA analysis (RT-PCR)	Not Applicable	As wildtype control	{PMID12759930:Claes et al. (2003)}		BRCA2_00409		cloned	in vitro	1						830	2285	0	15	9	0025_0009257_-999984	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9485		-16 T to C	-	IVS24-16T/C	c.9257-16T>C	?	Co-occurrence with deleterious mutation	Not Applicable	Predicted neutral	{PMID12759930:Claes et al. (2003)}		BRCA2_00409		cloned	in vitro	1						831	2286	0	15	9	0025_0009257_-999984	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9485		-16 T to C	-	IVS24-16T/C	c.9257-16T>C	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00409		cloned	in vitro	1						832	2287	0	55	9	0025_0009257_-999984	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9485		-16 T to C	-	IVS24-16T/C	c.9257-16T>C	?	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00409		cloned	in vitro	1						833	2288	0	55	9	0025_0009257_-999984	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9485		-1 G to C	-	IVS24-1G>C	c.9257-1G>C	?	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00434		cloned	in vitro	1						835	2290	0	95	9	0025_0009257_-999999	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9491	3088	C to T	Ala to Val	A3088V	c.9263C>T	p.Ala3088Val	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00435		cloned	in vitro	1						836	2291	0	95	9	0025_0009263_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9499	3091	G to A	Val to Ser	V3091S	c.9271G>A	p.Val3091Ser	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00436		cloned	in vitro	1						837	2292	0	95	9	0025_0009271_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9499	3091	G to A	Val to Ile	V3091I	c.9271G>A	p.Val3091Ile	"HR assay, LOH assay"	not applicable	"predicted pathogenic, no LOH"	{PMID21671020:Balia et al. (2011)}		BRCA2_00509		not applicable	in vitro	1						968	2516	0	75	9	0025_0009271_0000000	27	0	3/23/12 18:41	4	3/29/12 8:44	0	3/23/12 18:41		
25	9503	3092	A to C	Tyr to Ser	Y3092S	c.9275A>C	p.Tyr3092Ser	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00439		cloned	in vitro	1						841	2296	0	95	9	0025_0009275_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9503	3092	A to G	Tyr to Cys	Y3092C	c.9275A>G	p.Tyr3092Cys	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00438		cloned	in vitro	1						839	2294	0	15	9	0025_0009275_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9503	3092	A to G	Tyr to Cys	Y3092C	c.9275A>G	p.Tyr3092Cys	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00438		cloned	in vitro	1						840	2295	0	95	9	0025_0009275_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9513	3095	C to G	Asp to Glu	D3095E	c.9285C>G	p.Asp3095Glu	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00440		cloned	in vitro	1						842	2297	0	95	9	0025_0009285_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9513	3095	C to G	Asp to Glu	D3095E	c.9285C>G	p.Asp3095Glu	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00440		cloned	in vitro	1						843	2298	0	55	9	0025_0009285_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9513	3095	C to G	Asp to Glu	D3095E	c.9285C>G	p.Asp3095Glu	Multifactorial likelihood-ratio model	Not Applicable	Inconclusive	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00440		cloned	in vitro	1						844	2299	0	55	9	0025_0009285_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9513	3095	C to G	Asp to Glu	D3095E	c.9285C>G	p.Asp3095Glu	Multifactorial likelihood-ratio model	Not Applicable	Predicted deleterious	{PMID17924331:Easton et al. (2007)}		BRCA2_00440		cloned	in vitro	1						845	2300	0	95	9	0025_0009285_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9513	3095	C to G	Asp to Glu	D3095E	c.9285C>G	p.Asp3095Glu	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00440		cloned	in vitro	1						846	2301	0	95	9	0025_0009285_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9513	3095	C to G	Asp to Glu	D3095E	c.9285C>G	p.Asp3095Glu	Centrosome amplification	Not Applicable	As mutant control	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00440		cloned	in vitro	1						847	2302	0	55	9	0025_0009285_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9513	3095	C to G	Asp to Glu	D3095E	c.9285C>G	p.Asp3095Glu	Embryonic stem cell assay	Not Applicable	No rescue ES cell lethality	{PMID22678057:Biswas et al. (2012)}		BRCA2_00440		not applicable	in vitro	1						1020	2633	0	75	9	0025_0009285_0000000	10	4	2/19/14 21:34	4	2/19/14 22:26	4	2/19/14 21:34		
25	9514	3096	G to T	Glu to Stop	E3096X	c.9286G>T	p.Glu3096X	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00441		cloned	in vitro	1						848	2303	0	55	9	0025_0009286_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9514	3096	G to T	Glu to Stop	E3096X	c.9286G>T	p.Glu3096X	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00441		cloned	in vitro	1						849	2304	0	95	9	0025_0009286_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9520	3098	T to C	Tyr to His	Y3098H	c.9292T>C	p.Tyr3098His	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00442		cloned	in vitro	1						850	2305	0	15	9	0025_0009292_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9520	3098	T to C	Tyr to His	Y3098H	c.9292T>C	p.Tyr3098His	?	?	?	{PMID12474142:Edwards et al. (2003)}		BRCA2_00442		cloned	in vitro	1						851	2306	0	55	9	0025_0009292_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9520	3098	T to C	Tyr to His	Y3098H	c.9292T>C	p.Tyr3098His	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00442		cloned	in vitro	1						852	2307	0	55	9	0025_0009292_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9529	3101	C to G	Leu to Val	L3101V	c.9301C>G	p.Leu3101Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00443		cloned	in vitro	1						853	2308	0	15	9	0025_0009301_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9530	3101	T to G	Leu to Arg	L3101R	c.9302T>G	p.Leu3101Arg	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00444		cloned	in vitro	1						854	2309	0	95	9	0025_0009302_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9535	3103	A to G	Ile to Val	I3103V	c.9307A>G	p.Ile3103Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00445		cloned	in vitro	1						855	2310	0	15	9	0025_0009307_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9537	3103	A to G	Ile to Met	I3103M	c.9309A>G	p.Ile3103Met	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00446		cloned	in vitro	1						856	2311	0	15	9	0025_0009309_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9578	3117	A to C	His to Pro	H3117P	c.9350A>C	p.His3117Pro	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00447		cloned	in vitro	1						858	2313	0	55	9	0025_0009350_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9581	3118	T to C	Met to Thr	M3118T	c.9353T>C	p.Met3118Thr	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00448		cloned	in vitro	1						859	2314	0	15	9	0025_0009353_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9595	3123	A to G	Ser to Gly	S3123G	c.9367A>G	p.Ser3123Gly	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00449		cloned	in vitro	1						860	2315	0	55	9	0025_0009367_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9599	3124	A to T	Asn to Ile	N3124I	c.9371A>T	p.Asn3124Ile	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00450		cloned	in vitro	1						861	2316	0	95	9	0025_0009371_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9599	3124	A to T	Asn to Ile	N3124I	c.9371A>T	p.Asn3124Ile	Embryonic stem cell assay	Not Applicable	No rescue ES cell lethality	{PMID22678057:Biswas et al. (2012)}		BRCA2_00450		Not applicable	in vitro	1						1021	2634	0	75	9	0025_0009371_0000000	10	4	2/19/14 21:36	4	2/19/14 22:26	4	2/19/14 21:36		
25	9602	3125	T to A	Leu to His	L3125H	c.9374T>A	p.Leu3125His	Protein likelihood ratio model	Not Applicable	Predicted deleterious	{PMID19043619:Karchin et al. (2008)}		BRCA2_00451		cloned	in vitro	1						862	2317	0	95	9	0025_0009374_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9604	3126	C to T	Gln to Stop	Q3126X	c.9376C>T	p.Gln3126X	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00452		cloned	in vitro	1						863	2318	0	95	9	0025_0009376_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9608	3127	G to A	Trp to Stop	W3127X	c.9380G>A	p.Trp3127X	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00453		cloned	in vitro	1						864	2319	0	95	9	0025_0009380_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9613	3129	C to G	Pro to Ala	P3129A	c.9385C>G	p.Pro3129Ala	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00454		cloned	in vitro	1						865	2320	0	15	9	0025_0009385_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9629	3134	G to T	Gly to Val	G3134V	c.9401G>T	p.Gly3134Val	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00455		cloned	in vitro	1						866	2321	0	15	9	0025_0009401_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9642	3138	A to G	Leu to Leu	9642A/G (L3138L)	c.9414A>G	p.Leu3138Leu	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00456		cloned	in vitro	1						867	2322	0	15	9	0025_0009414_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9653	3142	A to G	Asp to Gly	D3142G	c.9425A>G	p.Asp3142Gly	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00457		cloned	in vitro	1						868	2323	0	15	9	0025_0009425_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9677	3150	C to T	Pro to Leu	P3150L	c.9449C>T	p.Pro3150Leu	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00458		cloned	in vitro	1						869	2324	0	55	9	0025_0009449_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9677	3150	C to T	Pro to Leu	P3150L	c.9449C>T	p.Pro3150Leu	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00458		cloned	in vitro	1						870	2325	0	95	9	0025_0009449_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9682	3152	G to A	Glu to Lys	E3152K	c.9454G>A	p.Glu3152Lys	Co-localization to predicted ESEs	Not Applicable	Predicted deleterious	{PMID17899372:Pettigrew et al. (2007)}		BRCA2_00459		cloned	in vitro	1						871	2326	0	95	9	0025_0009454_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9682	3152	G to A	Glu to Lys	E3152K	c.9454G>A	p.Glu3152Lys	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00459		cloned	in vitro	1						872	2327	0	15	9	0025_0009454_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9683	3152	A to G	Glu to Gly	E3152G	c.9455A>G	p.Glu3152Gly	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00460		cloned	in vitro	1						873	2328	0	15	9	0025_0009455_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9686	3153	G to C	Gly to Ala	G3153A	c.9458G>C	p.Gly3153Ala	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00461		cloned	in vitro	1						874	2329	0	15	9	0025_0009458_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9705	3159	C to A	Phe to Leu	F3159L	c.9477C>A	p.Phe3159Leu	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00462		cloned	in vitro	1						875	2330	0	15	9	0025_0009477_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9728	3167	A to C	Glu to Ala	E3167A	c.9500A>C	p.Glu3167Ala	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00463		cloned	in vitro	1						876	2331	0	15	9	0025_0009500_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9501		A to T	-	c.9501+3A>T	c.9501+3A>T	?	mRNA analysis and splicing reporter minigene	Not Applicable	Inconclusive	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00437		cloned	in vitro	1						838	2293	0	55	9	0025_0009501_0000003	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9729	NA	A to G	Not applicable	c.9501+4A>G	c.9501+4A>G	?	splicing reporter minigene/patient RNA analysis	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00544		cloned	in vitro	1						1016	2592	0	55	9	0025_0009501_0000004	0	4	2/19/14 14:34	4	2/19/14 22:26	4	2/19/14 14:34		
25	9729		+9 A to C	-	IVS25+9A>C	c.9501+9A>C	?	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00464		cloned	in vitro	1						877	2332	0	55	9	0025_0009501_0000009	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9729		+9 A to C	-	IVS25+9A>C	c.9501+9A>C	?	cDNA analysis	Not Applicable	Predicted neutral	{PMID12955719:Campos et al. (2003)}		BRCA2_00464		cloned	in vitro	1						878	2333	0	15	9	0025_0009501_0000009	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9729		+9 A to C	-	IVS25+9A>C	c.9501+9A>C	?	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00464		cloned	in vitro	1						879	2334	0	15	9	0025_0009501_0000009	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9729		+9 A to C	-	IVS25+9A>C	c.9501+9A>C	?	mRNA analysis (RT-PCR)	Not Applicable	As wildtype control	{PMID12759930:Claes et al. (2003)}		BRCA2_00464		cloned	in vitro	1						880	2335	0	15	9	0025_0009501_0000009	1	0	10/3/09 17:15			0	10/3/09 17:15		
25	9729	NA	A to C	Not applicable	c.9501+9A>C	c.9501+9A>C	?	exon inclusion	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00464		cloned	in vitro	1						1017	2593	0	55	9	0025_0009501_0000009	0	4	2/19/14 14:34	4	2/19/14 22:27	4	2/19/14 14:34		
26	9730		-71 G to T	-	IVS25-71G/T	c.9502-71G>T	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00466		cloned	in vitro	1						882	2337	0	15	9	0026_0009502_-999929	1	0	10/3/09 17:15			0	10/3/09 17:15		
26	9737	3170	A to G	Asp to Gly	D3170G	c.9509A>G	p.Asp3170Gly	Protein likelihood ratio model	Not Applicable	Inconclusive	{PMID19043619:Karchin et al. (2008)}		BRCA2_00467		cloned	in vitro	1						883	2338	0	55	9	0026_0009509_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
26	9737	3170	A to G	Asp to Gly	D3170G	c.9509A>G	p.Asp3170Gly	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00467		cloned	in vitro	1						884	2339	0	15	9	0026_0009509_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
26	9770	3181	T to G	Met to Arg	M3181R	c.9542T>G	p.Met3181Arg	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00468		cloned	in vitro	1						885	2340	0	15	9	0026_0009542_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
26	9780	3184	G to C	Leu to Leu	c.9552G>C	c.9552G>C	p.=	splicing reporter minigene	not applicable	No splicing defect	{PMID21673748:ThM-^Nry et al. (2011)}		BRCA2_00537		cloned	in vitro	1						1008	2584	0	55	9	0026_0009552_0000000	0	4	2/19/14 14:34	4	2/19/14 22:27	4	2/19/14 14:34		
26	9790	3188	G to A	Asp to Asn	D3188N	c.9562G>A	p.Asp3188Asn	Protein likelihood ratio model	Not Applicable	Predicted neutral	{PMID19043619:Karchin et al. (2008)}		BRCA2_00469		cloned	in vitro	1						886	2341	0	15	9	0026_0009562_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
26	9820	3198	T to C	Cys to Arg	C3198R	c.9592T>C	p.Cys3198Arg	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00470		cloned	in vitro	1						887	2342	0	15	9	0026_0009592_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
26	9860	3211	C to A	Thr to Lys	T3211K	c.9632C>A	p.Thr3211Lys	Histopathology	Not Applicable	Predicted neutral	{PMID18824701:Spearman et al. (2008)}		BRCA2_00471		cloned	in vitro	1						888	2343	0	15	9	0026_0009632_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
26	9876		+54 G to A	-	IVS26+54G/A	c.9648+54G>A	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00473		cloned	in vitro	1						890	2345	0	15	9	0026_0009648_0000054	1	0	10/3/09 17:15			0	10/3/09 17:15		
26	9876		+84 G to A	-	IVS26+84G/A	c.9648+84G>A	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00474		cloned	in vitro	1						891	2346	0	15	9	0026_0009648_0000084	1	0	10/3/09 17:15			0	10/3/09 17:15		
26	9648		delT	-	c.9648+106delT	c.9648+106delT	?	mRNA analysis and splicing reporter minigene	Not Applicable	Predicted neutral	{PMID18424508:Bonnet et al. (2008)}		BRCA2_00465		cloned	in vitro	1						881	2336	0	15	9	0026_0009648_0000106	1	0	10/3/09 17:15			0	10/3/09 17:15		
26	9876		+106 del T	-	IVS26+106delT	c.9648+106delT	?	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00465		cloned	in vitro	1						889	2344	0	15	9	0026_0009648_0000106	1	0	10/3/09 17:15	2	2/2/14 10:24	0	10/3/09 17:15		
27	9877		-20 C to T	-	IVS26-20C/T	c.9649-20C>T	?	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00475		cloned	in vitro	1						892	2347	0	15	9	0027_0009649_-999980	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	9998	3257	A to G	Lys to Arg	K3257R	c.9770A>G	p.Lys3257Arg	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00476		cloned	in vitro	1						893	2348	0	15	9	0027_0009770_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10056	3276	A to T	Arg to Ser	R3276S	c.9828A>T	p.Arg3276Ser	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00477		cloned	in vitro	1						894	2349	0	15	9	0027_0009828_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10152	3308	C to G	Tyr to Stop	Y3308X	c.9924C>G	p.Tyr3308X	Homology-directed repair assay	Not Applicable	As mutant control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00479		cloned	in vitro	1						896	2351	0	55	9	0027_0009924_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10152	3308	C to G	Tyr to Stop	Y3308X	c.9924C>G	p.Tyr3308X	Nuclear foci formation	BRCA2/BRC3 domain - Rad51	As mutant control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00479		cloned	in vitro	1						897	2352	0	55	9	0027_0009924_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10152	3308	C to G	Tyr to Stop	Y3308X	c.9924C>G	p.Tyr3308X	Cell viability (in BRCA-/- cells)	Not Applicable	Inconclusive	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00479		cloned	in vitro	1						898	2353	0	55	9	0027_0009924_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10152	3308	C to T	Tyr to Tyr	10152C/T (Y3308Y)	c.9924C>T	p.Tyr3308Tyr	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00478		cloned	in vitro	1						895	2350	0	15	9	0027_0009924_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10153	3309	G to T	Glu to Stop	E3309X	c.9925G>T	p.Glu3309X	Cell viability (in BRCA-/- cells)	Not Applicable	Inconclusive	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00480		cloned	in vitro	1						899	2354	0	55	9	0027_0009925_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	10204A/T (K3326X)	c.9976A>T	p.Lys3326X	Co-occurrence with deleterious mutation	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00481		cloned	in vitro	1						900	2355	0	15	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	10204A/T (K3326X)	c.9976A>T	p.Lys3326X	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00481		cloned	in vitro	1						901	2356	0	55	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	10204A/T (K3326X)	c.9976A>T	p.Lys3326X	Centrosome amplification	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00481		cloned	in vitro	1						902	2357	0	15	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	10204A/T (K3326X)	c.9976A>T	p.Lys3326X	Homology-directed repair assay	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00481		cloned	in vitro	1						903	2358	0	15	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	10204A/T (K3326X)	c.9976A>T	p.Lys3326X	Survival assay with VC8 (after MMC treatment)	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00481		cloned	in vitro	1						904	2359	0	15	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	10204A/T (K3326X)	c.9976A>T	p.Lys3326X	Nuclear localisation	Not Applicable	As wildtype control	{PMID15695382:Wu et al. (2005)}		BRCA2_00481		cloned	in vitro	1						905	2360	0	15	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	10204A/T (K3326X)	c.9976A>T	p.Lys3326X	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00481		cloned	in vitro	1						906	2361	0	15	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	10204A/T (K3326X)	c.9976A>T	p.Lys3326X	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID08896551:Mazoyer et al. (1996)}		BRCA2_00481		cloned	in vitro	1						907	2362	0	15	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	10204A/T (K3326X)	c.9976A>T	p.Lys3326X	Evolutionary conservation analysis	Not Applicable	Predicted neutral	{PMID15695382:Wu et al. (2005)}		BRCA2_00481		cloned	in vitro	1						908	2363	0	15	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	K3326X	c.9976A>T	p.Lys3326X	?	?	?	{PMID17341484:Johnson et al. (2007)}		BRCA2_00481		cloned	in vitro	1						909	2364	0	55	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	K3326X	c.9976A>T	p.Lys3326X	?	?	?	{PMID15695382:Wu et al. (2005)}		BRCA2_00481		cloned	in vitro	1						910	2365	0	55	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	K3326X	c.9976A>T	p.Lys3326X	?	?	?	{PMID15876480:Salazar et al. (2006)}		BRCA2_00481		cloned	in vitro	1						911	2366	0	55	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	K3326X	c.9976A>T	p.Lys3326X	?	?	?	{PMID18451181:Farrugia et al. (2008)}		BRCA2_00481		cloned	in vitro	1						912	2367	0	55	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	K3326X	c.9976A>T	p.Lys3326X	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00481		cloned	in vitro	1						913	2368	0	55	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	K3326X	c.9976A>T	p.Lys3326X	?	?	?	{PMID12552570:Hadjisavvas et al.(2003)}		BRCA2_00481		cloned	in vitro	1						914	2369	0	55	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10204	3326	A to T	Lys to Stop	K3326X	c.9976A>T	p.Lys3326X	Cell viability (in BRCA-/- cells)	Not Applicable	As wildtype control	{PMID18607349:Kuznetsov et al (2008)}		BRCA2_00481		cloned	in vitro	1						915	2370	0	15	9	0027_0009976_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10348	3349	A to G	Thr to Ala	T3349A	c.10045A>G	p.Thr3349Ala	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00549		cloned	in vitro	1						919	2374	0	55	9	0027_0010045_0000000	1	0	10/3/09 17:15	4	3/30/15 8:45	0	10/3/09 17:15		
27	10348	3349	A to G	Thr to Ala	T3349A	c.10045A>G	p.Thr3349Ala	Multifactorial likelihood-ratio model	Not Applicable	Predicted neutral	{PMID17924331:Easton et al. (2007)}		BRCA2_00549		cloned	in vitro	1						920	2375	0	15	9	0027_0010045_0000000	1	0	10/3/09 17:15	4	3/30/15 8:46	0	10/3/09 17:15		
27	10319	3364	del CT	Stop3366	10319delCT	c.10091_10092del	p.Ser3364CysfsX3	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00482		cloned	in vitro	1						916	2371	0	15	9	0027_0010091_0000000_0010092_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10338	3370	G to A	Arg to Arg	10338G/A (R3370R)	c.10110G>A	p.Arg3370Arg	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00483		cloned	in vitro	1						917	2372	0	55	9	0027_0010110_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10338	3370	G to A	Arg to Arg	R3370R	c.10110G>A	p.Arg3370Arg	?	?	?	{PMID12955716:Diez et al. (2003)}		BRCA2_00483		cloned	in vitro	1						918	2373	0	55	9	0027_0010110_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10462	3412	A to G	Ile to Val	I3412V	c.10234A>G	p.Ile3412Val	?	?	?	{PMID15317758:Freedman et al (2004)}		BRCA2_00485		cloned	in vitro	1						921	2376	0	55	9	0027_0010234_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10462	3412	A to G	Ile to Val	I3412V	c.10234A>G	p.Ile3412Val	?	?	?	{PMID17341484:Johnson et al. (2007)}		BRCA2_00485		cloned	in vitro	1						922	2377	0	55	9	0027_0010234_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10462	3412	A to G	Ile to Val	I3412V	c.10234A>G	p.Ile3412Val	Prevalence in normal controls	Not Applicable	Predicted neutral	{PMID09971877:Wagner et al. (1999)}		BRCA2_00485		cloned	in vitro	1						923	2378	0	15	9	0027_0010234_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
27	10462	3412	A to G	Ile to Val	I3412V	c.10234A>G	p.Ile3412Val	?	?	?	{PMID11389159:Bergthorsson et al. (2001)}		BRCA2_00485		cloned	in vitro	1						924	2379	0	55	9	0027_0010234_0000000	1	0	10/3/09 17:15			0	10/3/09 17:15		
